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Abstract 
This thesis describes the further development of a borate ester, B(OCH2CF3)3, as a 
reagent for amidation with a focus on carboxylic acids, including N-protected amino 
acids, and on the amidation of unprotected amino acids. In addition, a novel 
methodology for the determination of enantiomeric ratio in chiral amines is reported. 
 
The B(OCH2CF3)3-mediated direct amidation of carboxylic acids furnishes the amide 
product in generally excellent yield (A). A formylation method using DMF as the 
formyl donor was also developed (B).  The B(OCH2CF3)3-mediated amidation method 
allows the amidation of α-chiral acids (for example, N-protected amino acids) in good 
yield with excellent retention of enantiopurity (C). Importantly, a solid-phase work-up 
procedure was developed which enables the purification of all of these amide products 
without the need for column chromatography or aqueous work-up. The application of 
B(OCH2CF3)3 to the amidation of unprotected amino acids is described (D). This covers 
an optimisation study and an investigation into the scope of the reaction. As a result of 
this study a new method for the determination of enantiomeric purity of chiral amines 
was developed. Using an aldehyde derived from lactic acid the enantiopurity of chiral 
amines can be determined by NMR, circumventing the need for chiral HPLC. 
 
Additionally, a mechanistic study of the direct amidation reaction is discussed. A 
reaction intermediate as well as a tentative mechanism are proposed based on the results 
of this mechanistic study and preliminary experimental evidence.  
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1. Introduction  
The amide bond is incredibly important in organic chemistry, particularly in 
pharmaceutical chemistry, as it is present in over 25% of top-selling drugs.1 The moiety 
is found in natural products such as vitamin B5 1 and β-lactam antibiotics, penicillin 2 
and cephalexin 3 as well as drugs such as lidocaine 4 and paracetamol 5 (Figure 1). As a 
result amidation reactions are amongst the most commonly used reactions in medicinal 
and pharmaceutical chemistry. In fact, representatives of GSK, AstraZeneca and Pfizer 
carried out a small survey of 128 drug candidate molecules, from this survey set they 
found that around 10% of the reactions used in their synthesis involved an amidation 
reaction (N-acylation or amino protection).2 A more recent survey of the literature from 
GSK, AstraZeneca and Pfizer of 3566 medicinal compounds found that amidations 
accounted for 16% of all reaction carried out in the synthesis of these compounds.3 The 
amide bond was found in over half of these molecules. Even though there is increasing 
interest directed towards the development of new amidation methods, many of the 
methods currently used for the synthesis of the amide bond tend to have large quantities 
of potentially hazardous by-products that can result in purification difficulties as well as 
more serious environmental impacts. 
 
Figure 1 Structure of a selection of amide containing natural products and drugs 
In 2005, the ACS Green Chemistry Institute (ACS GCI) alongside several large 
pharmaceutical companies set up the ACS GCI Pharmaceutical Roundtable to develop 
the use of green chemistry in the pharmaceutical industry (and in academic research as 
an extension).4 The result of this Roundtable was a list of reactions that required 
improved reagents as a matter of urgency, as well as a list of reactions that are desirable 
for use in industry but require further development, and a list of improvements to the 
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use of solvents and the way they are used. Following a vote by representatives of the 
pharmaceutical companies involved ‘Amide formation avoiding poor atom economy 
reagents’ came top of the list for reactions that companies would strongly prefer better 
reagents for (Table 1).  
Table 1 Reactions in use for which better reagents are required 
Research area Number of votes 
Amide formation avoiding poor atom economy reagents 6 
OH activation for nucleophilic substitution 5 
Reduction of amides without hydride reagents 4 
Oxidation/epoxidation methods without the use of chlorinated 
solvents 
4 
Safer and more environmentally friendly Mitsunobu reactions 3 
 
As a consequence, these industrially important reactions have driven many 
advancements in amidation, which have been reported in recent years and highlighted 
by the pharmaceutical industry.5 As there is such focus on developing these amidation 
reactions to have a lower environmental impact, i.e. reducing waste by-products and 
solvents used, there have been several articles from the pharmaceutical industry that 
evaluate these ‘green’ goals.6 
There are numerous reviews on methods of amidation with a focus on traditional 
methods of amide bond formation,7-8 metal-catalysed amide bond formation,9-10 and 
new catalytic methodology,11 as well as native peptide ligation strategies,12 and 
ribosomal protein synthesis.13 Given the incredibly vast area of the literature that is 
devoted to the synthesis of amide bonds and the development of reagents and catalysts 
for amidation, this introductory review will focus on more recent advances in the area as 
well as a more general overview of the development of boron based reagents and 
catalysts for amidation.14 
By far the most widely used method for activation of carboxylic acids for amidation is 
as an acid chloride 6 by, for example, thionyl chloride.2,15 The first reports of this 
method were in the 1880s by Schotten16 and Baumann.17 The acid chloride formation is 
generally performed in situ, although the acid chloride can be isolated in some cases, 
and then reacted with amine in the presence of a base (Scheme 1). While this can be an 
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efficient route to amides, the main problem associated with acid chlorides is 
racemisation of α-chiral acids via ketene 7 formation (Scheme 2). 
 
Scheme 1 Amidation by formation of an acid chloride 
 
Scheme 2 Racemisation by ketene 7 formation from acid chloride 6 
Coupling reagents such as carbodiimides are widely used in the synthesis of amides.2 
Examples of these carbodiimides include dicyclohexylcarbodiimide (DCC, 8) and 
diisopropyl carbodiimide (DIC, 9) (Figure 2).7 This proceeds via an O-acylurea 12 
formed by reaction of carboxylic acid and DIC, 12 can then react by a number of routes 
(Scheme 3). Firstly, formation of the amide by reaction of 12 with amine, or formation 
of an unreactive N-acylurea by-product 13. Finally, formation of the acid anhydride 14 
by reaction of another molecule of acid with 12, which is not detrimental to the reaction 
as this anhydride 14 can react with the amine to form the amide product.  
 
Figure 2 Examples of carbodiimide reagents and HOBt 
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Scheme 3 DIC-mediated amidation 
Epimerisation can be a problem in carbodiimide-mediated amidations via oxazolone 
formation from 12. In order to reduce epimerisation these carbodiimides are generally 
used in conjunction with an additive, e.g. N-hydroxybenzotriazole (HOBt, 10) which is 
thought to increase the reactivity of the active ester 16 through hydrogen bonding to the 
amine (Scheme 4). However, these benzotriazoles must be handled with care as they 
can be shock-sensitive as well as sensitive to heat and pressure.18 The main issue with 
the use of carbodiimides is the urea by-product 15 formed during the reaction that can 
impede purification of the amide product as it is difficult to remove. However, 
improvements in the purification of carbodiimide-mediated amidation have been made 
with the synthesis of water-soluble bis[[4-(2,2-dimethyl-l,3-
dioxolyl)]methyl]carbodiimide (BDDC, 11) which can be more easily removed.19 
 
Scheme 4 HOBt additive in carbodiimide-mediated amidation 
In addition, active ester formation by iso-butylchloroformate 17, for example, is classed 
as a ‘green’ reaction.15 This can activate the carboxylic acid as a mixed anhydride 18, in 
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the presence of a base to sequester the HCl generated, which can then react with an 
amine to give the amide product (Scheme 5). 
 
Scheme 5 iso-Butylchloroformate active ester formation and amidation 
Carbonyldiimidazole (CDI) has also found wide use as an amidation reagent,2 including 
in the synthesis of a number of drug molecules, for example, sildenafil citrate.20 The 
active acylating agent is an N-acylimidazole 19 which can react with the amine (Scheme 
6). Although the by-products of CDI-mediated amidation are relatively innocuous – 
imidazole and CO2 – the synthesis of CDI is not ideal as it is formed from phosgene and 
imidazole. 
 
Scheme 6 CDI-mediated amidation 
Despite their prevalence, these routes to the amide bond are not ideal as they can 
generate hazardous and corrosive by-products, which can result in purification as a well 
as environmental issues. As a result there is still a considerable effort from the research 
community in the development of new amidation methods. With these issues in mind it 
is clear that a widely applicable amidation reagent or catalyst is still required. 
1.1.  Recent developments in amide bond formation 
The thermal synthesis of amides is obviously a very desirable route as this would 
provide a direct route to amides without the need for any coupling reagents or catalysts 
(i.e. minimising waste by-products). However, the formation of an amide by the 
reaction of a carboxylic acid and an amine with the expulsion of a molecule of water is 
not necessarily as simple as it would appear in theory (Scheme 7). Traditionally, the 
synthesis of amides from the thermal reaction of an amine and a carboxylic acid had 
been thought to be an unviable approach due to the favourable formation of an 
ammonium carboxylate salt 20 that will not undergo condensation to form an amide 
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(Scheme 8). However, this is not necessarily the case as the ammonium carboxylate salt 
formation is dependent on the reaction conditions (i.e. solvent) and the reactants 
employed. A thermal synthesis of amides has previously been reported that required 
high temperatures to proceed with the requisite elimination of water from the 
ammonium carboxylate salt that can form in the absence of solvent.21 Under these 
conditions, the reaction can be carried out neat, only heating the amine and acid mixture 
in an open flask. This method is not ideal as these are obviously harsh conditions and 
require the reactants to be non-volatile and thermally stable at high temperatures.  
 
Scheme 7 Simplified amidation reaction 
 
Scheme 8 Ammonium carboxylate salt formation 
A computational and experimental study carried out by Whiting et al., in 2011, has 
provided some insight into the mechanism of the thermal amidation reaction.22 The 
activated carboxylic acid species was proposed as a hydrogen bonded carboxylic acid 
dimer 21 which can then be attacked by the amine along with a concerted proton 
transfer in transition state 22 which can then undergo the requisite elimination of water 
to form the amide product (Scheme 9). The ammonium carboxylate salt formation can 
still occur, especially with strong acids as well as in the presence of excess acid or 
amine. Active water removal is required to ensure the stability of the dimer 21, if any 
water generated in the reaction is not removed from the reaction mixture then the 
hydrogen bonds of dimer 21 are broken, deactivating this species. The acidity of the 
carboxylic acid strongly influences the reactivity of the acid under these conditions with 
acids with lower pKas being unreactive. This is thought to be due to the increased 
ammonium carboxylate salt formation from stronger acids. The effect of the amine 
partner, on the other hand, is not quite as clear cut and appears to be the result of a 
combination of electronic and steric effects.  
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Scheme 9 Proposed mechanism of thermal amidation 
This potential reagent and catalyst free thermal amidation was recently exploited by 
Gooßen et al. in 2009.23 They showed that the direct thermal condensation of carboxylic 
acids and amines to furnish amides can achieved at 160 °C. This route requires neat 
conditions as well as 3Å molecular sieves (MS) to remove the water generated in the 
reaction (Scheme 3). Initially the reaction was carried out at 120 °C and during 
optimisation of this method it was observed that MS did not have a noticeable effect on 
the yield of the reaction, in fact, the reaction yield was the same in the absence of MS 
(Table 2, entries 1 and 2). The reaction yield could be improved, however, by increasing 
the reaction temperature to 160 °C but the same effect with MS was observed (Table 2, 
entries 3 and 4). To prevent any pressure build up in the reaction flask MS were used to 
remove the water by-product from the reaction. The explored scope of this reaction is 
somewhat limited, however, alcohols and phenols were tolerated (Scheme 10).  
Table 2 Comparison of temperature and the use of MS in thermal amidation 
Entry MS Temperature (°C) Yield (%) 
1 Yes 120 49 
2 No 120 49 
3 Yes 160 89 
4 No 160 95 
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Scheme 10 Direct thermal amidation examples 
Recently, in 2012, the Williams group published on the direct amide formation from 
amines and carboxylic acids using toluene as the reaction solvent.24 Due to the non-
polar nature of toluene, ammonium carboxylate salt formation is disfavoured allowing 
direct attack of the amine on the carboxylic acid. This method also requires high 
temperatures although the reaction is carried out at a lower temperature than the Gooßen 
procedure (110 °C) and does not require water removal (MS, Dean-Stark, etc.) but 
anhydrous reaction conditions are used. This procedure has a broad substrate scope and 
a wide functional group tolerance (Scheme 11). Enantiopure α-chiral acids are tolerated 
under the reaction conditions with no observable racemisation. Less reactive substrates, 
such as anilines and benzoic acids, gave lower yields under the standard conditions, 
however, these could be improved by using refluxing xylenes as the solvent (150 °C) or 
by the addition of a zirconium catalyst (ZrCl4 or Cp2ZrCl2). 
 
Scheme 11 Direct thermal and Zr catalysed amidation in toluene 
At the same time as the report by Williams et al., Adolfsson et al. also reported the 
ZrCl4-catalysed direct amidation.
25 This report required active water removal through 
the use of 4 Å MS but the reaction could be carried out at the lower temperature of 70 
°C, although the less active acids, such as benzoic acids, and amines, such as secondary 
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amines, required a higher reaction temperature (100 °C). A range of aliphatic, aromatic 
and heteroaromatic acids and amines were tolerated under the reaction conditions in 
generally good yield (Scheme 12). α-Chiral acids underwent amidation without any 
observable racemisation. The reaction is amenable to scale-up as a large scale synthesis 
can be carried out without a detrimental effect on the yield (>5g). 
 
Scheme 12 ZrCl4-catalysed amidation examples 
The Zr-catalysed amidation has been proposed to activate the carboxylic acid in a 
number of different ways (Scheme 13).25 In an analogous fashion to the dimer 21 
proposed by Whiting for thermal amidation, Zr may act as a Lewis acid to activate the 
carbonyl of the dimer 23 or alternatively the carboxylic acid monomer (Scheme 13a).22 
Alternatively, Zr can activate the carboxylic acid carbonyl as a Lewis acid in addition to 
activation of the leaving group by hydrogen bonding (Scheme 13b). Activation of the 
leaving group by Zr provides the final possible mode of activation (Scheme 13c). 
 
Scheme 13 Possible mechanisms of activation in Zr-catalysed amidation 
Soon after, Adolfsson et al. also reported the use of Ti(OiPr)4 as a catalyst for the direct 
amidation of carboxylic acids using similar reaction conditions to that reported for 
ZrCl4.
26 Aliphatic, (hetero)aromatic and unsaturated acids undergo amidation with both 
primary and secondary amines (Scheme 14). The amidation of three α-chiral acids is 
reported, while no racemisation is observed for the amidation of Boc-ʟ-proline or Boc-
ʟ-alanine, some racemisation was observed in the case of (S)-ibuprofen (83% ee). Due 
to the Lewis acidity of Ti(OiPr)4, this catalyst can presumably activate carboxylic acids 
to amidation in a similar fashion to that reported for ZrCl4 (Scheme 13). 
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Scheme 14 Ti(OiPr)4-catalysed amidation examples 
Additionally, during the reaction optimisation, several other transition-metal salts were 
found to catalyse the amidation reactions (Table 3).26 Due to the low price and 
commercial availability of Ti(OiPr)4, this was deemed the most suitable catalyst for 
further study. 
Table 3 Catalyst screen for transition metal-catalysed amidation of phenylacetic acid 
with benzylamine 
Catalyst Amide yield (%) 
Ti(OiPr)4 91 
Ti(OBu)4 89 
ZrCl4 >99 
Zr(OEt)4 93 
Zr(OtBu)4 93 
Hf(OtBu)4 89 
Nb(OEt)5 88 
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Li et al. (2012) have reported that AlMe3 can mediate amidation reactions although 
stoichiometric quantities are required.27 In addition, dry reaction conditions are required 
as well as a three-fold excess of the amine and AlMe3. Preformation of the 
dimethylaluminium amide 24 is required before reaction with the carboxylic acid 
(Scheme 15). 
 
Scheme 15 AlMe3-mediated amidation mechanism 
A range of examples were reported, however, the method displays limited functional 
group tolerance as ester, nitro and cyano groups are not stable under the reaction 
conditions. Aliphatic and aromatic as well as secondary amines provide the 
corresponding amides in good to excellent yield when coupled with aromatic and 
aliphatic acids (Scheme 16). More sterically encumbered examples, such as those 
derived from tert-butylamine are also reported. Excellent retention of enantiopurity was 
observed in the amidation of (R)-2-phenylpropanoic acid (100% ee), however, the low 
basicity of pentafluoroaniline may contribute to this observation. Again, considering the 
high temperatures and the solvent (toluene), the background reaction may be significant, 
however, it is not reported.24 
 
Scheme 16 Examples of AlMe3-mediated amidation 
In 2009, Clark et al. reported on the use of ‘off-the-shelf’ Kieselgel 60 (K60) silica as 
an efficient catalyst for amidation following activation at 700 °C.28 This method does 
not require active water removal or an inert atmosphere, in fact, it tolerates addition of 
water into the toluene solvent. The catalyst can be removed by filtration and reused up 
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to four times following reactivation at 700 °C. The functional group tolerance was not 
explored, however, a range of aliphatic and aromatic acids and amines were investigated 
(Scheme 17). For less reactive substrates higher catalyst loadings are required (50 
mol%). They also demonstrate the applicability of this catalyst in flow. 
 
Scheme 17 K60 silica-catalysed amidation examples 
Komura et al. (2011) describe the use of mesoporous silica MCM-41 as a catalyst for 
the amidation of fatty acids by long chain amines.29 MCM-41 is composed of 
amorphous silica with a mesoporous framework that is utilised widely as a catalyst. In 
their search for a catalyst that is suitable for long-chain aliphatic acids and amines 
MCM-41 was identified as a suitable candidate as it displayed high catalytic activity in 
a catalyst screen. MCM-41 catalyses the amidation at relatively high catalyst loadings 
(20 wt%) at azeotropic reflux in toluene (Scheme 18). In addition to the long-chain 
aliphatic amines MCM-41 also displays activity with smaller aliphatic and aromatic 
amines but is not active with bulky amines such as tert-butylamine. There is a 
significant background reaction in some cases as can be expected due to the high 
temperatures involved in the reaction (see thermal amidation, vide supra). 
 
Scheme 18 MCM-41 catalysed amidation of fatty acids. aThermal amidation in the 
absence of MCM-41. 
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Flow chemistry has very recently (2014) been applied to the synthesis of dipeptides by 
Fuse et al.30 Using triphosgene as the carboxylic acid activating agent (residence time 
0.5 s) and then reacting this active species with an amine (residence time 4.3 s) in flow 
resulted in excellent yields of the dipeptides and very low levels of epimerisation as 
compared to the batch reactions. Boc and Fmoc protecting groups are untouched under 
these conditions. 
1-tert-Butoxy-2-tert-butoxycarbonyl-1,2-dihydroisoquinoline 25 (BBDI) has been 
described as a novel coupling reagent which can mediate amidation reactions effectively 
at room temperature.31 The carboxylic acid is activated as a mixed anhydride by 
reaction with BBDI. The large isoquinoline is produced as a by-product in the formation 
of the mixed anhydride as well as tert-butanol and CO2 so in terms of atom-economy 
this procedure is not ideal (Scheme 19). An excess of both BBDI and the amine are 
required for this reaction to proceed in good yield.  
 
Scheme 19 BBDI-mediated amidation 
Aliphatic amines, anilines and secondary amines could be coupled with aliphatic, 
benzoic, heteroaromatic and unsaturated acids effectively under the reaction conditions 
(Scheme 20). More sterically hindered acids and amines resulted in lower yields but 
these could be improved by increasing the reaction temperature from rt to reflux. The 
amidation of protected amino acids was explored, although enantiopurities were not 
reported for all examples, low levels of racemisation were observed for some of these α-
chiral acids.  
 
Scheme 20 Examples of BBDI-mediated amidation. aReaction time of 5 h. 
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1.2.  Boron in amide bond formation 
1.2.1.  Stoichiometric boron amidation reagents 
One of the first examples of a stoichiometric boron-based amidation reagent was 
reported by Pelter et al. in 1965.32 Formation of the ionic species 26, followed by attack 
of the carboxylic acid to form bisdialkylaminoacyloxyboron species 27, was postulated 
as the reaction mechanism. This intermediate 27 can then react with liberated molecule 
of amine to yield the amide product (Scheme 21). The amine investigated in this case 
was pyrrolidine in tripyrrolidinylborane, which acts as the amidation reagent as well as 
the amine donor. A small selection of examples are reported (aromatic and aliphatic 
carboxylic acids) with good yields. Only one of the three amine groups is involved in 
the amidation as using 1/3 equivalent only gives 1/3 of the yield. Carboxylic acids with 
lower reactivity (benzoic and pivalic acid) require reflux in benzene while phenylacetic 
acid and hexanoic acid react at room temperature. 
 
Scheme 21 Trisdialkylaminoborane mediated amidation 
Soon after, in 1966, Pelter et al. also described the use of trismonoalkylaminoboranes to 
form secondary amides in a similar fashion to that described for 
trisdialkylaminoboranes (Scheme 22).33 Again, these reactions proceed in good yield in 
refluxing benzene, however, limited scope was explored. 
 
Scheme 22 Trismonoalkylaminoborane mediated amidation 
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In 1970, Pelter et al. then described the use of trimethylborate alongside a catalytic 
amount of p-toluenesulfonic acid as an amidation reagent.34 One example is reported, 
formation of N-butylhexanamide, which proceeds in good yield at 65 °C with a seven-
fold excess of B(OMe)3 (78%). The utility of B(OMe)3 was not explored further as the 
conditions did not prove suitable for the peptide synthesis they wished to carry out. 
 
Scheme 23 Formation of N-butylhexanamide mediated by B(OMe)3 
Inoue et al. reported the first use of boron trifluoride etherate as a reagent for amidation, 
in 1975.35 This procedure requires an inert solvent, such as toluene or benzene, under 
azeotropic reflux conditions as well as an excess of amine and BF3·Et2O and long 
reaction times (Scheme 24).  
 
Scheme 24 BF3·Et2O-mediated amidation examples 
They observed that aliphatic primary amines react in refluxing benzene but aniline 
derivatives and aliphatic secondary amines do not. As these unreactive amines reacted 
in refluxing toluene the choice of solvent allowed for amidation of amino-substituted 
benzoic acids without protection of the amine group. Again, there is likely to be a 
significant background reaction in some cases (vide supra).24 The substrate scope 
investigated is rather limited. The acid partner is generally benzoic acid or a derivative 
(NO2, NH2 or Cl) with only one aliphatic and one unsaturated example. And the amine 
component is generally aliphatic or aromatic with no additional functionality aside from 
a tertiary amine. 
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Catechol borane has been described as a reagent for the amidation of carboxylic acids 
with an excess of amine by Ganem et al., in 1978.36 A small sample of amines were 
coupled with nonanoic acid in good to excellent yield, although very little functionality 
was explored (Scheme 25). This method has also been applied to optically active acids 
with good retention of enantiopurity (N-benzoyl-ʟ-leucine, >98% ee). Additionally, 3-
methoxy and 4-nitrocatechol borane were both shown to act as amidation reagents. 
 
Scheme 25 Catechol borane-mediated amidation examples 
In the same paper Ganem et al. also reported a method for the lactamisation of amino 
acids using catechol borane.36 This procedure was not as efficient as the amidation 
method; lactamisation to small rings gave excellent yields but medium and large rings 
were synthesised in low yields. Some dimerisation was observed for the ω-amino acids 
that would produce large or medium rings by lactamisation (Scheme 26).  
 
Scheme 26 Catechol borane-mediated lactamisation examples 
In 1983, Trapani et al. described the use of trimethylamine borane complex as an 
amidation reagent that is effective for the formation of both secondary and tertiary 
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amides (Scheme 27).37 This reaction requires anhydrous conditions and high 
temperatures to give a range of aromatic and aliphatic amides. 
 
Scheme 27 BH3·NMe3 mediated amidation 
Huang et al., in 2007, reported on the synthesis of amides by the proposed formation of 
triacyloxyboranes 28 from the reaction of BH3·THF complex with the carboxylic acid 
(Scheme 28).38 No evidence of 28 is reported so it is possible that mono- and 
diacyloxyboranes are involved in the reaction. This acyloxyborane is then reacted with 
an excess of amine to afford amides in generally high yields. This method tolerates 
aromatic and aliphatic acids and amines as well as more sterically hindered reactants 
and secondary amines. Functional groups that are prone to reduction such as the cyano 
group are also tolerated during the reaction. Presumably a similar mechanism is at play 
for Trapani’s report of the trimethylamine borane complex (vide supra). 
 
Scheme 28 BH3·THF-mediated amidation. 
aToluene : THF (5:1 used as solvent), 
bBH3·THF (1.1 equiv.), acid (3 equiv.), amine (1 equiv.) 
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1.2.2.  Boronic acids as catalysts for amidation 
The first example of the use of a boronic acid for amidation was reported in 1959 by 
Soloway.39 This was a fortuitous discovery as reduction of 2-nitrobenzene-1,4-diboronic 
acid 29 was expected to yield 2-amino-1,4-diboronic acid 30; instead 2-
acetamidobenzene-1,4-diboronic acid monoanhydride 31 was thought to have formed 
via the mixed anhydride 32 (Scheme 29). Deboronation of this compound gave 
acetanilide which lent evidence to the proposed structure 31. This was also the case for 
the reduction of o-nitrobenzeneboronic acid 33, which also formed acetanilide 
following deboronation (Scheme 30) but not for m-nitrobenzeneboronic acid 34 which 
exclusively formed the reduced m-aminobenzeneboronic acid (Scheme 31). This 
suggests that a mixed anhydride is formed between acetic acid and the boronic acid 
which can then be attacked by the o-amino group but not the m-amino group. This 
indicated, for the first time, that boronic acids can promote the acylation of amines.   
 
 
Scheme 29 Boronic acid-mediated acylation following reduction of 2-nitrobenzene-1,4-
diboronic acid 
 
Scheme 30 Boronic acid-mediated acylation following reduction of o-
nitrobenzeneboronic acid 
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Scheme 31 Reduction of m-nitrobenzeneboronic acid to m-aminobenzeneboronic acid 
Groziak et al. later published a report, in 1994, confirming the structure of 31 by 
synthesising it from 33 as reported by Soloway, as well as reducing the nitro group in 
the absence of acetic acid then reacting the resultant o-aminobenzeneboronic acid 35 
with acetic anhydride (Scheme 32).40 Both of these routes produced 31 as proposed by 
Soloway. 
 
Scheme 32 Structure of 31 confirmed by Groziak 
The first report of the use of a boronic acid catalyst developed specifically for amidation 
was reported by Yamamoto et al. in 1996.41 3,4,5-Trifluorobenzene boronic acid 36 
showed the highest catalytic activity in the study of a small selection of boronic acids 
(Scheme 33). Trace quantities of the amide product were observed in the absence of a 
boronic acid catalyst. 
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Scheme 33 Yamamoto et al. screen of boronic acids for amidation 
Although limited examples were explored, bulky and unsaturated acids as well as 
aliphatic, aromatic and secondary amines underwent amidation catalysed by 36 
(Scheme 34). The examples reported proceed in good yield although very high 
temperatures and long reaction times are required. 36 also catalysed the lactamisation of 
amino acids in excellent yield. For some of the more reactive combinations the 
background reaction might be expected to be significant when considering the thermal 
amidations that can be achieved in toluene.24 
 
Scheme 34 Examples of 36-catalysed amidation 
Subsequently, in 2000, Yamamoto et al. successfully applied catalyst 36 to the 
polycondensation of dicarboxylic acids and diamines, although the reaction required 
very high temperatures to give good yield (300 °C), which would presumably result in a 
significant background reaction.42 
In a development of their 3,4,5-trifluorobenzeneboronic acid catalyst 36, in 2001, 
Yamamoto et al. reported the catalytic ability of a perfluoroboronic acid, 3,5-
bis(perfluorodecyl)phenylboronic acid 40, in amidation reactions.43 In the model 
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reaction, the catalyst gives excellent yield over 15 h in refluxing toluene with active 
water removal (Scheme 35). The key advantage of 40 as a catalyst is its potential for 
recyclability into a fluorous phase. The catalyst 40 can be fully recovered from the 
reaction mixture and reused in further amidations up to ten times without the need for 
purification. The catalyst 40 can either be extracted into perfluorodecalin from toluene 
and o-xylene at room temperature (1:1:1 solvent ratio) or, due to the insolubility of 40 
in toluene/o-xylene, the catalyst can be isolated by decanting the reaction mixture and 
leaving the catalyst residue in the flask for reuse. The scope of this reaction was not 
fully assessed. 
 
Scheme 35 40-catalysed amidation 
In a further advance on the recyclability of boronic acid catalysts, and the first report of 
a polystyrene-bound boronic acid catalyst in 2001, Wang et al. reported polystyrene-
bound pyridinium boronic acid 41.44 A relatively small substrate scope was explored but 
aliphatic and aromatic amines are tolerated in addition to unsaturated acids and 
secondary amines (Scheme 36). This catalyst 41 is unsuitable for the synthesis of 
dipeptides and presumably the amidation of α-chiral acids as the synthesis of Cbz-Phe-
Ala-OtBu resulted in total racemisation. 41 can be recycled without a detrimental effect 
on the yield of amide product; however, even longer reaction times are required when 
using recycled catalyst. 
 
Scheme 36 Polystyrene-bound catalyst 41 amidation examples 
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The use of N-alkyl-4-boronopyridinium salts 42 and 43 as amidation catalysts was later 
described by Yamamoto et al., in 2005 (Figure 3).45 By carrying out the reaction in a 
biphasic mixture of toluene or o-xylene with [emim][OTf] (an ionic liquid) at azeotropic 
reflux, the catalyst 42 can be recycled in the ionic liquid and used up to three times with 
no effect on the amide yield on the second and third run (Scheme 37). This procedure 
has a reasonable substrate scope with conjugated acids, α-substituted acids and benzoic 
acids as well as aliphatic amines, anilines and secondary amines all tolerated under the 
reaction conditions. 
 
Figure 3 Boronopyridinium salt catalysts 
 
Scheme 37 Examples of 42-catalysed amidation 
As an extension to this methodology to aid in the recyclability of the catalyst and 
remove the need for the use of an ionic liquid, Yamamoto et al. developed a related N-
polystyrene-bound boronic acid catalyst 43 (Figure 3).45 This displayed similar utility to 
42, although a smaller substrate scope was trialled in the amidation (Scheme 38). In this 
case the catalyst can be removed from the reaction mixture by filtration and reused up to 
three times. 
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Scheme 38 Examples of 43-catalysed amidation 
Additionally, Yamamoto et al. reported a catalyst, 4,5,6,7-tetrachlorobenzo[d]-
[1,3,2]dioxaborole 44, which can catalyse the formation of amides from more sterically 
demanding carboxylic acids in excellent yield.46 Compared with the original Yamamoto 
catalyst 36, 44 displays superior activity in the case of more sterically demanding 
carboxylic acids but lower activity for non-sterically demanding acids (Scheme 39). 
This catalyst shows excellent activity for bulky carboxylic acids including adamantane 
carboxylic acid as well as Boc-ʟ-alanine, which displays some erosion of enantiopurity. 
 
Scheme 39 Synthesis of more sterically demanding amides catalysed by 44 
The use of bifunctional catalyst, o-N,N-di-isopropylbenzylaminoboronic acid 45, as an 
amidation catalyst was explored by Whiting et al in 2008.47 This commercially 
available boronic acid can catalyse amide bond formation in refluxing fluorobenzene, or 
toluene if higher reaction temperatures are required (Scheme 40). This methodology 
made advances in boronic acid-catalysed amidation by allowing the use of a lower 
boiling azeotropic solvent, fluorobenzene; although this temperature was not suitable in 
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all cases. Generally moderate to good yields were achieved, although some 
combinations could not be improved by increasing the reaction temperature. 
 
Scheme 40 45-catalysed amidation examples 
Interestingly, Tang reported the use of cheap, commercially available boric acid as an 
amidation catalyst in 2005.48 This had previously been trialled as an amidation catalyst 
by Yamamoto et al. under similar conditions, although over shorter reaction times, in a 
catalyst screen but it was found to give very low amide yields.46 The reaction is carried 
out in toluene at azeotropic reflux for up to 20 h (Scheme 41). This method tolerates 
free hydroxyl groups and phenols and the corresponding ester product is not observed. 
Aliphatic and aromatic acids are tolerated under the reaction conditions, even in the 
presence of α-substituents. Additionally aromatic, aliphatic and secondary amines all 
undergo amidation including electron-poor anilines. 
 
Scheme 41 B(OH)3-catalysed amidation examples. 
aB(OH)3 (25 mol%). 
Bandichhor et al. have subsequently displayed the utility of B(OH)3 as an amidation 
catalyst for the synthesis of some Active Pharmaceutical Ingredients (API).49 A range of 
functionalised amides were prepared by this methodology (Scheme 42). Monoacylation 
of piperazine was possible using this methodology, although a small quantity of the 
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diacylated product was observed. This procedure results in minimal racemisation of α-
chiral acids. 
 
Scheme 42 B(OH)3-catalysed amidation of APIs 
Until 2008, the state-of-the-art boronic acid amidation catalyst required high reaction 
temperatures, generally in refluxing toluene. To improve the applicability of boronic 
acid catalysts Hall et al. identified a range of o-substituted benzeneboronic acids which 
catalysed amide bond formation at room temperature.50 The most promising of these 
was o-iodobenzeneboronic acid 46 (Scheme 43). Aromatic and aliphatic acids and 
amines, including secondary amines, are tolerated in good yield. Benzoic acids require 
increased reaction temperatures, however even at these higher temperatures 
comparatively low conversion was observed. 
 
Scheme 43 Examples of 46-catalysed amidation. a46 (20 mol%), 50 °C; b46 (20 mol%) 
Four years later, Hall et al. reported an improvement on catalyst 46 with 2-iodo-5-
methoxybenzeneboronic acid 47, the presence of an electron-donating group on the ring 
significantly improved the catalyst activity.51 This is in contrast to the previously 
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reported boronic acid catalysts which contain electron-poor aromatic rings. The 
electron-donating methoxy group is thought to improve the activity of the catalyst by 
increasing the electron density on iodine, which in turn may stabilise the transition state 
of the reaction. This methodology is suitable for the amidation of aliphatic, 
(hetero)aromatic and α-branched acids, although benzoic acids are still challenging 
substrates for this catalyst; however, some improvements compared to catalyst 46 are 
observed. Aliphatic and cyclic secondary amines are tolerated under the reaction 
conditions, but acyclic secondary amines are unreactive (Scheme 44). 
 
Scheme 44 47-catalysed amidation examples 
Additionally, Hall et al. have patented a number of boronic acid amidation catalysts, 
some of which show excellent activity at room temperature.52 Firstly, (4-iodofuran-3-
yl)boronic acid 48 has been shown to have superior activity to 47 over a 3 h reaction 
time at rt (Scheme 45). 
 
Scheme 45 Comparison of catalysts 47 and 48 in amidation 
Further boronic acids reported for the amidation of carboxylic acids include 
alkenylboronic acids (Scheme 46).52 Alkenylboronic acids containing halogen atoms 
display excellent activity in the amidation reagent (49 and 50). On the other hand, the 
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absence of a halogen atom on the alkene significantly affects the activity of the catalyst 
resulting in negligible amide formation (51). 
 
Scheme 46 Amidation catalysed by alkenylboronic acids 47 and 49-51 
The boronic acid catalyst 47 reported by Hall et al. has been derivatised as a solid 
supported catalyst 52 to further improve the ‘greenness’ of this catalyst.53 To reduce any 
impact on the electronic properties of 47 the linker was introduced on the m-methoxy 
substituent (Figure 4). 
 
Figure 4 Solid-supported derivative of boronic acid catalyst 52 
This catalyst was applied to a selection of the amide couplings reported for 47 (Scheme 
47). The high catalyst activity is limited to primary amines, which form the secondary 
amide in good to excellent yield, as a comparable yield for amidation with a cyclic 
secondary amine was not achieved. Although a thorough study of the recyclability of 
the catalyst has not yet been carried out, the same batch of catalyst was used for all 
amidations reported in the paper so it can be reused at least five times. 
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Scheme 47 Examples of 52-catalysed amidation 
A primary alkyl boronic acid catalyst for amidation of α-hydroxycarboxylic acids has 
been reported by Ishihara et al., in 2013.54 In the model reaction – mandelic acid and 
3,5-dimethylpiperidine – the previously discussed catalysts 36, 45 and 46 gave poor 
yield of the amide product (8%, 8% and 6%, respectively). However, primary alkyl 
boronic acids (methyl 53 and butyl 54) show good activity (73% and 89%, 
respectively). The amidation yields can be improved by the addition of benzoic acid (10 
mol%) as an additive (96% and 99%, respectively). Under the reaction conditions 
aliphatic acids and amines are tolerated as well as secondary and α-branched amines. 
The corresponding esterification of hydroxyl groups is not observed (Scheme 48). In 
general, no observable racemisation occurred, with the notable exception of the 
combination of (R)-mandelic acid and 2-phenylethylamine (79% ee). This can be 
improved by using the lower boiling 1,2-dichloroethane as the solvent (94% ee), 
although at the expense of amide yield (98% reduced to 63%). Interestingly, the 
amidation of the benzoic acid additive is not reported to occur even in low yield. 
 
Scheme 48 Examples of methylboronic acid 53 catalysed amidation 
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Of course the high temperatures required for some of these boron-mediated or catalysed 
reactions, excluding the room temperature amidations reported by Hall,50-53 are likely to 
result in a significant background reaction when the toluene thermal amidation reported 
by Williams is taken into consideration.24 
1.3.  Project background 
Following work by a previous PhD student, the Sheppard Group has reported on the 
development of stoichiometric boron reagent, tris(2,2,2-trifluoroethyl)borate 54 for 
direct amidation reactions after it was identified as an amidation reagent with 
advantages over B(OMe)3.
55-56 This reagent has a number of advantages over current 
stoichiometric boron reagents as reactions can be carried out open to the air, without the 
need for active water removal and only stoichiometric quantities of carboxylic acid and 
amine are required to give the amide products in good to excellent yield. The scope of 
the reaction explored is detailed in Scheme 49. Aliphatic and aromatic acids and amines 
are tolerated as well as conjugated acids and α-substituted acids and amines, including 
Boc-ʟ-alanine. A number of functional groups are compatible with the reaction 
conditions – alkenes, alkynes, hydroxyls, esters and nitro groups. 
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Scheme 49 Previous examples of B(OCH2CF3)3-mediated amidation. Thermal yield in 
parentheses 
In addition, B(OCH2CF3)3 was shown to mediate the transamidation of primary amides 
in good yield (Table 4). Four examples were reported including those containing free 
hydroxyl as well as heteroaromatic groups. 
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Table 4 B(OCH2CF3)3-mediated transamidation 
 
Entry Product Yield (%) 
1 
 
73 
2 
 
63 
3 
 
82 
4 
 
62 
 
This thesis focuses on further development of the use of B(OCH2CF3)3 in the synthesis 
of amide bonds. Chapter two details further investigation into the synthesis of amides 
mediated by B(OCH2CF3)3. This includes the direct amidation of carboxylic acids, N-
protected amino acids and the formylation of amines by transamidation of DMF. The 
development of a solid-phase work-up procedure for these amidation reactions is also 
described. 
Chapter three details the application of B(OCH2CF3)3 to the amidation of unprotected 
amino acids. This covers an optimisation study and the scope of the reaction, as well as 
the development of a new method for the determination of enantiomeric purity of chiral 
amines. 
Chapter four describes a mechanistic study into the direct amidation reaction. A reaction 
intermediate as well as a tentative mechanism are proposed based on the results of this 
mechanistic study and preliminary experimental evidence.  
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2. B(OCH2CF3)3 as a reagent for direct amidation 
2.1.  Synthesis of B(OCH2CF3)3 
As discussed in the introduction, this thesis focuses on the use of B(OCH2CF3)3, as an 
amidation reagent. B(OCH2CF3)3 has been previously prepared in the group using 2,2,2-
trifluoroethanol (CF3CH2OH) and boron tribromide (BBr3) in strictly anhydrous 
conditions (Scheme 50).55 Despite the high yield (90%) of this reaction, a milder route 
avoiding highly reactive BBr3 was sought.  
 
Scheme 50 Synthesis of B(OCH2CF3)3 from BBr3 
The first alternative route attempted utilised cheap boric acid and CF3CH2OH under 
Dean-Stark conditions in toluene. However, the high temperature required led to the 
removal of CF3CH2OH from the reaction mixture and, therefore, an unsuccessful 
synthesis of B(OCH2CF3)3 (Scheme 51).
57  
 
Scheme 51 Attempted synthesis of B(OCH2CF3)3 from B(OH)3 
Another, more successful, synthesis was established using B2O3 and CF3CH2OH 
(Scheme 52).58 Although synthesising B(OCH2CF3)3 from B2O3 instead of BBr3 results 
in a lower final yield (48% compared to 90%), this route is significantly more attractive 
from an operational perspective.59 The handling and use of B2O3 is much safer and more 
convenient as it is not sensitive to moisture. An additional advantage is that B2O3 
drastically reduces the cost of the synthesis as BBr3 costs around £90/mol compared to 
98p/mol for B2O3. In addition, the unreacted CF3CH2OH (£12/mol) can be recovered 
for reuse during distillation. 
 
Scheme 52 Synthesis of B(OCH2CF3)3 from B2O3 
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2.2.  Comparison of different boron reagents 
The efficacy of B2O3, B(OMe)3, B(OCH2CF3)3 as amidation reagents was tested. The 
amidation of phenylacetic acid with benzylamine was chosen as the model system to 
compare these reagents (Table 5). Previous work in the Sheppard group investigated 
these reactions over a reaction time of 15 h.55 However, it was observed that this length 
of reaction time was not necessary in the case of B(OCH2CF3)3 (Table 5, entries 1 and 
2). B(OMe)3, however, required the longer reaction time (Table 5, entries 3 and 4). 
B2O3 from which B(OCH2CF3)3 is synthesised, is also slightly active as an amidation 
reagent but is significantly less efficient than B(OMe)3 or B(OCH2CF3)3 (Table 5, entry 
5).  
Table 5 Amidation study of boron reagents 
 
Entry Boron reagent Time (h) Yield (%) 
1 B(OCH2CF3)3 15 91 
2 B(OCH2CF3)3 5 88 
3 B(OMe)3 15 92 
4 B(OMe)3 5 69 
5 B2O3 5 15 
 
Boroxines have been shown to have a higher Lewis acidity than borate esters using the 
Acceptor Number (AN) scale.57 B(OCH2CF3)3 has an AN of 66.4 (higher than that of 
the non-halogenated parent borate ester, B(OnPr)3 with an AN of 20.3). With this in 
mind, trimethoxyboroxine (55, Table 6) was trialled in the amidation of phenylacetic 
acid and benzylamine. From the AN of triethoxyboroxine (80.1) and tri(n-
propoxy)boroxine (79.1), it can be inferred that trimethoxyboroxine 55 has a similar AN 
and, therefore, a higher Lewis acidity than B(OCH2CF3)3. Trimethoxyboroxine 
performs reasonably well as an amidation reagent but is not comparable to B(OMe)3 or 
B(OCH2CF3)3 even over 15 h (Table 6, entries 1 and 2).  
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Table 6 Amidation study of 55 
 
Entry Boron reagent Time (h) Yield (%) 
1 55 5 72 
2 55 15 81 
 
The simplicity of the use of B(OCH2CF3)3 as well as its synthesis make it a highly 
attractive option for amidation reactions. Additionally, the B(OCH2CF3)3 reagent is now 
commercially available from Sigma-Aldrich (product number RNI00014). 
2.3.  Investigation of solid phase work-up 
With a view to optimising the total reaction efficiency we wanted to streamline the work 
up procedure. Previous work made use of aqueous work ups.55 Due to the nature of the 
reaction we envisioned that the components of the reaction mixture could all be 
removed with appropriate solid-phase resins. To determine whether this was a suitable 
method for purifying the amide products, AmberlystTM 15, which was readily available 
in the laboratory, was trialled in the reaction mixture. The reaction of phenylacetic acid 
and benzylamine was chosen as the model reaction (Scheme 53).  
 
Scheme 53 Solid-phase work-up test reaction 
AmberlystTM 15 is a widely used macro reticular polystyrene resin with an acidic 
sulfonic acid residue (Figure 5a). The uses of AmberlystTM 15 as a heterogenous 
catalyst in synthesis cover a vast area and have recently been reviewed.60 Initially 
AmberlystTM 15 was used in a test reaction of the amidation of phenylacetic acid by 
excess benzylamine, however the borate reagent remained. Ideally an acidic as well as a 
basic resin was required to remove both the residual carboxylic acid and residual amine. 
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Figure 5 Resins used in B(OCH2CF3)3-mediated amidation purification. a) 
AmberlystTM 15, b) AmberlystTM A26(OH) and c) AmberliteTM IRA743 
AmberlystTM A26(OH) is a basic resin with an ammonium hydroxide residue (Figure 
5b). This resin has found use as a catalyst in a number of reactions as well as for 
neutralisation of reactions by removal of acid.61 For example, AmberlystTM A26(OH) 
has been used to purify a pentasaccharide by removing DDQ from the reaction mixture 
following its conversion to dihydroquinone by ʟ-ascorbic acid.62 The use of 
AmberlystTM A26(OH) as a support for the hydrogen peroxide epoxidation of α,β-
unsaturated ketones at room temperature has also been reported.63 Ester hydrolysis can 
also be effected with AmberlystTM A26(OH).64 
Following the use of AmberlystTM 15 and AmberlystTM A26(OH), 1H and 13C-NMR 
spectra showed clean product 56, however a yield of 111 % was recorded. This 
suggested that boron residues remained in the final product and elemental analysis 
indicated that the product was impure.  
Therefore, a resin that could scavenge boron from the reaction mixture was required. At 
the time of our investigation into the possible use of a resin to scavenge any boron 
residues from the B(OCH2CF3)3-mediated amidation reactions, there was only one 
report in the literature of AmberliteTM IRA743 used for this purpose (Figure 5c). Ley 
described the use of a series of immobilised reagents and scavengers in the synthesis of 
Epithilone C, which included an aldol reaction mediated by a borane-N-
tosylphenylalanine complex (Scheme 54).65 It was felt that a similar procedure could 
also be applied to our B(OCH2CF3)3-mediated amidation reactions to aid in the 
purification of the amide products. 
 
Scheme 54 Use of AmberliteTM IRA743 by Ley 
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In addition to this reference to the use of AmberliteTM IRA743 as a boron scavenger in 
organic synthesis, there are numerous references to this resin in the removal of boron in 
water treatment processes,66 as well as its use in enzyme immobilisation67 and removal 
of metals.68 Use of AmberliteTM IRA743 as a boron scavenger was successful in 
removing the boron residues still present in the reaction mixture and the clean sample 
was confirmed by elemental analysis. 
In summary, we required three different resins: an acidic resin to remove any amine 
residues, a basic resin to remove any carboxylic acid residues and a boron scavenger to 
remove any boron residues. Three resins were found to be suitable for this purpose – 
AmberlystTM 15 (an acidic resin), AmberlystTM A26(OH) (a basic resin) and 
AmberliteTM IRA743 (a boron scavenger). 
2.3.1.  Use of solid-phase resins in amidation reactions 
After finding these three suitable resins we sought to establish whether the combination 
of these resins would prove fruitful for a solid-phase work-up to remove any residual 
acid and amine as well as any boron residues 
After carrying out the B(OCH2CF3)3-mediated amidation a work-up was necessary to 
remove residual starting materials as well as any boron residues. Using a combination 
of these resins in a mixture of CH2Cl2 and water (6:1 v/v, on a 1 mmol scale – CH2Cl2 3 
mL and H2O 0.5 mL) and stirring at room temperature for 30 min removes any residual 
starting materials and any boron residues. Following water and resin removal by MgSO4 
and filtration, respectively, the analytically pure amide product is directly isolated 
(Figure 6).59 In place of CH2Cl2 in the solid-phase work-up EtOAc is also suitable as the 
solvent (a ‘greener’ option). The simplicity of this method is incredibly advantageous as 
only a filtration is required to yield the clean product. Therefore, this amidation method 
coupled with the solid-phase work-up procedure could potentially be automated. 
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Figure 6 Solid-phase work-up method 
2.4. Amidation investigation 
2.4.1.  Scope of the B(OCH2CF3)3-mediated amidation reaction 
In order to evaluate the full scope of the reaction the amidation was carried out using a 
wide range of amines and carboxylic acids.59 
The amine scope was evaluated through the synthesis of a series of phenylacetamides 
by reaction of phenylacetic acid with a range of different amines (Scheme 55). These 
were prepared using the standard reaction conditions [phenylacetic acid (1 equiv.), 
amine (1 equiv.), B(OCH2CF3)3 (2 equiv.), MeCN (0.5 M), 80 °C], and any deviation 
from this method is noted. Benzylamines are well tolerated under the reaction 
conditions (56, 57a-b), as well as functionalised aliphatic amines (heterocycle 57c and 
perfluoro 57d). Cyclic secondary amines generally undergo amidation in excellent yield 
(57e-i) although N-phenylpiperazine (57f) required a higher reaction temperature of 100 
°C to improve the yield from 53% to 76%. In terms of amidation with acyclic secondary 
amines, this is less efficient than amidation with cyclic secondary amines. 
Dimethylamine hydrochloride can undergo amidation in good yield as long as two or 
more equivalents of the salt are used alongside the same number of equivalents of 
DIPEA to liberate the free amine (57j). More than two equivalents are required due to 
the low boiling point of the free amine (7 °C). The other acyclic secondary amine 
investigated, dibenzylamine gave a low yield of the amide product (57k), alongside a 
significant quantity of 56, suggesting that debenzylation had taken place. The overall 
low conversion of dibenzylamine to either of the product amides (57k and 56) is likely 
due to steric crowding by the free movement of the benzyl arms, this would not have 
been the case with cyclic secondary amines or dimethylamine. Less nucleophilic 
amines, such as aniline, its derivatives and tert-butylamine reacted with phenylacetic 
acid to give the corresponding amide product, although, higher temperatures were 
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required in some cases to give good yields (57l-57r). In the case of 2-aminopyridine, 
high temperatures and long reaction times produced only a very low yield (57q, 12%). 
To ensure that this low yield is not an artefact of the pyridyl nitrogen deactivating 
B(OCH2CF3)3 by coordination, amidation with 3-aminopyridine was carried out, and 
this gave a moderate yield (57p, 53%) indicating that the pyridyl nitrogen is not 
deactivating B(OCH2CF)3. Adamantylamine (57s) and 2-aminothiophenol (57t) were 
completely unreactive under the reaction conditions. 
The purification of the amide products from dibasic amines (57f and 57g) was slightly 
more complex than the standard resin purification. Residual acid and any boron residues 
were removed using Amberlyst® A-26(OH) and Amberlite® IRA743. The unreacted 
amine was then separated from the product by flash column chromatography.  
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Scheme 55 Scope of amine functionality in B(OCH2CF3)3-mediated amidation. All 
reactions were carried out at 80 °C for 5 h and the solid phase work-up procedure was 
used unless otherwise stated; aAqueous work-up procedure; b80 °C for 15 h; c100 °C for 
15 h in a sealed tube; dPurified by column chromatography; eFrom 1 equiv. 
Me2NH.HCl, 1 equiv. DIPEA; 
fFrom 2 equiv. Me2NH.HCl, 2 equiv. DIPEA; 
gFrom 3 
equiv. Me2NH.HCl, 3 equiv. DIPEA;
 h6% of  56 was also isolated;  i100 °C for 24 h in a 
sealed tube. 
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To evaluate the carboxylic acid scope in the B(OCH2CF3)3-mediated amidation reaction 
the synthesis of a range of N-benzylamides was carried out with a range of carboxylic 
acids (Scheme 56).59 Phenylacetic acid (57a) and substituted phenylacetic acids as well 
as heteroaromatic acids were well tolerated under the reaction conditions to give the 
corresponding amide in excellent yield (58a-58i). α-Substituted acids undergo 
amidation to give the product in good to excellent yield (58b, 58k, 58m and 58s). 
Amidation of unsaturated conjugated acids proceeds in excellent yield (58k and 58k), 
although the more hindered α-methylcinnamic acid requires a higher reaction 
temperature to give reasonable yield (58k). The less reactive hindered aliphatic acids 
trifluoroacetic acid and pivalic acid (58l and 58m) also required a higher reaction 
temperature to give the amide product in reasonable yield. Similar to anilines, benzoic 
acids displayed lower reactivities and required higher reaction temperatures in order to 
achieve reasonable conversion (58n-58r). The more sterically hindered benzoic acid, α-
phenyl-o-toluic acid, underwent amidation in good yield with an increase in reaction 
temperature (58q). α-Chiral acids such as (S)-(+)-ibuprofen undergo amidation in 
excellent yield with total retention of enantiopurity (58s). This is gratifying as ibuprofen 
is known to racemise under basic conditions.69 
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Scheme 56 Scope of acid amidation using B(OCH2CF3)3. All reactions were carried out 
at 80 °C for 5 h and the solid phase work-up procedure was used unless otherwise 
stated; a100 °C for 15 h in a sealed tube. 
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A selection of other amidations were carried out to further demonstrate the utility of this 
method (Scheme 57). Amidation of p-tolylacetic acid with n-butylamine proceeded in 
excellent yield (59a). The more challenging picolinic acid underwent amidation with 
glycine methyl ester with purification by column chromatography to give 59b in good 
yield. Pleasingly, monoamidation of a dicarboxylic acid, 1,4-phenylenediacetic acid, 
could be effected with 0.5 equivalents of benzylamine in moderate yield (59c). Due to 
the acid functionality present in the product this amide could not be purified by solid-
phase work-up procedures, instead an aqueous work up was carried out, still avoiding 
column chromatography. Paracetamol (59d) could also be synthesised in good yield by 
amidation of acetic acid with p-aminophenol mediated by B(OCH2CF3)3. 
 
Scheme 57 Other examples of B(OCH2CF3)3-mediated amidation. 
aPurified by column 
chromatography; bAqueous work-up procedure. 
The use of B(OCH2CF3)3 was investigated in intramolecular amidations (lactamisations) 
using 5-aminovaleric acid and 6-aminocaproic acid to prepare piperidin-2-one 60a and 
azepan-2-one 60b, respectively (Scheme 58). Cyclisation to six-membered ring 
piperidin-2-one 60a proceeds in excellent yield, whereas the seven-membered ring 
cyclisation to azepan-2-one 60b proceeds in moderate yield at 80 °C and excellent yield 
at 100 °C. The background reaction of these lactamisations is low at 80 and 100 °C. The 
lactamisation of N-Boc-ʟ-ornithine was also carried out in excellent yield (60c). The 
optical purity of lactam 60c was confirmed by carrying out an [α measurement as N-
Boc-ᴅʟ- or ᴅ-ornithine were not commercially available to allow measurement of the er 
by chiral HPLC. 
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Scheme 58 Examples of lactamisation by B(OCH2CF3)3. 
aYield without B(OCH2CF3)3; 
b100 °C for 5 h in a sealed tube; c[α  −9.5 (c 1.22, MeOH) [Lit.16 [α  −10.6 (c 1.22, 
MeOH)]; d80 °C for 15 h. 
The selective amidation of anthranilic acid 61 was attempted. Anthranilic acid was used 
as either the carboxylic acid or the amine partner (Scheme 59). Unfortunately this was 
unsuccessful and did not produce either the N-acylated anthranilic acid 62 or benzamide 
63, even at high temperatures and extended reaction times. Presumably this lack of 
reactivity under these reaction conditions is due to the low nucleophilicity of the amine 
and the low electrophilicity of the acid. 
 
Scheme 59 a) Attempted acylation of anthranilic acid; b) Attempted benzamide 
formation from anthranilic acid 
2.4.2.  Reaction scale-up 
We wished to determine whether the B(OCH2CF3)3-mediated amidation was amenable 
to larger scale reactions so we attempted the synthesis of a secondary (59a) and a 
tertiary (57h) amide on a gram scale (Scheme 60).  Pleasingly, gram-scale amidation 
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using our methodology was successful, albeit with a slight reduction in yield. In each 
case, more than 1 g of amide was synthesised and purified by the solid-phase work-up 
procedure without the need for column chromatography. This procedure required less 
than 15 mL of MeCN, whereas, the same reaction using a boronic acid catalyst is 
reported to require around 70 mL of solvent.51 
 
Scheme 60 Gram-scale amidation of a) secondary amide 59a and b) tertiary amide 57h 
2.4.1.  N-Formylation of amines by transamidation of DMF 
During the course of our further investigation into the B(OCH2CF3)3-mediated 
transamidation reaction a method for the transamidation of primary amides was 
published by the Williams group which described transamidation of primary amides 
with amines using hydroxylamine hydrochloride as a catalyst.70 This method sees 
excellent yields for most of the transamidation products and good reaction scope 
(Scheme 61).  
 
Scheme 61 Transamidation using hydroxylamine hydrochloride as a catalyst 
In addition to this report a number of other procedures for transamidation have recently 
been reported, including organic – PhI(OAc)2,71 B(OH)372 and ʟ-proline73 – as well as 
metal – Cp2ZrCl2,74 Cu(OAc)275 and CeO276 – catalysts and reagents. As a result of 
these and other recent methods it was felt that the utility of B(OCH2CF3)3 as a reagent 
for transamidation was limited and would not be worth pursuing. However, during the 
initial solvent screen at the start of the direct amidation project B(OCH2CF3)3 was 
shown to mediate the transamidation of DMF. As a result of this observation we sought 
to investigate the utility and scope of this reaction. There are number of recently 
reported literature methods for the formylation of amines. For example, the 
transamidation of formamide by NaOMe,77 NH2OH·HCl
70 or Cp2ZrCl2;
74 and the 
amidation of formic acid catalysed by protic ionic liquids,78 and/or sodium formate.79 
45 
 
However, these methods generally require anhydrous conditions as well as purification 
by column chromatography. The N-formylation of amines specifically by 
transamidation of DMF with several reagents and catalysts has recently been reported - 
PhI(OAc)2,
71 B(OH)3,
72 ʟ-proline,73 and imidazole.80 Again, these methods require high 
temperatures, long reaction times, and/or purification by column chromatography. 
Compared to the conditions required for the transamidation of DMF using the catalysts 
and reagents detailed above, the B(OCH2CF3)3-mediated transamidation of DMF for N-
formylation of amines would be a comparatively straightforward procedure given that 
the products could easily be purified by the solid-phase work-up procedure. 
To explore the efficacy of this reaction the formylation of benzylamine was used as a 
model system. The background reaction, neat DMF in the absence of B(OCH2CF3)3, 
was negligible (Table 7, entry 1). Surprisingly, using only 1 equivalent of DMF in 
MeCN as solvent gave improved yields compared to using neat DMF (Table 7, entries 2 
and 3). Increasing the quantity of DMF used in the formylation in MeCN increased the 
formylation to almost quantatitive yield (Table 7, entries 4-8). Using higher quantities 
of DMF than 10 equivalents decreased the final yield, perhaps due to complexation and 
deactiviation of B(OCH2CF3)3 by DMF which would also explain the lower yield 
observed in neat DMF (Table 7, entry 9). The reaction temperature could be lowered 
from 100 °C to 80 °C without any impact on the yield of formamide product (Table 7, 
entry 10). The formamide product can be isolated pure following the solid-phase work-
up and evaporation of DMF. As a result of this optimisation study the final 
B(OCH2CF3)3-mediated formylation procedure is as follows: amine (1 equiv.), DMF 
(10 equiv.), B(OCH2CF3)3 (2 equiv.) in MeCN (0.5 M) at 80 °C for 5 h.
59 
The formylation of benzylamine could also be carried out with two other related formyl 
donors – formamide (88%) and N-methylformamide (94%) – in similar yield to that 
achieved with DMF as the formyl donor. However, the use of DMF is more attractive as 
it has a lower boiling point than formamide and N-methylformamide (152 °C compared 
to 210 °C and 183 °C, respectively) as well as being significantly cheaper than these 
other formyl donors. 
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Table 7 Optimisation of B(OCH2CF3)3-mediated formylation 
 
Entry DMF (equiv.) Yield (%)a 
1 Neatb 11 
2 Neatc 41 
3 1 60 
4 2 62 
5 3 66 
6 4 72 
7 5 74 
8 10 98 
9 15 92 
10d 10 95 
Product isolated by solid phase work-up followed by column chromatography unless 
otherwise stated. aIsolated yield; bDMF (0.5 M) as solvent, no B(OCH2CF3)3; 
cDMF (0.5 
M) as solvent; d80 °C, solid phase work-up followed by evaporation of DMF, no 
column chromatography required. 
The scope of the B(OCH2CF3)3-mediated N-formylation reaction was evaluated on a 
selection of amines (Scheme 62). Benzylic and aliphatic amines all underwent N-
formylation via this method in good to excellent yield (64a-g). n-Butylamine is 
formylated in good yield as measured by 1H-NMR, however, the product is volatile so a 
large proportion is lost on isolation (64g). α-Substituted amines, such as α-
methylbenzylamine and cyclohexylamine, were well tolerated under the reaction 
conditions giving the formamide product in excellent yield (64d and 64f). Due to low 
nucleophilicity of aniline and the related indoline these amines underwent formylation 
in lower yields (64h and 64i). The procedure was also suitable for the formylation of 
secondary amines although these amines required higher reaction temperatures to give 
reasonable yield (64i and 64j). 
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Scheme 62 Scope of B(OCH2CF3)3-mediated N-formylation. 
aYield measured by 1H-
NMR with naphthalene internal standard; b100 °C reaction temperature. 
2.5.  N-Protected amino acid coupling 
Due to the success of the amidation of S-(+)-ibuprofen with regards to the retention of 
enantiopurity, the amidation of N-protected amino acids was investigated to determine 
whether a B(OCH2CF3)3-mediated amidation would be a feasible route to N-protected 
amino acid amides. This would provide a simple route to these products, in addition to 
the multitude of methods available, which would require only a solid-phase work-up for 
purification.59 
2.5.1.  Secondary amides 
A series of N-protected amino acids with common protecting groups was investigated 
under the B(OCH2CF3)3-mediated amidation conditions; reaction times were, however, 
extended up to 15 h (Scheme 63). The scope of this reaction was evaluated by reaction 
of the N-protected amino acids with benzylamine. The N-Boc protecting group is well 
tolerated under the reaction conditions, with N-Boc-phenylalanine undergoing 
amidation in excellent yield, albeit with some erosion of enantiopurity (65a). This can 
be rectified by reducing the reaction time; however, the yield of the reaction is reduced. 
Amidation of N-Boc-methionine proceeds in excellent yield with complete retention of 
enantiopurity (65b). Similarly, N-Boc-proline retains excellent enantiopurity with good 
yield of the amide product (65c). The N-Cbz protecting group is also well tolerated in 
the B(OCH2CF3)3-mediated amidation reaction with N-Cbz-alanine undergoing 
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amidation with benzylamine in excellent yield with good retention of enantiopurity 
(65d). N-Boc-sarcosine also gives the amide product in excellent yield (65e). 
 
Scheme 63 Scope of B(OCH2CF3)3-mediated amidation of N-protected amino acids. 
aReaction time of 8 h. 
2.5.2.  Tertiary amides 
Tertiary amides derived from N-Boc-protected amino acids can be difficult to 
synthesise. A number of groups have published on the amidation of N-Boc-protected 
amino acids with secondary amines using carbodiimides and additives,81 or uronium 
salts.82 The drawbacks of these methods are the large reagents required to activate the 
carboxylic acid and the associated by-products which are often hazardous and difficult 
to remove from the amide product. At present, there are no reports in the literature on 
the amidation of N-Boc-protected amino acids with secondary amines promoted by a 
boron reagent or catalyst. 
Pleasingly, our method is a viable alternative to the established routes to these N-Boc-
protected amino acid tertiary amides as it produces the product in reasonable yield and 
only requires purification by the simple solid-phase work-up. Tertiary amide 
preparation compared to secondary amide preparation requires longer reaction times (24 
h) and higher temperatures (100 °C) for any reaction to occur (Scheme 64). At 80 °C no 
reaction is observed, even at prolonged reaction times.  N-Boc-ʟ-alanine and 
phenylalanine both undergo amidation with cyclic secondary amines, pyrrolidine and 
thiomorpholine, in moderate yield with reasonable retention of enantiopurity (66a-c). In 
the case where poor retention of enantiopurity is observed, this can be improved by 
49 
 
reducing the reaction time in an analogous fashion to amidation of N-Boc-protected 
amino acids with primary amines (66a). N-Bz-protected amino acids are also well 
tolerated under the reaction conditions to give the tertiary amide product in moderate 
yield with good retention of enantiopurity (66d-e). The amidation of N-Boc-amino acids 
with acyclic secondary amines was unsuccessful (66f-g).  
 
Scheme 64 B(OCH2CF3)3-mediated synthesis of N-protected amino acid tertiary 
amides. aer measured by derivatisation as N-benzoylamide; bReaction time of 8 h. 
2.5.3.  Dipeptide Synthesis 
The applicability of B(OCH2CF3)3 to dipeptide synthesis was investigated by 
synthesising a dipeptide from ʟ-phenylalanine methyl ester hydrochloride and ᴅ-
phenylalanine methyl ester hydrochloride with Boc-ʟ-alanine (Scheme 65, 67a-b). Both 
dipeptides were synthesised in good yield with no measurable racemisation. Although 
our yields are moderate, these dipeptides can be isolated pure following the simple 
solid-phase work-up with no measurable loss in enantiopurity. Previously, these 
dipeptides have been synthesised by carbodiimide coupling in good to excellent yield 
but purificiation required aqueous work-up, column chromatography or recrystallisation 
to remove the urea by-product and yield the pure dipeptide.83  
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Scheme 65 Synthesis of dipeptide 67a and 67b 
All of these N-Boc protected amino acid amides were purified using the solid-phase 
work-up procedure. Interestingly, we found the N-Boc protecting group to be stable to 
AmberlystTM 15 at room temperature in CH2Cl2 for 30 min, despite precedent in the 
literature.84 Romo et al. report the use of AmberlystTM 15 to deprotect and purify N-Boc 
amines, although these reactions are carried out under similar conditions to our solid-
phase work-up they require at least 4 h, and in some cases 4 days, for the deprotection 
to occur. The observed stability of our N-Boc amino acid amide products is likely due to 
their relatively short exposure to AmberlystTM 15 (30 min) compared to the several 
hours (or days) of the Romo deprotection method. 
There are limited reports of boron reagents used to mediate or catalyse amidation of N-
protected amino acids. Levitt reports on the use of chlorodimethoxyborane 68 to 
mediate the amidation of N-benzoyl-ʟ-leucine with glycine ethyl ester.34 Carrying out 
this reaction at room temperature in benzene gave a low yield but good retention of 
enantiopurity (>90% ee). Increasing the reaction temperature resulted in complete 
racemisation of the α-chiral centre and using a more polar solvent (MeCN) had a similar 
effect. 
 
Scheme 66 (MeO)2BCl-mediated amidation of benzoyl-ʟ-leucine 
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In Yamamoto’s report on the use of 3,4,5-trifluorobenzeneboronic acid 36 as an 
amidation catalyst, there is one example of the use of an amino acid.41 The lactamisation 
of ʟ-proline was reported to proceed in excellent yield with high retention of 
enantiopurity (Scheme 67). 
 
Scheme 67 36-catalysed lactamisation of ʟ-proline 
Additionally, Yamamoto reports on the use of the boron-based catalyst 44 (vide supra) 
which is effective for the amidation of more sterically demanding carboxylic acids.46 
Using this catalyst Boc-ʟ-alanine can undergo amidation with benzylamine to give the 
amide product in excellent yield, however, some erosion of enantiopurity is observed 
(86% ee). 
Following our report of the amidation of N-protected amino acids mediated by 
B(OCH2CF3)3,
59 Whiting et al. reported the amidation of N-Boc-protected amino acids 
and the synthesis of dipeptides catalysed by o-nitrophenylboronic acid 69 and o-
tolylboronic acid 70 under anhydrous conditions.85 The amidation of amino acids 
proceeds in excellent yield with unhindered amines, however, more sterically 
encumbered amines lower the yield of the amide product (Scheme 68).  
 
Scheme 68 Amidation of N-protected amino acids catalysed by 69 
In the case of dipeptide formation a 1:1 ratio (100 mol%) of 69 and 70 was required as 
the reagent to give the dipeptide in moderate yield (Scheme 69). Acid-labile protecting 
groups such as Boc are tolerated under the reaction conditions. Importantly, 
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enantiopurity is maintained during the reaction. In this case, limited side-chain 
functionality was explored. 
 
Scheme 69 Dipeptide formation catalysed by 69 and 70 
The use of B(OCH2CF3)3 as a reagent in N-protected amino acid amidations is therefore 
of synthetic value in terms of boron-based reagents as it represents an advancement on 
the current state of the art. N-Protected amino acid secondary amides can be synthesised 
in good to excellent yield with low levels of racemisation. In the cases where 
racemisation does occur (65a, 66a and 66e), this can be reduced by shortening the 
reaction time, although this is at the expense of amide yield. The synthesis of N-
protected amino acid tertiary amides is possible with B(OCH2CF3)3 in moderate yield 
with excellent retention of enantiopurity when cyclic secondary amines are used, 
however no reaction is observed with acyclic secondary amines. All of these amide 
products can be isolated following the solid-phase work-up procedure which simplifies 
the process and avoids the need for column chromatography. 
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3. B(OCH2CF3)3-mediated amidation of unprotected amino acids 
3.1.  Background  
The amidation of unprotected amino acids generally requires protection and 
deprotection of any functional groups not involved in the coupling to prevent any 
undesired side reactions. In addition, the preactivation of the carboxylic acid partner is 
required (Scheme 70). The protection and deprotection of either the amine or acid 
functionality as well as the protection of any sidechain functionality adds at least two 
extra steps to any synthetic sequence. Ideally a reagent that could accomplish both 
protection and activation of the unprotected amino acid is required. There are few 
procedures which accomplish this feat without the need for protecting groups and 
preactivation of the acid. 
 
Scheme 70 Simplified route to the amidation of unprotected amino acids 
Burger et al. have described and reviewed the use of hexafluoroacetone for the 
protection/activation of unprotected amino acids to form 2,2-bis(trifluoromethyl)-1,3-
oxazolidin-5-ones 71 (Scheme 71).86-87 Protection with hexafluoroacetone also allows 
for selective functionalisation on the amino acid side-chain, particularly amine or acid 
functionality, as well as activation of the carboxylic acid for nucleophilic attack. 
Importantly, these lactone-type rings 71 are stable and can be isolated. However, despite 
its great utility, hexafluoroacetone is a very toxic gas so great care must be taken when 
handling it. 
 
Scheme 71 Reaction of amino acid with hexafluoroacetone 
In 2002, Liskamp et al. reported a simultaneous protection-activation method for the 
synthesis of amino acid amides. This procedure utilised dichlorodialkylsilanes as the 
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protecting group and the coupling reagent. Due to the propensity of 
dichlorodialkylsilanes towards hydrolysis this reaction requires anhydrous conditions.88 
The report focused on dichlorodimethylsilane, however, bulkier dichlorodialkylsilanes 
were also investigated (Scheme 72).  They postulate that the reaction proceeds through 
the reactive cyclic silane intermediate 73. Isolation of 73 was not possible but indirect 
evidence for its presence in the mechanism is provided by the absence of the reaction in 
carboxylic acids without a free α-amino group as N-protected amino acids do not 
undergo amidation. This procedure is limited to primary amine nucleophiles that lack 
substituents in the α-position, the presence of a substituent at this position significantly 
affects the yield of the reaction. For example, using ʟ-phenylalanine methyl ester as the 
amine nucleophile gives a low yield (17 %) and use of even bulkier isopropylamine or 
sec-butylamine give yields of less than 5 %. In this report no er (or ee) data is given and 
no discussion of the retention of enantiopurity is made. 
 
Scheme 72 Unprotected amino acid amidation using dichlorodialkylsilanes 
Following this report, in 2005, Liskamp et al. published a related procedure using boron 
trifluoride diethyl etherate in a similar protection-activation strategy (Scheme 73).89 In 
this case the additional step of forming the lithium salt of ʟ-phenylalanine was required 
compared to the previous example. The lithium salt is then reacted with BF3.Et2O. In 
this case the cyclic intermediate, 2,2-difluoro-1,3,2-oxazaborolidin-5-one 75, could be 
isolated in 90 % yield. Attack of an amine on 75 yields the amide products. However, 
the yields compared to the dichlorodialkylsilane equivalent are significantly lower. The 
lower yields observed for the product are thought to be due to steric hindrance around 
the carbonyl reaction centre. Under these reaction conditions absolutely no reaction was 
observed with amines containing α-substituents (76c-d), the reaction can only be carried 
out with primary amines with no α-substituents. Again, no discussion of possible 
racemisation of the chiral centre of the amino acids was made and ers (or ees) were not 
reported. 
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Scheme 73 Unprotected amino acid amidation using BF3.OEt2 
Additionally, Li et al. have shown one example of unprotected amino acid amidation 
mediated by AlMe3.
27 They describe the amidation of ʟ- and ᴅ-proline with p-anisidine, 
which both proceed in excellent yield although significant racemisation was observed 
(Scheme 74). This procedure also requires anhydrous conditions. 
 
Scheme 74 AlMe3-mediated amidation of a) ʟ- and b) ᴅ-proline with p-anisidine 
With these reports in mind, it was worth investigating the potential of B(OCH2CF3)3 as 
a reagent for the amidation of unprotected amino acids. The conditions required could 
provide a significantly milder procedure for the amidation of unprotected amino acids 
without the need for anhydrous conditions by using the air stable B(OCH2CF3)3 reagent. 
We expected that B(OCH2CF3)3 would protect and activate the unprotected amino acid 
in a similar fashion to that described by Liskamp (Figure 7).89 
 
Figure 7 Proposed unprotected amino acid protection-activation by B(OCH2CF3)3 
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3.2.  Initial attempt at reaction optimisation 
3.2.1.  Previous work in the Sheppard group 
Two test reactions on the amidation of unprotected amino acids carried out by a 
previous PhD student in the Sheppard group showed that B(OCH2CF3)3 could be used 
to mediate the amidation of unprotected amino acids (Table 8).56 In the absence of a 
base (DIPEA) no amidation was observed in the model system, however on addition of 
DIPEA (1 equiv.) a 35 % conversion was observed. The base was thought to aid the 
solubility of ʟ-alanine in MeCN. No significant dipeptide formation by the amidation of 
ʟ-alanine with another molecule of ʟ-alanine was observed.  
Table 8 Initial unprotected amino acid amidation work 
 
Entry Additive Conversion (%)a 
1 No additive 0 
2 DIPEA 35 
aBy 1H-NMR 
3.2.2.  This work 
Following this initial finding a more thorough investigation of the reaction was 
undertaken. The preliminary optimisation studies focused on the B(OCH2CF3)3-
mediated amidation of ʟ-alanine with benzylamine as a model system. Firstly, a solvent 
screen was carried out to determine whether the pre-established conditions using 
acetonitrile as the solvent for B(OCH2CF3)3-mediated amide couplings were suitable for 
unprotected amino acid couplings (Table 9). MeCN, either anhydrous or HPLC grade, 
has been shown to be the best solvent of those investigated in this screen (Table 9, 
entries 1 and 2). Reducing the reaction time from 15 h to 5 h decreases the conversion 
of the reaction (Table 9, entry 3). There is no measured background reaction in MeCN 
(Table 9, entry 4). Low conversion was observed in 1,4-dioxane, EtOAc, toluene and 
chloroform although the N-benzylacetamide amidation product resulting from 
transamidation of EtOAc was observed (Table 9, entries 5-8). Negligible conversion 
occurred in petrol (40-60 °C) and THF (Table 9, entries 9 and 10). No reaction occurred 
in methyl tert-butyl ether, DMSO or 1,2-dichloroethane (Table 9, entries 11-13). Use of 
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an alcoholic solvent gave no reaction, presumably as a result of deactivation of 
B(OCH2CF3)3 (Table 9, entries 14-16). 
Table 9 Solvent screen for ʟ-alanine and benzylamine coupling 
 
Entry Solvent Temperature (°C) Conversion (%)a 
1 MeCN 80 65 
2 MeCNb 80 65 
3 MeCNc 80 34 
4 MeCNd 80 0 
5 1,4-Dioxaneb 80 12 
6 EtOAc 80 14e 
7 Toluene 80 18 
8 CHCl3 60 14 
9 Petrol (40-60 °C) 60 5 
10 THF 60 2 
11 TBME 60 0 
12 DMSO 80 0 
13 1,2-Dichloroethane 80 0 
14 MeOH 60 0 
15 CF3CH2OH 80 0 
16 EtOH 80 0 
aMeasured relative to residual benzylamine by 1H-NMR; bAnhydrous; c5 h instead of 15 
h reaction time; dNo B(OCH2CF3)3;
 eBnNHCOMe, an amidation product of EtOAc was 
also present. 
A concentration screen of the reaction was carried out to determine the optimum 
concentration for the reaction (Table 10). Increasing or decreasing the concentration 
from the 0.5 M in MeCN used for the amidation of carboxylic acids reduces the 
conversion of the reaction (Table 10, entry 3). As a result the concentration used for the 
amidation of unprotected amino acids remains at 0.5 M. 
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Table 10 Concentration screen 
 
Entry Concentration (M) Conversion (%)a 
1 Neat 21 
2 0.1 19 
3 0.5 65 
4 1.0 38 
5 2.0 45 
aMeasured relative to residual benzylamine by 1H-NMR 
As an attempt to improve the conversion of the reaction and, therefore, the isolated yield 
we carried out a brief investigation into the use of microwave heating to perform the 
unprotected amino acid amidation. Initial results suggested that this may be an efficient 
way to perform the reaction by giving reasonable conversion and greatly reducing the 
reaction time (Table 11, entries 1, 5 and 6). Increasing the reaction time at both 100 °C 
and 120 °C resulted in a decrease in purity of the crude product and an inability to 
measure the conversion by 1H-NMR (Table 11, entries 2-4, 7 and 8). As a result of this 
reduction in purity of the reaction we decided to avoid using the microwave as we 
wanted the reaction to be as clean as possible to aid in purification. 
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Table 11 Microwave reactions of ʟ-alanine and benzylamine 
 
Entry Temperature (°C) Time (mins) Conversion (%)a 
1 100 10 5 
2 100 20 - 
3 100 40 - 
4 100 60 - 
5 120 10 35 
6 120 20 68 
7 120 40 - 
8 120 60 - 
aMeasured relative to residual benzylamine by 1H-NMR 
An additive screen was carried out to determine whether the conversion to product 
could be improved with the presence of an additive other than DIPEA (Table 12). 
Initially varying the equivalents of the substrates as well as DIPEA was investigated. 
Excluding DIPEA from the reaction mixture gave a very low conversion compared to 
the use of DIPEA (Table 12, entries 1 and 2). Using an excess of ʟ-alanine gave 
comparable yields to that observed with one equivalent of ʟ-alanine (Table 12, entry 3). 
An excess of benzylamine reduced the observed conversion (Table 12, entry 4). Using 
an additional equivalent of B(OCH2CF3)3 as the additive along with one equivalent of 
DIPEA gave the best conversion (Table 12 entry 5). Use of MgSO4 as a drying agent to 
remove the water generated in the reaction and drive the reaction forward did quite the 
opposite as the reaction completely stopped (Table 12, entry 7). Several different 
tertiary amine bases were investigated as alternatives to DIPEA, however, none of these 
gave improved conversion (Table 12, entries 8-16). Use of ethanolamine based tertiary 
amines gave negligible conversion, this is presumably due to deactivation of 
B(OCH2CF3)3 by chelation. Using trimethoxyboroxine with and without DIPEA gave 
very low conversion (Table 12, entries 17 and 18), which is curious given that 
trimethoxyboroxine displays reasonable utility in the amidation of phenylacetic acid 
with benzylamine. 
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Table 12 Additive screen 
 
Entry Additive Conversion (%)a 
1 No additive 12 
2 DIPEA 65 
3 DIPEA, ʟ-Alanineb 63 
4 Benzylaminec 36 
5 B(OCH2CF3)3, DIPEA 71 
6 B(OCH2CF3)3, ʟ-Alanine, DIPEAb 48 
7 MgSO4 0 
8 Imidazole 13 
9 N-Methylimidazole 3 
10 NEt3 28 
11 n-Bu3N 11 
12 DBU 9 
13 Pyridine 49 
14 N, N-Diethylaniline 53 
15 Triethanolamine 1 
16 N,N-Dimethylethanolamine 7 
17 Trimethoxyboroxined 4 
18 Trimethoxyboroxine, DIPEA 4 
aMeasured relative to residual benzylamine by 1H-NMR, bL-alanine (0.5 equiv.), DIPEA 
(1.5 equiv.), c0.5 equiv., dNo DIPEA, 
As a result of these studies the optimum conditions for the B(OCH2CF3)3-mediated 
amidation of ʟ-alanine are as follows: carboxylic acid (1 equiv.), amine (1 equiv.), 
DIPEA (1 equiv.) and B(OCH2CF3)3 (3 equiv.) in MeCN (0.5 M) at 80 °C for 15 h.   
3.2.3.  Further optimisation of unprotected amino acid amidation 
We decided to approach the further optimisation of this reaction from a different angle, 
this time utilising an internal standard to directly quantify the yield of the reaction 
relative to the limiting reagent. For this optimisation we used the amidation of ʟ-
phenylalanine by benzylamine as the model system as some solubility issues were 
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observed with ʟ-alanine. Additionally, separation of the ʟ-alanine benzylamide product 
from benzylamine was proving troublesome so we sought a more lipophilic amino acid 
to simplify the isolation process. We initially carried out a solvent screen which 
investigated ‘greener’ solvents than the solvents investigated in the solvent screen. 
Suitable, readily available, solvents were chosen with reference to GSK’s green solvent 
guide.90 
The reaction was carried out under the optimum conditions from the previous screens 
[acid (1 equiv.), amine (1 equiv.), B(OCH2CF3)3 (3 equiv.), DIPEA (1 equiv.) in MeCN 
(0.5 M)]. In this case alcoholic solvents were not investigated as they had previously 
been shown to be unsuitable. Following the selection of available solvents we found 
that toluene, EtOAc, 2-MeTHF and TBME all gave moderate conversions (Table 13, 
entries 2-5). Some of these solvents were investigated in the previous solvent screen and 
did not perform as well, this may be due to the relative solubilities of ʟ-alanine and ʟ-
phenylalanine in these solvents. We were pleasantly surprised that dimethylcarbonate 
gave a reasonable conversion and that cyclopentyl methyl ether (CPME) was 
comparable in performance to MeCN (Table 13, entries 1, 6 and 7). Carrying out the 
reaction in CPME at 100 and 125 °C led to further improvements in the conversion 
(Table 13, entries 8 and 9). 
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Table 13 Solvent screen for unprotected amino acid amidation 
 
Entry Solvent Yield (%)a 
1 MeCN 61 
2 Toluene 39 
3 EtOAc 33 
4 2-MeTHF 43 
5 TBME 39 
6 Dimethylcarbonate 51 
7 CPME 65 
8 CPMEb 69 
9 CPMEc 89 
aYield measured by 1H-NMR using naphthalene internal standard; b100 °C; c125 °C 
Due to the similar conversion observed using both MeCN and CPME we elected to 
optimise the reaction in both solvents. As we had seen a potential solubility difference 
between ʟ-alanine and ʟ-phenylalanine in the two solvent screens we felt that either 
MeCN or CPME would be suitable for the amidation depending on the amino acid used. 
The optimisation of the reaction in MeCN is detailed in Table 14. Compared to the yield 
observed in MeCN for equimolar quantities of ʟ-phenylalanine and benzylamine using a 
slight excess of ʟ-phenylalanine does not have a detrimental effect on the yield, 
however a larger excess does have an impact on the yield of the reaction (Table 14, 
entry 1-3). However, excess benzylamine has a positive effect on the yield of the 
reaction, which plateaus around 2 equivalents (Table 14, entries 4 and 5). Providing the 
excess base as a tertiary amine (DIPEA) that does not take part in the reaction does not 
improve the reaction yield (Table 14, entry 6). 
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Table 14 Unprotected amino acid amidation optimisation in MeCN 
 
Entry 
ʟ-Phenylalanine 
(equiv.) 
Benzylamine 
(equiv.) 
DIPEA (equiv.) 
Yield 
(%)a 
1 1 1 1 61 
2 1.5 1 1.5 62 
3 2 1 2 40 
4 1 2 1 84 
5 1 3 1 86 
6 1 1 2 61 
aYield measured by 1H-NMR using naphthalene internal standard.  
We also carried out a reaction optimisation in CPME as this would be the preferred 
solvent due its green credentials (Table 15). The observations of this optimisation are in 
agreement with those made in the reaction optimisation in MeCN (Table 15). However, 
in this case increasing the number of equivalents of ʟ-phenylalanine to 1.5 does begin to 
have a positive effect on the yield of the reaction, although increasing to 2 equivalents 
begins to reduce the yield observed (Table 15, entries 1-3). In keeping with the 
observations of the MeCN optimisation, increasing the number of equivalents of 
benzylamine significantly improves the yield of the reaction (Table 15, entries 4 and 5). 
Using triethylamine as the basic additive in place of DIPEA has a detrimental effect in 
the yield (Table 15, entry 6). Again, using DIPEA to provide the excess base instead of 
excess benzylamine decreases the reaction yield (Table 15, entry 7). In the presence of 
excess benzylamine, the basic DIPEA additive is not required as a comparable reaction 
yield is observed (Table 15, entry 8). Reducing the loading of B(OCH2CF3)3 from 3 to 2 
equivalents still gives a reasonable yield but it is nowhere near the excellent yield 
observed in the presence of 3 equivalents of B(OCH2CF)3 (Table 15, entry 9).  
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Table 15 Unprotected amino acid amidation optimisation in CPME 
 
Entry 
ʟ-Phenylalanine 
(equiv.) 
Benzylamine 
(equiv.) 
DIPEA (equiv.) 
Yield 
(%)a 
1 1 1 1 65 
2 1.5 1 1.5 74 
3 2 1 2 68 
4 1 2 1 86 
5 1 3 1 90 
6 1 3 1b 82 
7 1 1 2 63 
8 1 3 0 95 
9c 1 3 0 72 
aYield measured by 1H-NMR using naphthalene internal standard; bNEt3 used in place 
of DIPEA; cB(OCH2CF3)3 (2 equiv.). 
The commercially available B(OMe)3 was trialled in the reaction to ensure that 
B(OCH2CF3)3 also conferred an advantage in the case of unprotected amino acid 
amidation, the yield observed using B(OMe)3 was negligible (Scheme 75). 
 
Scheme 75 B(OMe)3-mediated amidation of ʟ-phenylalanine. Conversion measured by 
1H-NMR using naphthalene internal standard 
As the boiling point of CPME is significantly higher than MeCN (106 °C compared to 
81 °C) we investigated whether a higher temperature would be advantageous to the 
yield in the unprotected amino acid amidation (Table 16). Increasing the reaction 
temperature to 100 °C does not have a significant impact on the yield whereas 
increasing the reaction tempertature to 125 °C results in a large increase in the yield 
(Table 16, entries 1 and 2). At this higher temperature increasing the equivalents of 
benzylamine used does not have an impact on the yield (Table 16, entries 3 and 4). 
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Again, removing DIPEA from the reaction mixture does not have a detrimental effect 
on the yield (Table 16, entry 5). 
Table 16 Unprotected amino acid amidation optimisation in CPME at higher 
temperatures 
 
Entry 
ʟ-Phenylalanine 
(equiv.) 
Benzylamine 
(equiv.) 
DIPEA 
(equiv.) 
T 
(°C) 
Yield 
(%)a 
1 1 1 1 100 69 
2 1 1 1 125 89 
3 1 2 1 125 82 
4 1 3 1 125 92 
5 1 3 0 125 91 
aYield measured by 1H-NMR using naphthalene internal standard. 
As a result of this series of optimisations the final procedure for B(OCH2CF3)3-
mediated amidation of unprotected amino acids is as follows: amino acid (1 equiv.), 
amine (3 equiv.), B(OCH2CF3)3 (3 equiv.) in CPME at 80 °C for 15 h. If this procedure 
does not give sufficient yield of the amide product this may be a result of low amino 
acid solubility in CPME, in this case MeCN can be used as the solvent to improve 
amino acid solubility. 
If it is the case that the amidation is being carried out with a ‘valuable’ amine then it is 
possible to perform the reaction with the amino acid in excess albeit in lower yield 
(Table 17). Carrying out the amidation with excess ʟ-phenylalanine and DIPEA gives 
the amide product in poor yield (Table 17, entry 1). This can be improved upon by 
using NEt3 as the excess base (Table 17, entry 2). 
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Table 17 Unprotected amino acid amidation optimisation for ‘valuable’ amine 
 
Entry 
ʟ-Phenylalanine 
(equiv.) 
Benzylamine 
(equiv.) 
Tertiary amine 
Yield 
(%)a 
1 1 ⅓ DIPEA 14 
2 1 ⅓ NEt3 49 
aYield measured by 1H-NMR using naphthalene internal standard. 
3.3.  Scope of the B(OCH2CF3)3-mediated amidation of unprotected amino 
acids 
To evaluate the scope of the B(OCH2CF3)3-mediated unprotected amino acid amidation 
we subjected all natural as well as some unnatural amino acids to an amidation with n-
propylamine (Scheme 76). n-Propylamine was used for this study due to its low boiling 
point and hence the ease with which any excess amine could be removed from the 
reaction mixture. The conversion to amide product was measured by 1H-NMR in the 
presence of naphthalene as an internal standard. Some of the examples in which the 
amide product was obtained in a synthetically useful conversion (>~70%) were isolated 
as either the hydrochloride salt or the free amine. These amides were purified with the 
solid-phase work-up, in this case only AmberlystTM A26(OH) and AmberliteTM IRA743 
were used. The excess n-propylamine could be removed under vacuum. 
Amino acids with nonpolar side chains – ʟ-phenylalanine, ʟ-methionine, ʟ-leucine, ʟ-p-
hydroxyphenylglycine, ʟ-proline and sarcosine – all react well under the reaction 
conditions to give the amide product in excellent yield (77a-77f). Diamidation of ʟ-
aspartic acid can be carried out in good yield, although 6 equivalents of amine and 4 
equivalents of B(OCH2CF3)3 are required (77g). Lactamisation of the side chain of ʟ-
glutamic acid as well as amidation of the carboxylic acid proceeds in good yield (77h). 
β-Alanine undergoes amidation in moderate yield in CPME and a switch to MeCN did 
not improve the yield (77i). Interestingly, ʟ-cysteine provides the amide product in good 
yield in CPME at 125 °C, but no reaction occurs in MeCN (77j). Similarly, increasing 
the reaction temperature to 125 °C in CPME gives quantitative conversion for the ʟ-
valine amidation (77k). Amidation proceeds in excellent yield in the case of ʟ-alanine 
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and ʟ-phenylglycine in MeCN (77l and 77m). The amidation of glycine, ʟ-isoleucine 
and ʟ-tyrosine occurs in poor yield in CPME, a solvent change to MeCN improved 
these to moderate yields (77n-77p). Subjecting ʟ-lysine to the reaction conditions 
results in lactamisation of the amine in the amino acid side-chain (77q). 
Heteroaromatic-containing amino acids, ʟ-tryptophan and ʟ-histidine, undergo 
amidation in low to moderate yield in both CPME and MeCN (77r and 77s). Amino 
acids with primary amide side chains, ʟ-asparagine and ʟ-glutamine, both give low 
yields for the amidation in both CPME and MeCN (77t and 77u). In the case of ʟ-
glutamine a significant quantity of the cyclisation product from transamidation was also 
observed (77h). ʟ-Serine does not undergo amidation at all either in CPME or MeCN, 
interestingly ʟ-homoserine and ʟ-threonine do undergo amidation in CPME and MeCN, 
respectively, however only in low yield (77v-77x). Presumably the lack of reactivity in 
ʟ-serine is due to complex formation between the hydroxyl group on ʟ-serine and 
B(OCH2CF3)3, which does not form in the case of ʟ-homoserine and ʟ-threonine. In the 
case of ʟ-serine only decomposition was observed by 1H-NMR. ʟ-Arginine did not 
undergo amidation at all in either CPME or MeCN, only starting material remained 
presumably due to a lack of solubility in either of these solvents (77y). 
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Scheme 76 Amino acid scope in B(OCH2CF3)3-mediated unprotected amino acid 
amidation. Conversion measured by 1H-NMR with naphthalene internal standard, 
isolated yield in parentheses. aCPME (0.5 M); bIsolated as hydrochloride salt; cIsolated 
as free amine; dB(OCH2CF3)3 (4 equiv.), propylamine (6 equiv.); 
eIsolated yield; f125 
°C; gMeCN (0.5 M); hNo propylamine, DIPEA (3 equiv.); i15% transamidation 
cyclisation product 77h also observed. 
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Amides 77a, 77f, 77g and 77l were obtained as the hydrochloride salt. Amides 77b, 
77c, 77e and 77k were isolated as the free amine as the hydrochloride salts of these 
amides were incredibly hygroscopic and could not be obtained as a sufficiently dry salt. 
The isolated yields of these amide products was in good agreement with the conversion 
measured by 1H-NMR.  
The amine scope for the B(OCH2CF3)3-mediated amidation reaction was evaluated by 
preparing amides of ʟ-phenylalanine (Scheme 77). The amidation of ʟ-phenylalanine 
with benzylamine derivatives all proceed in excellent conversion, including those 
containing pyridine rings (78a-e). Although benzylamine derivatives with α-substituents 
require a higher reaction temperature to achieve reasonable conversion (78e). Aliphatic 
amines, including unsaturated amines, those with α-substituents and perfluoroamines, 
amidate ʟ-phenylalanine in excellent conversion (78f-i). Amines with lower 
nucleophilicity such as aniline and the more electron-rich p-anisidine furnish the 
corresponding amide product under the reaction conditions, however, higher reaction 
temperatures are necessary to achieve a synthetically useful conversion (78j and 78k). 
Tertiary amides can be prepared by amidation of ʟ-phenylalanine with secondary 
amines, although higher temperatures are required for reasonable conversion (78l and 
78m). Ethanolamine and tert-butylamine were unreactive under the reaction conditions, 
even at 125 °C (78n and 78o). 
Amides 78b, 78c and 78h were isolated as the free amine, 78f was isolated as the 
hydrochloride salt. No racemisation was observed in the case of 78e. The 
enantiopurities of 78b and 78f were measured by chiral HPLC, in these cases some 
racemisation was observed. The source of this racemisation is not clear but may be 
related to the excess amine present in the reaction mixture. 
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Scheme 77 Amine scope in B(OCH2CF3)3-mediated unprotected amino acid amidation. 
Conversion measured by 1H-NMR with naphthalene internal standard, isolated yield in 
parentheses. aIsolated as free amine; ber measured by chiral HPLC; c125 °C; dIsolated as 
hydrochloride salt. 
3.4.  A new chiral amine enantiomeric ratio determination method 
3.4.1.  Background 
During the course of our research into the amidation of unprotected amino acids 
mediated by B(OCH2CF3)3, it became necessary to find a simple way to measure the er 
of the products. We initially intended to use chiral HPLC, however, due to the free 
amine present in the product, an additional step would be required to protect the amine. 
The amine would be protected with either Boc anhydride or benzoyl chloride 
(depending on whether the product contained a chromophore) and the products of both 
these protection methods require purification. Additionally, synthesising the N-Boc or 
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N-benzoyl derivative of the product would somewhat defeat the objective of the 
methodology. We felt that a less laborious method of determining the er of these 
unprotected amino acid amides would be preferable, ideally by use of easily accessible 
1H-NMR. 
With this in mind, we sought a way to derivatise these chiral products as diastereomers 
to measure the er by 1H-NMR. The use of Mosher’s acid (α-methoxy-α-
trifluoromethylphenylacetic acid) was a possibility (Scheme 78a).91 However, this can 
require the use of the acid chloride to ensure that the amidation proceeds to completion. 
Additionally, the use of the similar Trost’s O-methylmandelic acid protocol could also 
be considered (Scheme 78b).92 However, the derivatisation of the amine required either 
a DCC-mediated amide coupling or use of pre-synthesis of the acid chloride, followed 
by purification by column chromatography, before the dr could be measured by NMR. 
Both of these derivatisation methods result in the formation of an irreversible bond and 
can give rotamers of the amide product, which can complicate the NMR analysis and 
potentially give inaccurate dr measurements. Obviously these procedures are more 
laborious than we had envisaged. 
 
Scheme 78 a) S- and R- α-methoxy-α-trifluoromethylphenylacetic acid; b) S- and R-O-
methylmandelic acid; a) S- and R- α-methoxy-α-trifluoromethylphenylacetic acid 
The eventual chosen method was using a chiral aldehyde to generate diastereomeric 
imines which should be distinguishable by 1H-NMR and allow recovery of the amino 
acid amide product following er determination. After searching the literature to establish 
if such a method has been published, we found one paper describing the use of 2-
formylphenyl boronic acid and (S)-BINOL in combination with a racemic amine to 
generate diastereomeric imine complexes that are distinguishable in 1H-NMR (Scheme 
79, 79-(S,R) and 79-(S,S)).93  
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Scheme 79 Diastereomeric imine complex to determine ee of chiral amine 
Applying this method to our unprotected amino acid amides was not entirely reliable as 
there were some issues with solubility of the complex so we could not be sure that all of 
the unprotected amino acid amide had reacted to form the complex or that the results 
would be reproducible. Additionally, this method has only been shown to measure the 
ee of an amine on one example, α-methylbenzylamine, with reasonable accuracy (Table 
18). 
Table 18 ee measurement using chiral BINOL imine complex 
Proton Integration %ee 
CHN 11.1:1 83.5 
CH(CH3)N 8.3:1 78.5 
 
A review of the literature shows that Dufrasne et al. made use of 1R-(−)-myrtenal as a 
chiral derivatising agent (Scheme 80).94 This is a simple method as it only requires the 
reaction of two components (the chiral amine and the chiral aldehyde), however, the 
reaction is left for 12 h before the 1H-NMR is run which is not ideal as we sought a 
method that would provide an er measurement in a timely fashion. This er 
determination method can be used for aliphatic primary amines, β-aminoalcohols, β-
diamines and α-amino-acids. Only amines with α- or β-aryl substituents could be 
resolved using this methodology. A complement to this method is also reported by 
Dufrasne et al., that utilises 13C-NMR integrations to measure the er of the produced 
imines. In this case the amines do not need to contain an aromatic moiety.95 They 
measure either C=N-C or C=N-C to determine the er of the amine after shaking the two 
73 
 
components in an NMR tube at rt for 1 h. One drawback of the use of 1R-(−)-myrtenal 
is that both enantiomers of the chiral amine are required to reliably determine the 
enantiopurity of the amine. This may not always be possible depending on the method 
used to synthesise the amine. Ideally, using 1S-(+)-myrtenal would avoid this and 
provide a check for the enantiopurity, however, 1S-(+)-myrtenal is not commercially 
available. 
 
Scheme 80 1R-(−)-Myrtenal as a chiral derivatising agent 
3.4.2.  Our method 
Due to the ready availability of both enantiomers of citronellal in our labs, initial 
attempts at this proposed method of er determination looked at the use of this chiral 
aldehyde. Our initial hope was to generate the imines of ʟ- and ᴅʟ-alanine propylamide 
from (+)-citronellal and to analyse these by 1H-NMR. We hoped to use the ratio of the 
imine proton of each diastereomer to measure the ratio of enantiomers. Unfortunately 
this was not as simple as we had hoped as the imine peaks for each diastereomer were 
obviously triplets and also overlapped in the spectrum making it impossible to 
separately integrate the two signals. However, separation of the two imine carbon 
signals was observed in the 13C-NMR. These signals were separate but rather close in 
proximity (0.05 ppm) so there is the potential for overlap when looking at different 
chiral amines. Ideally we wished to integrate signals in the 1H-NMR to determine the er 
of the amine. We sought another chiral aldehyde to determine whether we could observe 
separation in the 1H-NMR or even larger separation in the 13C-NMR. 
 
Scheme 81 (+)-Citronellal 
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With this in mind, we looked at the aldehyde derived from TBS-protected ethyl lactate 
80. This is synthesised by protection of S-ethyl lactate with TBS-Cl to give ester 80 
followed by DIBAL-H reduction of ester 80 to aldehyde 81 (Scheme 82). 
 
Scheme 82 Preparation of chiral aldehyde (S)-81 
Reaction of aldehyde (S)-81 with both enantiomers of a model amine (ʟ and ᴅʟ-alanine 
propylamide) was carried out to determine whether the imine proton, or carbon, in the 
diastereomeric imines ʟ and ᴅʟ-82 were distinguishable by NMR (Scheme 83). 
Unfortunately, we observed overlap of the imine protons by 1H-NMR (Figure 8), but the 
imine carbons were distinguishable by 13C-NMR and could be integrated (Figure 9). As 
analogous diastereomeric carbons which share the same environment are being 
integrated it is possible to infer a dr (and therefore er) from the integral ratio. 
 
Scheme 83 Formation of diastereomeric imines 
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Figure 8 1H-NMR of ʟ and ᴅʟ-82 
 
Figure 9 13C-NMR of ʟ and ᴅʟ-82 
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The initial investigation had been carried out in MeOD-d4 so a comparison of other 
deuterated solvents was carried out to determine which gave the largest peak separation 
of the imine carbon peak. While the imine carbon signal is distinguishable in all the 
deuterated solvents explored, the largest peak separation was observed with MeOD-d4 
(Table 19). 
Table 19 Comparison of imine carbon peak separation in different deuterated solvents 
Entry Solvent Peak separation (ppm) 
1 CDCl3 0.11 
2 DMSO-d6 0.09 
3 MeOD-d4 0.21 
4 C6D6 0.13 
 
To develop a robust method to determine er which would not depend on having both 
enantiomers of the chiral amine, we synthesised the R enantiomer of 81 to provide a 
check of the enantiopurity measured by (S)-81. This was synthesised in a similar way to 
(S)-81 starting from R-methyl lactate as this is significantly cheaper than R-ethyl lactate 
(Scheme 84). 
 
Scheme 84 Preparation of chiral aldehyde (R)-81 
With this in mind, we wanted to ensure that the aldehyde was reliable as a chiral 
derivatising agent. This was carried out by analysis of both enantiomers of three 
commercially available α-chiral amines, α-methyl benzylamine, 1,2,3,4-tetrahydro-1-
naphthylamine and 1-cyclohexylethylamine as well as some ‘real’ examples taken from 
earlier amidation work: N-Boc-ʟ-methionine-benzylamide, N-Boc-ʟ-alanine-
benzylamide and N-Boc-ʟ-phenylalanine-benzylamide. 
Reaction of (S)- and (R)-81 with (S)- and (R)-1-cyclohexylethylamine 83 gives 4 
diastereomers and 2 enantiomers (Scheme 85). The imine carbons of these 
diastereomers are distinguishable by 13C-NMR. With both enantiomers of aldehyde 81, 
we were able to form the diastereomeric imines from each enantiomer of the amine to 
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measure the optical purity of these chiral amines (Table 20). In addition, a roughly 
50:50 sample of both enantiomers of 83 was prepared (R:S 49:51) which displays the 
accuracy of this method. 
 
Scheme 85 Reaction of (S)- and (R)-81 with (S)- and (R)-83 
Table 20 er for 1-cyclohexylethylamine 83 
Amine 83 Aldehyde 81 S R 
R  2:98 99:1 
S  98:2 1:99 
R:S (49:51)  51:49 49:51 
 
In parallel with the evaluation of (S)- and (R)-83, we also carried out the same study 
with (S)- and (R)-1,2,3,4-tetrahydro-1-naphthylamine 84 (Scheme 86). Again, there is 
good distinction between the imine carbons by 13C-NMR and good agreement with the 
measured er values (Table 21). 
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Scheme 86 Reaction of (S)- and (R)-81 with (S)- and (R)-84 
Table 21 er for 1,2,3,4-tetrahydro-1-naphthylamine 84 
Amine 84 Aldehyde 81 S R 
R  2:98 99:1 
S  98:2 1:99 
R:S (51:49)  49:51 51:49 
 
Similarly, (S)- and (R)-α-methylbenzylamine 85 also display good agreement between 
each enantiomer of the chiral aldehyde 81, as well as distinguishable carbon signals to 
measure ratios of the amine (Scheme 87 and Table 22). 
 
 
Scheme 87 Reaction of (S)- and (R)-81 with (S)- and (R)-85 
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Table 22 er for α-methylbenzylamine 85 
Amine 85 Aldehyde 81 S R 
R  3:97 98:2 
S  98:2 1:99 
R:S (50:50)  52:48 49:51 
 
The real examples were synthesised via our standard amidation method (vide supra) and 
then the enantiopurity analysed by chiral HPLC.59 The enantiopurity was then measured 
with (S)- and (R)-81 using our chiral aldehyde method following Boc-deprotection with 
TFA/DCM (Table 23). There is good agreement between the er measured by chiral 
HPLC and the er measured by the chiral aldehyde method in each case. 
Table 23 Enantiopurity measurement of amines compared to chiral HPLC 
Amide er by chiral HPLC er by (S)-81a er by (R)-81a 
 
98:2 98:2 1:99 
 
>99:1 99:1 1:99 
 
99:1 98:2 3:97 
aer by chiral aldehyde method measured after Boc-deprotection by TFA/DCM 
These results indicate that er determination using aldehyde 81 is possible and that the 
method is in agreement with the er measured by chiral HPLC. In order to fully verify 
the method ‘blind tests’ were carried out with three chiral amines by three 
experimenters – Laure Benhamou, Sam Gibson and myself. Each experimenter prepared 
a sample of unknown enantiopurity from all three amines (83-85). This sample was then 
analysed by the other two experimenters and the measured er reported and then 
compared to the er as measured by weight (Table 24). The results of this blind test were 
generally promising with excellent agreement of the measured enantiopurity with the 
actual enantiopurity as well as between sample testers for each sample. However, 
amines with high enantiopurity are underestimated by this method (Table 24, samples 
85 – B, 85 – C and 83 – C). This suggests that the chiral aldehyde 81 may not be 
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enantiopure, which would affect amines with higher enantiopurities more than those 
with lower enantiopurities. However, based on the results above this does not appear to 
be the case. 
Table 24 ‘Blind test’ of aldehyde 81 er determination 
 
Sample 
Actual 
R:S 
Adjusted 
R:S* 
Tester 
(S)-aldehyde 
measurement 
(R)-aldehyde 
measurement 
85 – A 70:30 69:31 
B 32:68 71:29 
C 31:69 68:32 
84 – A 34:66 34:66 
B 65:35 34:66 
C 65:35 35:65 
83 – A 79:21 77:23 
B 23:77 77:23 
C 23:77 79:21 
85 – B 5:95 6:94 
A 9:91 92:8 
C 10:90 92:8 
84 – B 87:13 86:14 
A 86:14 13:87 
C 85:15 15:85 
83 – B 23:77 24:76 
A 76:24 25:75 
C 75:25 24:76 
85 – C 90:10 89:11 
A 12:88 87:13 
B 14:86 87:13 
84 – C 53:47 53:47 
A 48:52 53:47 
B 48:52 53:47 
83 – C 15:85 16:84 
A 82:18 17:83 
B 81:19 17:83 
* Adjusted in relation to measured enantiopurities of 83-85 (Table 20-Table 22) 
It is also possible that racemisation could occur during imine formation or on standing. 
This was investigated by rerunning the NMR of the inaccurate samples again, 4 days 
later, the imines had not racemised any further on standing (Table 25). This suggests 
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that there is potentially an as yet unidentified problem in the case of amines of high 
enantiopurity. 
Table 25 Check of inaccurate samples 
Sample 
Actual 
R:S 
Tester (S)-aldehyde rerun (R)-aldehyde rerun 
85 – B 5:95 A 9:91 92:8 
85 – C 90:10 A 13:87 88:12 
83 – C 15:85 A 82:18 17:83 
 
It seems that this method performs well although issues were evident with amines of 
high enantiopurity. However, with these results in hand we wished to trial this method 
for the er determination of some examples of the B(OCH2CF3)3-mediated unprotected 
amino acid amidation (Figure 10). Unfortunately, this method does not appear to be 
broadly applicable to this type of compound. In some cases the imine carbon signals 
from each diastereomer were distinct and could be easily integrated (77a-c and 77l-k). 
In general, good retention of enantiopurity was observed (77a-c and 77l), however in 
the case of ʟ-valine a significant erosion of enantiopurity was observed (77k). 
Presumably this can be attributed to the high reaction temperature required for the 
amidation. In the case of amides 77g, 78b, 78c, 77f and 78h the signals for each 
diastereomer were not separable so the er could not be measured by 13C-NMR in those 
cases. It must also be noted that these measures of er are an indication of the minimum 
level of the enantiopurity. 
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Figure 10 Attempted er measurement of unprotected amino acid amidation products 
with aldehyde 81 
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4. B(OCH2CF3)3-mediated amidation mechanistic study 
4.1.  Background 
With a view to gaining a deeper understanding of the mechanism of the B(OCH2CF3)3-
mediated amidation reaction, a mechanistic study was undertaken. We expected that the 
B(OCH2CF3)3-mediated amidation would proceed via a similar mechanism to that 
reported for boronic acid-catalysed amidations. 
The mechanism of boronic acid-catalysed amidation has been the subject of a number of 
recent studies. There is general agreement in the literature that boronic acid catalysis of 
amidation proceeds via an acyloxyboron intermediate (86 or 87), which is the active 
acylating species in the reaction. The monoacyloxyboron species 86 was isolated and 
partially characterised (1H-NMR and IR) by Yamamoto in the seminal work on boronic 
acid catalysis of amidation.41 However, in the mechanistic investigation by Whiting, the 
monoacyloxyboron species 86 was not observed by mass spectrometry methods but, 
interestingly, the diacyloxyboron species 87 was.96 
 
Scheme 88 Proposed formation of mono and diacyloxyboron species in boronic acid 
catalysed amidation 
Marcelli reported a gas phase theoretical study of the methyl boronic acid-catalysed 88 
amidation of acetic acid by methylamine (Scheme 89).97 Formation of the 
monoacyloxyboron species 89 from acetic acid and methylboronic acid is a facile 
process (step 1). The barrier to formation of a diacyloxyboron species was found to be 
too high and therefore not a feasible reaction intermediate.  Reaction of the tricoordinate 
acyloxyboron species 90 with methylamine to form 91 was found to be less favourable 
than reaction of the tetracoordinate acyloxyboron species 89 with methylamine (step 2). 
The rate determining step of this mechanism was proposed to be the formation of the 
amide from the boron bound hemiaminal (step 3). 
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Scheme 89 Boronic acid-catalysed amidation mechanism proposed by Marcelli 
Marcelli97 also investigated the o-iodophenylboronic acid catalyst reported by Hall50 to 
explain the exceptional reactivity it displays compared to other phenylboronic acid 
catalysts. It was shown that the iodine atom can stabilise the rate determining transition 
state via an intramolecular O−H···I hydrogen bond 92 (Figure 11).  
 
Figure 11 Proposed hydrogen-bonded transition state of o-iodobenzene boronic acid-
catalysed amidation 
Subsequently, Fu reported on the mechanism of the phenylboronic acid-catalysed 
amidation of acetic acid by methylamine.98 In contrast to Marcelli’s report, in this 
mechanistic study the role of the solvent (dichloroethane) was taken into account. 
Importantly, 2-phenylacetic acid can undergo amidation with benzylamine to give the 
corresponding amide in 31% yield. This amidation is catalysed by phenylboronic acid 
(20 mol%) in dichloroethane in the presence of 4 Å mol sieves at 35–40 °C for 48 h.50 
The most stable form of acetic acid and methylamine in dichloroethane was found to be 
as the individual molecules. The formation of both the mono 93 and diacyloxyboronic 
acid intermediates 94 was found to be kinetically favourable although the equilibrium 
lies to the left. This equilibrium can be driven to the right by removing water from the 
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reaction mixture (molecular sieves). The removal of water is not required in the 
mechanism proposed by Marcelli. 
 
Scheme 90 Formation of mono and diacyloxyboronic acid intermediates 
Fu established that the diacyloxyboronic acid intermediate 94 is unlikely to form and 
therefore the monoacyloxyboronic acid intermediate 93 is the most likely intermediate 
in the formation of the amide bond. The rate determining step was calculated to be the 
C-O bond cleavage to form the amide from the hemiaminal intermediate 95 (Scheme 
91). The proposed mechanism is shown in Scheme 92. 
 
Scheme 91 Formation of amide from monoacyloxyboronic acid intermediate 
 
Scheme 92 Mechanism for boronic acid-catalysed amidation proposed by Fu 
Fu also considered the o-iodophenylboronic acid reported by Hall.50 The steric bulk of 
the o-iodo substituent as well as the orbital overlap of the filled sp2 orbital of the iodine 
and the empty p orbital of the boron was proposed to assist in the stabilisation of the 
transition state 96 (Figure 12). 
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Figure 12 Proposed orbital overlap in transition state of o-iodobenzene boronic acid-
catalysed amidation 
Early work by Pelter et al. discussed the mechanism of the reaction between 
acyloxyboranes and amines (Scheme 93).99 Reaction of monoacyloxydialkyloxyboranes 
with amines was shown to be a viable route to amides, however, the conversion to 
amide product was low (30-50%). 
 
Scheme 93 In situ formation of 97 and subsequent amidation 
Pelter et al. investigated this reaction to elucidate the low conversions observed.99 A 
monoacyloxydialkoxyborane 97 formed from a dialkoxyborane and carboxylic was 
shown to be susceptible to reduction by any residual dialkoxyborane, however, in the 
case of B(OCH2CF3)3-mediated amidation this is not a consideration. 97 was stable in 
solution but degraded to anhydride in the presence of acid, however this should not be 
detrimental to the yield as the anhydride can also react to form amide as long as there 
are sufficient quantities of acid (Scheme 94).  
 
Scheme 94 Anhydride formation from 97 
Additionally, Pelter et al. highlighted observations that explain the lack of ester 
formation mediated by B(OMe)3 (or B(OCH2CF3)3).
99 Addition of iso-propanol to 97 
(where R1 = C5H11 and R
2 = iPr) exclusively led to triisopropoxyborane and hexanoic 
acid, and none of the corresponding ester was observed (Scheme 95). 
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Scheme 95 Solvolysis of 97 
To establish whether an amine would have a detrimental effect on the reaction by acting 
in the same way as an alcohol the reaction of di-n-butoxyethylaminoborane 98 and 
benzoic acid was carried out (Scheme 96). Although the reaction required high 
temperature and a long reaction time the corresponding amide was formed in moderate 
yield suggesting that 98 may be a viable intermediate. 
 
Scheme 96 Amidation of benzoic acid using 98 
4.2.  NMR study 
We expected that the B(OCH2CF3)3-mediated amidation might follow a similar 
mechanism to that reported in the literature for boronic acid-catalysed amidations 
(Scheme 97, vide supra). However, from the observations made in our preliminary 
NMR study, the B(OCH2CF3)3-mediated amidation does not seem to follow the reaction 
pathway shown in Scheme 89 or Scheme 91. 
 
Scheme 97 Proposed B(OR2)3-mediated amidation mechanism 
A brief NMR study was carried out to determine the different interactions in the 
reaction mixture over the course of the reaction (see Appendix). The model reaction 
investigated was the amidation of p-tolylacetic acid with butylamine due to the easily 
identifiable signals for the starting materials and product. The change in the 1H, 13C, 19F 
and 11B-NMR of the p-tolylacetic acid and B(OCH2CF3)3 mixture (Figure 13, entry 1), 
n-butylamine and B(OCH2CF3)3 (Figure 13, entry 2) as well as the reaction mixture 
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(Figure 13, entry 3) was monitored over time. Each sample was heated at 80 °C over 5 h 
in MeCN-d3 and an aliquot taken before heating and then at 30 min, 3 h and 5h. 
 
Figure 13 NMR reaction mixtures 
The results of the NMR study of the reaction mixture containing p-tolylacetic acid and 
B(OCH2CF3)3 are inconclusive. No interaction between p-tolylacetic acid and 
B(OCH2CF3)3 was observed by 
1H, 13C, 11B and 19F-NMR as both reagents appear 
unchanged over the reaction period (Figure 14). An acyloxyboron species analogous to 
that observed for boronic acid catalysed amidation is not observed by NMR following 
the interaction of p-tolylacetic acid and B(OCH2CF3)3 at 80 °C over 5 h (Figure 13, 
entry 1). However, it is possible that any formation of an acyloxyboron species is too 
rapid on the NMR timescale. This result is broadly in agreement with observations 
reported by Levitt on the B(OMe)3-mediated amidation reaction.
34 B(OMe)3 and 
hexanoic acid were found to interact weakly at room temperature. However, no 
acyloxyboron species was formed. On addition of a catalytic amount of p-
toluenesulfonic acid, facile formation of the acyloxyboron species was observed. Pelter 
found that a solution of 97 was stable in solution over night so it seems likely that if an 
analogous acyloxyboron species is formed in our case that it would be observable by 
NMR.99 
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Figure 14 13C-NMR comparison of p-tolylacetic acid, B(OCH2CF3)3 and p-tolylacetic 
acid-B(OCH2CF3)3 
The NMR evidence suggests that, in the case of B(OCH2CF3)3, one of active species (or 
reaction intermediates) may be an amine-B(OCH2CF3)3 complex, either trigonal 99 or 
tetrahedral 100 at boron (Figure 15). An intermediate of the form 99 would be in 
keeping with observations made by Pelter et al. in the case of B(OMe)3.
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Figure 15 Possible amine-B(OCH2CF3)3 complexes 
Addition of B(OCH2CF3)3 to butylamine at room temperature shows immediate 
disappearance of B(OCH2CF3)3, appearance of CF3CH2OH, and appearance of a new 
amine derived species in both 1H- and 13C-NMR (Figure 16). The signal due to the NH2 
protons in 1H-NMR is shifted downfield from ~1.1 ppm to ~5.3 ppm suggesting 
complexation through nitrogen to B(OCH2CF3)3. As there are two NH protons present 
this indicates the complex may be a structure like 100 with a tetrahedral boron centre 
(Figure 15).  
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Figure 16 13C-NMR comparison of n-butylamine, B(OCH2CF3)3 and n-butylamine-
B(OCH2CF3)3 complex 
This is supported by the results of 11B-NMR which shows the formation of two new 
peaks at 2.7 and 10.0 ppm as the signal due to B(OCH2CF3)3 disappears (17.9 ppm), one 
of these new peaks could be due to the tetrahedral boron species and the other may be 
due to a trigonal boron species (Figure 17). An analogous example to the 
B(OCH2CF3)3-n-butylamine complex is reported in the literature of the ethylamine 
complex of B(OEt)3, B(OEt)3-NH2Et.
100 This pair displays a shift from 18.1 ppm for 
B(OEt)3 to 13.7 ppm for  B(OEt)3-NH2Et.  
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Figure 17 11B-NMR comparison of n-butylamine, B(OCH2CF3)3 and n-butylamine-
B(OCH2CF3)3 complex 
Additionally, two new peaks are also observed in the 19F-NMR spectrum in the absence 
of a B(OCH2CF3)3 signal. The results of the 
19F-NMR are in agreement with the 
observations of the 11B-NMR spectra as both indicate the formation of two new species 
from the mixture of B(OCH2CF3)3 and n-butylamine by the appearance of two new 
signals in both the 11B- and 19F-NMR. 
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Figure 18 19F-NMR comparison of n-butylamine, B(OCH2CF3)3 and n-butylamine-
B(OCH2CF3)3 complex 
We were able to crystallise and obtain a crystal structure of one component of the n-
butylamine-B(OCH2CF3)3 mixture. The species observed in this crystal structure is the 
ammonium salt, [(CF3CH3O)4B]
-[H3N
nBu] (Figure 19 and Figure 20). The origin of the 
additional molecule of CF3CH2OH in this crystal is unclear. However, if the other 
intermediate is the trigonal boron species 99 then the formation of that species can 
explain the source of the additional CF3CH2OH. Alternatively, hydrolysis of 
B(OCH2CF3)3 by any water present in the reaction mixture would liberate CF3CH2OH, 
which could form the salt observed in the crystal structure. This may not necessarily be 
an intermediate in the reaction and may be an artefact of the crystallisation process in 
the presence of water. A similar observation was made by Pelter et al. as on addition of 
methanol to a mixture of trimethoxyborane and tert-butylamine they observed 
[(MeO)4B]
-[H3N
tBu].99 
 
Figure 19 Chemical structure of isolated crystal 
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Figure 20 Crystal structure of isolated borate-amine complex 
Observing the NMR spectra (1H, 13C, 19F and 11B) of the reaction mixture [p-tolylacetic 
acid, n-butylamine and B(OCH2CF3)3] over the course of the reaction indicated that the 
initial complex seen in the reaction mixture is the same as that observed on mixing 
butylamine and B(OCH2CF3)3. This suggests that this complex reacts with the 
carboxylic acid to form the amide product. The amide NH peak can be seen by 1H-NMR 
before the reaction mixture is heated to 80 °C indicating that amide formation takes 
place to some degree at room temperature in the presence of B(OCH2CF3)3. In 
13C-
NMR, the amide C=O peak can be seen gradually increasing alongside the reduction of 
the acid C=O peak over the course of the reaction. These observations suggest that any 
other intermediates present in the reaction mixture may be too short-lived to be 
observable on the NMR timescale. 
4.3.  Rate study 
A rate study was also undertaken with the aim of elucidating the rate law of the 
reaction. Using the same reaction model as that used for the NMR study (p-tolylacetic 
acid and n-butylamine), the reaction was monitored over time by NMR. Each reaction 
was carried out in an NMR tube heated at 50 °C then cooled on ice to analyse the 
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sample. All reactions were carried out in 1 mL MeCN-d3 at a reaction concentration of 
0.5 M, unless otherwise stated. In a preliminary rate study carried out at room 
temperature, the conversion was found to be negligible, even over extended reaction 
times, so the time lapse between cooling the NMR tube and running the NMR (<10 
mins) was not significant. The conversion was measured relative to a naphthalene 
internal standard.  
Firstly, we looked at varying the concentration of p-tolylacetic acid in the reaction 
mixture (Figure 21). On increasing the concentration of acid in the reaction mixture, no 
change was observed in the initial rate of conversion. However, decreasing the 
concentration of the acid by half results in a small increase in the rate of the reaction. 
 
Figure 21 Graph of reaction dependence on p-tolylacetic acid concentration. Full 
conversion at 0.5 M product (0.25 M in the case of 0.25 M acid). Acid (varied), amine 
(0.5 M) and B(OCH2CF3)3 (1 M) in MeCN-d3 (1 mL). 
We then examined the effect of the amine concentration on the reaction (Figure 22). 
There is a negligible reduction in the rate of the reaction on reducing the concentration 
of n-butylamine. Increasing the concentration of n-butylamine has a significant effect on 
the rate of the reaction. However, the effect plateaus when the concentration of n-
butylamine is around 1.5 M. With this in mind, it appears that the improvement in rate 
observed on decreasing the concentration of p-tolylacetic acid is due to the relative 
excess of n-butylamine present in the reaction mixture and, therefore, the increase in pH 
of the reaction. 
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Figure 22 Graph of reaction dependence on n-butylamine concentration. Full 
conversion at 0.5 M product (0.25 M in the case of 0.25 M amine). Acid (0.5 M), amine 
(varied) and B(OCH2CF3)3 (1 M) in MeCN-d3 (1 mL). 
The positive effect that an excess of amine has on the reaction can be exploited to 
improve the yield of amidations involving more challenging substrates. The yield of the 
amidation of benzoic acid with benzylamine can be improved by adding two 
equivalents of excess base either in the form of benzylamine or triethylamine. This 
improves the yield from 47% at 100 °C for 15 h to 78% and 65%, respectively, at 80°C 
for 15 h. Unfortunately, the same effect was not observed for amidation of phenylacetic 
acid with 2-aminopyridine, addition of two equivalents of triethylamine gave a yield of 
15%, which is comparable to the 12% obtained without any excess base. 
To investigate the reaction dependence on B(OCH2CF3)3 we varied the B(OCH2CF3)3 
concentration and found that decreasing the concentration increases the rate of the 
reaction up to a point (Figure 23). At a B(OCH2CF3)3 concentration of around 0.375 M, 
the rate reaches an optimum after which it begins to decrease. This suggests that there is 
an ideal B(OCH2CF3)3 concentration for the reaction to proceed at the best possible rate. 
Adding B(OCH2CF3)3 did appear to improve the initial rate of the reaction, however, 
this improvement begins to tail off. 
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Figure 23 Graph of reaction dependence on B(OCH2CF3)3 concentration. Full 
conversion at 0.5 M product. Acid (0.5 M), amine (0.5 M) and B(OCH2CF3)3 (varied) in 
MeCN-d3 (1 mL). 
Finally, the overall concentration of the reaction has a negligible effect on the rate and 
conversion of the reaction compared to the effect seen on varying n-butylamine and 
B(OCH2CF3)3 concentrations (Figure 24). It appears that a concentration of 0.5 M is 
optimal. On increasing the concentration to 0.75 M and 1 M we observed poorer 
solubility that would potentially impact on the results of the study so the investigation 
of more concentrated samples was not carried out. 
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Figure 24 Graph of the reaction dependence on reaction concentration. Full conversion 
at 0.125, 0.25 and 0.5 M product, respectively. Concentration of reagents relative to 
overall reaction concentration. 
Although we cannot deduce the exact dependence of the reaction on each component, 
we can infer that the reaction is pH dependent. In addition, it appears that the active 
species is an amine-B(OCH2CF3)3 complex. From these results, we propose a tentative 
mechanism for the B(OCH2CF3)3-mediated amidation reaction: reaction of borate 101 
with a molecule of amine to form tetravalent boron species 102 which can then react 
with the carboxylic acid to form the active acylating species 103 with the concomitant 
elimination of a molecule of alcohol (Scheme 98a). This active species 103 can then be 
attacked by another molecule of amine to give heminal 104. Collapse of 104 can form 
the amide product 105 and tetravalent boron species 106, which could potentially 
activate a further molecule of carboxylic acid. Alternatively, reaction of the borate with 
a molecule of amine to displace a molecule of alcohol can form the trivalent species 
107, which can subsequently react with a molecule of the carboxylic acid to give the 
active tetravalent boron species 103 (Scheme 98b). The tetravalent boron species 103 
can then follow the same reaction pathway as detailed before. The improved rate 
observed with excess amine lends support to these possible reaction mechanisms. 
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Scheme 98 Proposed mechanism for B(OCH2CF3)3-mediated amidation 
The amidation of phenylacetic acid with ethylenediamine provides some preliminary 
experimental support for this proposed mechanism (Scheme 99). By 1H-NMR, the 
major product is that resulting from monoacylation of ethylene diamine and the minor 
product is the diamide formed by diacylation of ethylene diamine (95 mono : 5 di).  
 
Scheme 99 Monoacylation of ethylene diamine 
This experimental observation supports our proposed mechanism as it seems feasible 
that the incoming amine nucleophile, when tethered to the boron bound amine in 108, 
could form the seven-membered ring transition state to acylate on one end of the 
diamine and leave the other complexed to the boron, and therefore, ‘protected’ from 
acylation 109 (Scheme 100). 
 
Scheme 100 Proposed transition state in the monoacylation of ethylene diamine 
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In addition to this experimental evidence, we also have some computational evidence 
for 103 acting as the active species (Scheme 98). This computational work, carried out 
by Dr Mike Porter at UCL Chemistry, models one possible step in the trimethylborate-
mediated amidation of acetic acid by methylamine, the association of B(OMe)3 and 
acetic acid.101 The interactions of acetic acid and B(OMe)3 as well as acetic acid and 
B(OMe)2(NHMe) 110 were modelled (Scheme 101 and Scheme 102). Formation of the 
initial hydrogen-bonded complex, in the case of B(OMe)2(NHMe) (111) requires less 
energy than that of  B(OMe)3 (112). Similarly, the transition state for the reaction of 
B(OMe)2(NHMe) (113) with acetic acid is more energetically favourable than for  
B(OMe)3 (114). Also formation of 115 is significantly more favourable than formation 
of 116. Although we cannot yet say how 109 forms it is clear that this is more 
energetically favourable as a reaction pathway for activation of the carboxylic acid. This 
suggests that preactivation of the borate species by the amine (109) may be a key step in 
the reaction mechanism of borate-mediated amidation reactions. 
 
Scheme 101 DFT model for acetic acid + B(OMe)3 (Grel(MeCN)/kJmol
-1). ahydrogen-
bonded complex; bTransition state; cLocal minimum; dGlobal minimum. 
100 
 
 
Scheme 102 DFT model for acetic acid + B(OMe)2(NHMe) (Grel(MeCN)/kJmol
-1). 
ahydrogen-bonded complex; bTransition state; cLocal minimum; dGlobal minimum. 
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5. Conclusions and Future Work 
This thesis has focused on the use of B(OCH2CF3)3 as an amidation reagent. 
B(OCH2CF3)3 was initially synthesised from extremely reactive BBr3 so a milder 
synthesis of B(OCH2CF3)3 was developed which circumvented the use of BBr3 in 
favour of B2O3. This synthesis can be carried out on a multigram scale without the need 
for anhydrous conditions (Scheme 103). The B(OCH2CF3)3 reagent is now 
commercially available from Sigma-Aldrich (product number RNI00014).  
 
Scheme 103 Synthesis of B(OCH2CF3)3 
Additionally, a solid-phase work-up procedure utilising AmberlystTM 15, AmberlystTM 
A26(OH) and AmberliteTM IRA743 resins for the purification of products from the 
B(OCH2CF3)3-mediated amidation reactions has been developed. This is an 
operationally simple procedure that only requires stirring of the reaction mixture with 
the resins followed by a filtration to yield the analytically pure amide product (Figure 
25). In most cases, except those containing free acid or amine functionality, this avoids 
the need for column chromatography. There is the potential that this work-up procedure 
could be automated due to the inherent simplicity of the method. 
 
Figure 25 Solid-phase work-up of B(OCH2CF3)3-mediated amidation 
A general overview of the B(OCH2CF3)3-mediated amidation reactions discussed in this 
thesis is shown in Scheme 104. 
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Scheme 104 Overview of the use of B(OCH2CF3)3 in amidation 
The direct amidation of carboxylic acids by amines was fully explored and the scope 
and limitations of the method discussed (Scheme 104, A). This method is incredibly 
simple and gives the amide product in generally excellent yield. Lactamisations can be 
effected in good yield and this methodology can be scaled-up to furnish over a gram of 
amide product. All of the amide products could be purified and isolated by the solid-
phase work-up procedure. No column chromatography was necessary except in 
examples containing amine or acid functionality, in which an aqueous work-up or 
column chromatography was required. 
A method for the formylation of amines via transamidation of DMF was developed and 
the scope investigated with 10 amines (Scheme 105, B). This can be applied to 
aliphatic, aromatic and secondary amines in good to excellent yield. The products of 
this reaction can be purified by the simple solid-phase work-up followed by evaporation 
of DMF. No column chromatography was necessary in the purification of these 
formamides. 
As an extension to the direct amidation methodology, the direct amidation of N-
protected amino acids with primary and secondary amines was described (Scheme 104, 
C). Boc, Cbz and Bz protecting groups are tolerated under the reaction conditions to 
give the N-protected amino acid amide products in good to excellent yield. The 
retention of enantiopurity is generally good, although in cases where a significant 
erosion of enantiopurity is observed, this can be improved by shortening the reaction 
time.  
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B(OCH2CF3)3 can be used as a reagent for the amidation of unprotected amino acids 
(Scheme 104, D). An optimisation study was carried out to investigate the effect of 
solvent, concentration and any additives. The ideal solvent was either CPME or MeCN. 
As CPME is a green solvent this was the first choice, however, in some cases the amino 
acid solubility was improved in MeCN leading to better product yields. The optimum 
reaction was found to be: amino acid (1 equiv.), amine (3 equiv.), B(OCH2CF3)3 (3 
equiv.) in CPME or MeCN (0.5 M) at 80 °C for 15 h (Scheme 105). This was trialled 
with all natural and several unnatural amino acids with generally moderate to excellent 
conversion although in some cases very little or no reaction was observed. In addition, 
the amine scope of the reaction was evaluated by the amidation of ʟ-phenylalanine with 
a range of amines, including aliphatic, aromatic and secondary amines. 
 
Scheme 105 B(OCH2CF3)3-mediated amidation of unprotected amino acids 
Due to the necessity of enantiopurity determination of the amine products a new method 
for the determination of enantiopurity of chiral amines was developed. Forming a 
diastereomeric imine from the amide product and a chiral aldehyde 81 gave a means to 
measure the enantiopurity by 13C-NMR (Scheme 106). The initial development of this 
method looked very promising and the procedure was operationally simple. However, in 
a ‘blind test’ the determination of the er of amines with high enantiopurity proved to be 
problematic. 
 
Scheme 106 Diastereomeric imine formation 
Applying this method to the unprotected amino acid amide products had variable 
results. Although the enantiopurity could be measured in some cases, there were other 
examples where the imine carbon signals were not separable in 13C-NMR. There 
remains a need to measure the er of all the amide products. Ideally a method avoiding 
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the use of HPLC would be used to remove the need for derivatisation of the amino 
functionality. The use of 1R-(−)-myrtenal as described previously could be investigated, 
although this would require the derivatisation of either the other enantiomer or the 
racemate in addition to the product.94,95 
If the issues with the er determination of highly enantiopure amines can be resolved this 
method would provide a simple way to determine the er of chiral amines. At present 
only α-chiral amines have been trialled in the new chiral amine determination method. 
The scope of this reaction is yet to be fully explored and the limit on the position of the 
chirality relative to the amine group is not yet clear. 
The amino acid moiety is present in a number of drug molecules. Midodrine 117, which 
is a drug used to treat low blood pressure by vasoconstriction, could potentially be 
synthesised from reaction of glycine and 2-amino-1-(2,5-dimethoxyphenyl)ethan-1-
ol.102 Although ethanolamine was unsuccessful in our reactions the additional steric 
bulk and lipophilicity of this arylethanolamine could potentially improve the reaction. 
Additionally, Cephalexin 118, which is an oral antibiotic could also be synthesised in 
one step from ᴅ-phenylglycine and 7-aminocephalosporanic acid.103 The B(OCH2CF3)3-
mediated amidation of unprotected amino acids could potentially be applied to the 
synthesis of such compounds to obtain them directly without the need for N-protecting 
groups.  
 
Scheme 107 Structure of Midodrine 117 and Cephalexin 118 
A mechanistic study was carried out to provide some insight into the B(OCH2CF3)3-
mediated amidation reaction. Although no firm conclusions were drawn a tentative 
mechanism was proposed as well as possible intermediates in the reaction. The reaction 
is proposed to proceed via reaction of the amine with active intermediate 103 to form 
hemiaminal 104 followed by the subsequent formation of the amide (Scheme 108). We 
have some preliminary computational support for 103 acting as the active acylating 
species.101 
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Scheme 108 Proposed key step in B(OCH2CF3)3-mediated amidation 
This obviously requires further investigation to elucidate the true mechanism of the 
reaction. Firstly, the amine-B(OCH2CF3)3 complexes observed by NMR should be 
isolated and characterised. Following that, these complexes should be subjected to the 
reaction conditions to determine whether they take part in the reaction. The 
experimental support for this mechanism in the form of the monoacylation of 
ethylenediamine is worthy of further study (Scheme 109). 
 
Scheme 109 Monoacylation of ethylene diamine 
The use of B(OCH2CF3)3 could provide a simple route to monoacylated diamines from 
equimolar quantities of acid and diamine. A number of methods for monoacylation of 
diamines have recently been reported. For example, Wang et al. describe the use of 9-
BBN to complex and deactivate one nitrogen atom of the diamine, the second nitrogen 
atom can then react with an acyl chloride (Scheme 110).104 This reaction requires 
anhydrous conditions as well as preparation of the acyl chloride. 
 
Scheme 110 Monoacylation by protection with 9-BBN 
More recently, CDI has been shown to mediate monoacylation as reported by Kaushik 
et al. requires ten equivalents of diamine as both the free amine and the hydrochloride 
salt as well as preformation of the N-acylimidazole from the carboxylic acid (Scheme 
111).105 
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Scheme 111 Monoacylation of diamines via an N-acylimidazole 
Therefore, B(OCH2CF3)3 displays potential as a reagent to mediate the monoacylation 
of diamines. This reaction can be performed ‘open-to-the-air’ with equimolar quantities 
of acid and diamine to give promising selectivity in the initial example with 
ethylenediamine and phenylacetic acid. 
Ultimately the development of a catalytic equivalent of B(OCH2CF3)3 is highly 
desirable. This catalyst could combine the activities of the boronic acid catalysts 
reported by Hall,50-53 as well as the stability and scope of B(OCH2CF3)3. There are a 
number of possible preliminary catalyst structures that could be targeted (Scheme 112). 
Ideally the alkoxy substituent on the boron should be replaced during the reaction with 
carboxylic acid or amine but reattach following the reaction. There is likely to be a 
delicate balance of the electronic effects to ensure that the catalyst can reform following 
dissociation of one of the alkoxy substituents on boron. 
 
Scheme 112 Possible catalyst structures 
Several attempts at the synthesis of catalyst 119 were made, all of which were 
unsuccessful. Firstly, the synthesis directly from phenylboronic acid using Dean-Stark 
conditions did not result in the desired 119 product (Scheme 113). 
 
Scheme 113 Unsuccessful synthesis of 119 from phenylboronic acid 
Additionally, the synthesis of 119 from dichlorophenylborane was investigated (Scheme 
114). This was unsuccessful and did not provide 119. 
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Scheme 114 Unsuccessful synthesis of 119 from dichlorophenylborane 
A final route from the potassium trifluoroborate salt of phenylboronic acid with TMS-
protected biphenol was attempted (Scheme 115).106 Again, this was unsuccessful and 
did not provide catalyst 119. 
 
Scheme 115 Unsuccessful synthesis of 119 from potassium phenyltrifluoroborate 
There may be an inherent instability in 119 as it is not reported in the literature. The 
synthesis of another of these proposed catalysts 120-122 may prove more fruitful. If the 
synthesis of a catalyst of this type is successful, then it can be trialled in an amidation 
reaction to determine whether they would provide a competitive advantage over the 
current boronic acid catalysts and B(OCH2CF3)3. 
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6. Experimental 
6.1.  General methods 
All solvents and chemicals were used as supplied unless otherwise indicated. Reactions 
in MeCN at 100 °C were performed in a sealed (screw cap) carousel tube. All resins 
were washed with CH2Cl2 and dried under vacuum prior to use. Column 
chromatography was carried out using silica gel and analytical thin layer 
chromatography was carried out using aluminium-backed silica plates. Components 
were visualized using combinations of UV (254 nm) and potassium permanganate. [α]
D
 
values are given in 10-1 deg cm2 g-1, concentration (c) in g per 100 mL. 1H NMR spectra 
were recorded at 300, 400, 500 or 600 MHz in the stated solvent using residual protic 
solvent CDCl3 ( = 7.26 ppm, s), DMSO ( = 2.56 ppm, qn) or MeOD ( = 4.87, s and 
3.31, quintet) as the internal standard. Chemical shifts are quoted in ppm using the 
following abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; qn, quintet; m, 
multiplet; br, broad or a combination of these. The coupling constants (J) are measured 
in Hertz. 13C NMR spectra were recorded at 75, 100, 125 or 150 MHz in the stated 
solvent using the central reference of CDCl3 ( = 77.0 ppm, t), DMSO ( = 39.52 ppm, 
septet) or MeOD ( = 49.15 ppm, septet) as the internal standard. Chemical shifts are 
reported to the nearest 0.1 ppm. Mass Spectrometry data were collected on either TOF 
or magnetic sector analysers. The ionization method is reported in the experimental 
data.  
6.2.  General Procedures 
6.2.1.  General Procedure for Amidation of Carboxylic acids 
All reactions were performed on a 1 mmol scale. B(OCH2CF3)3 (2.0 mmol, 2 equiv.) 
was added to a solution of acid (1.0 mmol, 1 equiv.) and amine (1.0 mmol, 1 equiv.) in 
MeCN (2 mL, 0.5 M). The reaction mixture was stirred at the indicated temperature (80 
°C, or 100 °C in a sealed tube) for the indicated time (5-24 h).  
Solid phase work-up 
After the indicated time, the reaction mixture was diluted with CH2Cl2 or EtOAc (3 mL) 
and water (0.5 mL). Amberlyst® A-26(OH) (150 mg), Amberlyst® 15 (150 mg) and 
Amberlite® IRA743 (150 mg) were added to the reaction mixture and it was stirred for 
30 min. MgSO4 was added to the reaction mixture which was then filtered and the 
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solids washed three times with CH2Cl2 or EtOAc and the filtrate concentrated in vacuo 
to yield the amide product.  
For amides 2i, 2j, 2t, 2u and 4e, Amberlyst® 15 was not used. In these cases, the 
product was separated from any excess amine by column chromatography. 
Aqueous work-up procedure 
After the reaction was complete, the solvent was removed under reduced pressure. The 
residue was redissolved in CH2Cl2 (15 mL) and washed with aqueous solutions of 
NaHCO3 (15 mL, 1 M) and HCl (15 mL, 1 M), dried over MgSO4, filtered and 
concentrated under reduced pressure to give the amide product. 
6.2.2.  General Procedure for the Formylation of Amines with DMF 
All reactions were performed on a 1 mmol scale. B(OCH2CF3)3 (2.0 mmol, 2 equiv.) 
was added to a solution of amine (1.0 mmol, 1 equiv.) and DMF (10.0 mmol, 10 equiv.) 
in MeCN (2 mL, 0.5 M). The reaction mixture was stirred at 80 °C for 5 h. After 5 h, 
the reaction mixture was diluted with CH2Cl2 or EtOAc (3 mL) and water (0.5 mL). 
Amberlyst® 15 (150 mg) and Amberlite® IRA743 (150 mg) were added to the reaction 
mixture and it was stirred for 30 min. The reaction mixture was dried over MgSO4, then 
filtered, and the solids washed three times with CH2Cl2 or EtOAc and the filtrate diluted 
with toluene (10 mL) and then concentrated in vacuo repeatedly (5 times) to yield the 
formamide product. 
6.2.3.  General Procedure for the amidation of unprotected amino acids 
All reactions were performed on a 0.5 mmol scale. B(OCH2CF3)3 (2.0 mmol, 2 equiv.) 
was added to a solution of amine (0.5 mmol, 3 equiv.) and amino acid (0.5 mmol, 1 
equiv.) in CPME or MeCN (1 mL, 0.5 M). The reaction mixture was stirred at 80 or 125 
°C for 15 h. After 15 h, the reaction mixture was diluted with CH2Cl2 or EtOAc (3 mL) 
and water (0.5 mL). Amberlyst® A26(OH) (80 mg) and Amberlite® IRA743 (80 mg) 
were added to the reaction mixture and it was stirred for 30 min. The reaction mixture 
was dried over MgSO4, then filtered, and the solids washed three times with CH2Cl2 or 
EtOAc. The filtrate was concentrated in vacuo. In the case of amides 77a-c, 77e-f, 77g, 
77l, 77k and 78f the product was isolated by removing the volatile amine under 
vacuum. Amide 78h was isolated by column chromatography and amides 78b-c were 
isolated by triturating the amide/residual amine mixture with Et2O. Amides 77a, 77f, 
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77g, and 77l were isolated as the hydrochloride salts. Amides 77b-c, 77e, 77k, 78b-c 
and 78h were isolated as the free amine as the hydrochloride salts were hygroscopic. 
Tris-(2,2,2-trifluoroethyl) borate 54 
25 g Scale  
A suspension of B2O3 (25.6 g, 0.37 mol) in 2,2,2-trifluoroethanol (53  mL, 0.73 mol) 
was stirred at 80 °C for 8 h. The reaction mixture was then filtered to remove excess 
boric anhydride. The filtrate was purified by distillation to give B(OCH2CF3)3 as a clear 
liquid (36.0 g, 117 mmol, 48%). 
50 g Scale (with CF3CH2OH recovery) 
A suspension of B2O3 (48.1 g, 0.69 mol) in 2,2,2-trifluoroethanol (100 mL, 1.37 mol) 
was stirred at 80 °C for 24 h. The reaction mixture was then filtered to remove excess 
boric anhydride. The filtrate was purified by distillation to give B(OCH2CF3)3 as a clear 
liquid (46.3 g, 150 mmol, 33%). 2,2,2-Trifluoroethanol (38.4 g, 28%) was recovered 
during the distillation. 
bp 122-125 °C (760 Torr) [Lit.55 120-123 °C (760 Torr)]; νmax (film/cm-1) 3165 (C-H), 
1441 (C-F), 1376 (B-O), 1156 (C-O); δH (300 MHz, CDCl3) 4.24 (6H, q, J 8.3, 3 × 
CH2); δC (75 MHz, CDCl3) 61.8 (3C, q, JC-F 36.5, 3 × CH2), 123.2 (3C, q, JC-F 276, 3 × 
CF3); δF (282 MHz, CDCl3) −77.06; Found (CI): [M+H]+ 309.0334 C6H7O3F9B, 
requires 309.0344. 
6.3. Characterisation of Amides 
N-Benzyl-2-phenylacetamide 56 
 
White solid; mp 113-114 °C (DCM) [Lit.55 118-120 °C]; νmax (solid/cm-1) 3003 (C-H), 
1639 (C=O); δH (500 MHz, CDCl3) 3.64 (s, 2H, CH2CO), 4.42 (d, J 5.75, 2H, CH2NH), 
5.65 (1H, br, 1H, NH), 7.18 (d, J 7.6, 2H, ArH), 7.22-7.32 (m, 6H, ArH), 7.33-7.37 (m, 
2H, ArH); δC (125 MHz, CDCl3) 43.7, 44.0, 127.5, 127.6, 128.7, 129.2, 129.6, 134.8, 
138.2, 170.9; Found (EI): [M]+ 225.11514 C15H15ON, requires 225.11482. 
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N-(2-Methoxybenzyl)-2-phenylacetamide 57a 
 
Yellow solid (256 mg, 99%); mp 94-95 ˚C (CH2Cl2); νmax (solid/cm-1) 3284 (N-H), 
3066, 3030, 2939, 2837 (C-H), 1646 (C=O); δH (600 MHz, CDCl3) 3.58 (s, 2H, 
CH2CO), 3.66 (s, 3H, OCH3), 4.39 (d, J 5.8, 2H, CH2NH), 6.01 (br s, 1H, NH), 6.80 (d, 
J 8.1, 1H, ArH), 6.87 (td, J 7.4, 0.9, 1H, ArH), 7.17 (dd, J 7.4, 1.6, 1H, ArH), 7.22-7.25 
(m, 3H, ArH), 7.27-7.30 (m, 1H, ArH), 7.33-7.36 (m, 2H, ArH); δC (150 MHz, CDCl3) 
40.0, 44.0, 55.1, 110.2, 120.7, 126.1, 127.4, 128.9, 129.0, 129.6, 129.7, 135.1, 157.6, 
170.7; Found (EI): [M]+ 255.12510 C16H17O2N, requires 255.12538. 
N-(4-Methoxybenzyl)-2-phenylacetamide 57b 
 
Yellow solid (252 mg, 99%); mp 139-141 ˚C (CH2Cl2) [Lit.107 138-139 °C]; νmax 
(solid/cm-1) 3235 (N-H), 3063, 3032, 2969, 2936 (C-H), 1623 (C=O); δH (600 MHz, 
CDCl3) 3.62 (s, 2H, CH2CO), 3.78 (s, 3H, OCH3), 4.34 (d, J 5.8, 2H, CH2NH), 5.60 (br 
s, 1H, NH), 6.81-6.83 (m, 2H, ArH), 7.09-7.12 (m, 2H, ArH), 7.25-7.26 (m, 1H, ArH), 
7.26-7.30 (m, 2H, ArH), 7.32-7.36 (m, 2H, ArH); δC (150 MHz, CDCl3) 43.2, 44.0, 
55.4, 114.1, 127.5, 129.0, 129.2, 129.6, 130.3, 134.9, 159.1, 170.9; Found (EI): [M]+ 
255.12571 C16H17O2N, requires 255.12538. 
N-(2-(1H-Indol-3-yl)ethyl)-2-phenylacetamide 57c 
 
Yellow solid (158 mg, 57%); mp 145-146 ˚C (CH2Cl2) [Lit.108 151-153 °C]; νmax 
(solid/cm-1) 3391 (N-H), 3249 (N-H), 3062, 3033, 2920, 2850 (C-H), 1634 (C=O); δH 
(500 MHz, CDCl3) 2.90 (t, J 6.7, 2H, CH2CH2NH), 3.50-3.56 (m, 4H, CH2CO and 
CH2NH), 5.44 (br s, 1H, NHCH2), 6.77 (s, 1H, ArH), 7.08-7.15 (m, 3H, ArH), 7.18-
7.22 (m, 1H, ArH), 7.23-7.28 (m, 1H, ArH), 7.26-7.30 (m, 2H, ArH), 7.35 (d, J 8.1, 1H, 
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ArH), 7.54 (d, J 7.8, 1H, ArH), 8.00 (br s, 1H indole NH); δC (125 MHz, CDCl3) 25.1, 
39.8, 44.0, 111.3, 112.8, 118.7, 119.6, 122.0, 122.3, 127.3, 129.0 (2C), 129.5, 135.0, 
136.4, 171.0; Found (ES): [M+Na]+ 301.1305 C18H18ON2Na, requires 301.1317. 
N-(2,2,3,3,4,4,5,5,5-nonafluoropentyl)-2-phenylacetamide 57d  
 
White solid (128 mg, 68%); mp 85-87 ˚C (CH2Cl2); νmax 3278 (NH), 3082 (C-H), 1661 
(C=O); δH (600 MHz, CDCl3)  3.66 (s, 2H, CH2CO), 3.97 (td, J 6.5, 15.6, 2H, CH2NH), 
5.64 (br s, 1H, NH), 7.25-7.25 (m, 2H, ArH), 7.31-7.34 (m, 1H, ArH), 7.39-7.40 (m, 
2H, ArH); δC (150 MHz, CDCl3) 39.1 (t, J 23.3), 43.6, two signals in the range 106.2-
112.6 (splitting results in multiplets), 115.3 (tt, J 31.8, 256.9), 117.3 (qt, J 33.7, 288.3), 
127.9, 129.4, 129.5, 133.9, 171.3; Found (ES+): [M+H]+ 368.0582 C13H11F9NO, 
requires 367.0619. 
N-Methyl-N’-phenylacetylpiperazine 57e 
 
Purified by column chromatography (89:10:1 Et2O:MeOH:NEt3). 
Yellow oil (170 mg, 96%); νmax (film/cm-1) 3029, 2940, 2853, 2795 (C-H), 1627 (C=O); 
δH (500 MHz, CDCl3)  2.20 (t, J 5.1, 2H, CH2NHCH3), 2.25 (s, 3H, CH3), 2.34 (t, J 5.1, 
2H, CH2NCH3), 3.45 (t, J 5.1, 2H, CH2NCO), 3.66 (t, J 5.1, 2H, CH2NCO), 3.72 (s, 2H, 
CH2CO), 7.21-7.25 (m, 3H, ArH), 7.29-7.33 (m, 2H, ArH); δC (125 MHz, CDCl3) 41.0, 
41.7, 46.0 (2C), 54.7, 55.0, 126.9, 128.7, 128.8, 135.1, 169.5. 
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N-Phenyl-N’-phenylacetylpiperazine 57f 
 
Purified by column chromatography (Et2O). 
Brown solid (209 mg, 76%); mp 91-93 ˚C (CH2Cl2); νmax (solid/cm-1) 2919, 2827 (C-H), 
1632 (C=O); δH (600 MHz, CDCl3) 2.95-2.98 (m, 2H, CH2NPh), 3.10-3.13 (m, 2H, 
CH2NPh), 3.56-3.59 (m, 2H, CH2NCO), 3.78-3.82 (m, 4H, CH2NCO and CH2CO), 
6.87-6.93 (m, 3H, ArH), 7.25-7.31 (m, 5H, ArH), 7.33-7.37 (m, 2H, ArH); δC (150 
MHz, CDCl3) 41.2, 41.8, 46.1, 49.3, 49.6, 116.7, 120.6, 127.1, 128.8, 129.0, 129.4, 
135.2, 151.0, 169.6; Found (ES): [M+H]+ 281.1656 C18H21ON2, requires 281.1654. 
N-Phenylacetylmorpholine 57g 
 
White solid (182 mg, 89%); mp 65-67 °C (CH2Cl2) [Lit.
109 62-64 °C]; νmax (solid/cm-1) 
3064, 3033, 2961, 2917, 2893, 2851 (C-H), 1640 (C=O); δH (400 MHz, CDCl3) 3.40-
3.44 (m, 2H, CH2O), 3.44-3.48 (m, 2H, CH2O), 3.63 (s, 4H, 2×CH2N), 3.72 (s, 2H, 
CH2CO), 7.21-7.27 (m, 3H, ArH), 7.29-7.34 (m, 2H, ArH); δC (100 MHz, CDCl3) 40.8, 
42.1, 46.5, 66.4, 66.8, 126.9, 128.5, 128.8, 134.8, 169.6. 
2-Phenyl-1-(pyrrolidin-1-yl)ethanone 57h 
 
Clear oil (185 mg, 97%); νmax (film/cm-1) 3061, 3030, 2971, 2874 (C-H), 1623 (C=O); 
δH (500 MHz, CDCl3) 1.80 (quintet, J 6.7, 2H, CH2CH2N), 1.88 (quintet, J 6.7, 2H, 
CH2CH2N), 3.39 (t, J 6.7, 2H, CH2N), 3.46 (t, J 6.7, 2H, CH2N), 3.63 (s, 2H, CH2CO), 
7.19-7.23 (m, 1H, ArH), 7.24-7.31 (m, 4H, ArH); δC (125 MHz, CDCl3) 24.4, 26.2, 
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42.3, 46.0, 47.0, 126.7, 128.6, 129.0, 135.0, 169.6; Found (ES+): [M+H]+ 190.12264 
C12H16ON, requires 190.12319. 
N-Phenylacetylthiomorpholine 57i 
 
Yellow solid (194 mg, 89%); mp 73-74 °C (CH2Cl2) [Lit.
110 73-75 °C]; νmax (solid/cm-1) 
3024, 2960, 2911 (C-H), 1639 (C=O); δH (400 MHz, CDCl3) 2.26-2.30 (m, 2H, CH2S), 
2.52-2.59 (m, 2H, CH2S), 3.65-3.70 (m, 2H, CH2N), 3.72 (s, 2H, CH2CO), 3.85-3.90 
(m, 2H, CH2CO), 7.20-7.26 (m, 3H, ArH), 7.29-7.34 (m, 2H, ArH); δC (100 MHz, 
CDCl3) 27.2, 27.4, 41.3, 44.4, 48.8, 126.9, 128.5, 128.9, 134.8, 169.4. 
N,N-Dimethyl-2-phenylacetamide 57j 
 
White solid (134 mg, 82%); mp 37-39 °C (CH2Cl2) [Lit.
111 38-40 °C]; νmax (solid/cm-1) 
3062, 3029, 2931 (C-H), 1634 (C=O); δH (600 MHz, CDCl3) 2.91 (s, 3H, CH3), 2.93 (s, 
3H, CH3), 3.66 (s, 2H, CH2), 7.17-7.23 (m, 3H, ArH), 7.25-7.28 (m, 2H, ArH); δC (150 
MHz, CDCl3) 35.7, 37.8, 41.1, 126.8, 128.7, 128.9, 135.2, 171.1 
N,N-Dibenzyl-2-phenylacetamide 57k 
 
Purified by column chromatography (Et2O:PE 3:1). 
Colourless oil (37 mg, 12%); νmax (film/cm-1) 3062, 3029, 2925 (C-H), 1639 (C=O); δH 
(500 MHz, CDCl3, 35 °C) 3.83 (s, 2H, CH2CO), 4.47 (s, 2H, CH2N), 4.66 (s, 2H, 
CH2N), 7.11-7.17 (m, 2H, ArH), 7.19-7.25 (m, 2H, ArH), 7.25-7.42 (m, 11H, ArH); δC 
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(125 MHz, CDCl3, 35 °C) 41.0, 48.3, 50.3, 126.5, 126.9, 127.4, 127.6, 128.3, 128.5, 
128.7, 128.8, 128.9, 135.0, 136.5, 137.3, 171.6.  
N,2-Diphenylacetamide 57l 
 
Off white solid (125 mg, 60%); mp 116-118 ˚C (CH2Cl2) [Lit.112 116-117 °C]; νmax 
(solid/cm-1) 3254 (N-H), 3135, 3061, 3025 (C-H), 1655 (C=O); δH (600 MHz, CDCl3) 
3.69 (s, 2H, CH2), 7.09 (t, J 7.4, 1H, ArH), 7.27 (t, J 7.8, 2H, ArH), 7.33-7.34 (m, 3H, 
ArH), 7.36-7.39 (m, 2H, ArH), 7.45 (d, J 8.0, 2H, ArH), 7.61 (br s, 1H, NH); δC (150 
MHz, CDCl3) 44.8, 120.1, 124.6, 127.7, 129.1, 129.3, 129.6, 134.7, 137.9, 169.6. 
N-(2-Methoxyphenyl)-2-phenylacetamide 57m 
 
Yellow solid (143 mg, 61%); mp 82-83 ˚C (CH2Cl2) [Lit.113 80-81 °C]; νmax (solid/cm-1) 
3284 (N-H), 3028, 3011, 2959, 2939, 2918, 2837 (C-H), 1648 (C=O), δH (500 MHz, 
CDCl3) 3.72 (s, 3H, CH3), 3.76 (s, 2H, CH2), 6.80 (dd, J 8.1, 1.1, 1H, ArH), 6.93 (td, J 
7.8, 1.1, 1H, ArH), 7.01 (td, J 7.8, 1.5, 1H, ArH), 7.31-7.37 (m, 3H, ArH), 7.37-7.42 
(m, 2H, ArH), 7.79 (br s, 1H, NH), 8.35 (dd, J 8.0, 1.4, 1H, ArH); δC (125 MHz, CDCl3) 
45.3, 55.7, 110.0, 119.6, 121.2, 123.8, 127.5, 127.7, 129.1, 129.7, 134.7, 147.9, 168.9. 
2-Phenyl-N-p-tolylacetamide 57n 
 
White solid (105 mg, 53%); mp 132-133 ˚C (CH2Cl2) [Lit.112 131-132 °C]; νmax 
(solid/cm-1) 3289 (N-H), 3063, 3031, 2922 (C-H), 1650 (C=O); δH (500 MHz, CDCl3) 
2.29 (s, 3H, CH3), 3.73 (s, 2H, CH2), 7.01 (br s, 1H, NH), 7.08 (d, J 8.4, 2H, ArH), 7.28 
(d, J 8.4, 2H, ArH), 7.31-7.36 (m, 3H, ArH), 7.38-7.42 (m, 2H, ArH); δC (125 MHz, 
CDCl3) 23.6, 47.4, 122.9, 130.2, 131.8, 132.2, 133.3, 136.8, 137.5, 138.0, 172.1. 
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N-(4-Methoxyphenyl)-2-phenylacetamide 57o 
 
White solid (164 mg, 68%); mp 122-123 ˚C (CH2Cl2) [Lit.114 124-125 °C]; νmax 
(solid/cm-1) 3315 (N-H), 3084, 3026, 3009, 2943 (C-H), 1650 (C=O); δH (500 MHz, 
CDCl3) 3.73 (s, 2H, CH2), 3.77 (s, 3H, CH3), 6.80-6.83 (m, 2H, ArH), 6.97 (br s, 1H, 
NH), 7.29-7.36 (m, 5H, ArH), 7.38-7.42 (m, 2H, ArH); δC (125 MHz, CDCl3) 44.8, 
55.5, 114.1, 121.9, 127.7, 129.3, 129.6, 130.7, 134.6, 156.6, 169.0.  
N-(Pyridin-3-yl)-2-phenylacetamide 57p 
 
Purified by column chromatography (4 % MeOH in EtOAc). 
White solid (114 mg, 53%); mp 107-108 ˚C (CH2Cl2); νmax (solid/cm-1) 3170 (N-H), 
3032, 2971 (C-H), 1686 (C=O); δH (500 MHz, CDCl3) 3.68 (s, 2H, CH2), 7.20 (dd, J 
8.3, 4.7, 1H, ArH), 7.23-7.33 (m, 5H, ArH), 8.06-8.10 (m, 1H, ArH), 8.27 (dd, J 4.7, 
1.2, 1H, ArH), 8.57 (d, J 2.4, 1H, ArH), 9.05 (br s, 1H, NH); δC (125 MHz, CDCl3) 
44.3, 123.9, 127.5, 127.6, 129.0, 129.3, 134.4, 135.4, 141.3, 144.9, 170.4; Found (EI): 
[M]+ 212.09471 C13H12ON2, requires 212.09441. 
N-(Pyridin-2-yl)-2-phenylacetamide 57q 
 
Purified by column chromatography (3:1 EtOAc:Petrol, 10 % NEt3). 
White solid (25 mg, 12%); mp 121-122 ˚C (CH2Cl2) [Lit.112 122-124 °C]; νmax 
(solid/cm-1) 3230 (N-H), 3046, 2959, 2921 (C-H), 1656 (C=O); δH (500 MHz, CDCl3) 
3.74 (s, 2H, CH2), 6.98-7.03 (m, 1H, ArH), 7.27-7.33 (m, 3H, ArH), 7.33-7.38 (m, 2H, 
ArH), 7.66-7.71 (m, 1H, ArH), 8.19-8.27 (m, 2H, ArH), 8.52 (br s, 1H, NH); δC (125 
MHz, CDCl3) 45.1, 114.1, 120.0, 127.8, 129.3, 129.6, 134.0, 138.5, 147.7, 151.3, 169.6; 
Found (ES): [M+H]+ 213.1035 C13H13ON2, requires 213.1028. 
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N-tert-Butyl-2-phenylacetamide 57r 
 
White solid (116 mg, 60%); mp 104-106 ˚C (CH2Cl2) [Lit.115 103 °C]; νmax (solid/cm-1) 
3303 (N-H), 3063, 2962, 2872 (C-H), 1638 (C=O); δH (600 MHz, CDCl3) 1.28 (s, 9H, 
3×CH3), 3.48 (s, 2H, CH2CO), 5.17 (br s, 1H, NH), 7.24 (d, J 7.2, 2H, ArH), 7.26-7.30 
(m, 1H, ArH), 7.35 (t, J 7.4, 2H, ArH); δC (150 MHz, CDCl3) 28.8, 45.0, 51.4, 127.3, 
129.1, 129.4, 135.6, 170.4. 
N-Benzyl-2-(naphthalen-2-yl)acetamide 58a 
 
Yellow solid (225 mg, 81%); mp 168-169 ˚C (CH2Cl2) [Lit.116 170-174 °C]; νmax 
(solid/cm-1) 3225 (N-H), 3053, 3030, 2976, 2936 (C-H), 1628 (C=O); δH (500 MHz, 
CDCl3) 3.79 (s, 2H, CH2CO), 4.41 (d, J 5.8, 2H, CH2NH), 5.81 (br s, 1H, NH), 7.18 (d, 
J 7.0, 2H, ArH), 7.21-7.30 (m, 3H, ArH), 7.39 (dd, J 8.3, 1.7, 1H, ArH), 7.46-7.52 (m, 
2H, ArH), 7.72 (br s, 1H, ArH), 7.78-7.82 (m, 1H, ArH), 7.82-7.85 (m, 2H, ArH); δC 
(125 MHz, CDCl3) 43.7, 44.1, 126.2, 126.5, 127.4, 127.5, 127.6, 127.7, 127.8, 128.4, 
128.7, 129.0, 132.3, 132.6, 133.6, 138.2, 170.8. 
N-Benzyl-2,2-diphenylacetamide 58b 
 
Yellow solid (247 mg, 81%); mp 127-128 ˚C (CH2Cl2) [Lit.117 126-128 °C]; νmax 
(solid/cm-1) 3311 (N-H), 3060, 3030, 2930 (C-H), 1634 (C=O); δH (500 MHz, CDCl3) 
4.48 (d, J 5.7, 2H, CH2NH), 4.96 (s, 1H, CH), 5.94 (br s, 1H, NH), 7.19-7.22 (m, 2H, 
ArH), 7.24-7.30 (m, 8H, ArH), 7.30-7.35 (m, 5H, ArH); δC (125 MHz, CDCl3) 43.9, 
59.3, 127.4, 127.6, 127.7, 128.8, 128.9, 129.0, 138.2, 139.4, 171.8. 
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N-Benzyl-2-(4-methoxyphenyl)acetamide 58c 
 
Yellow solid (232 mg, 90%); mp 134-135 ˚C (CH2Cl2) [Lit.118 136 °C]; νmax (solid/cm-1) 
3286 (N-H), 3082, 3063, 3033, 2968, 2838 (C-H), 1635 (C=O); δH (600 MHz, CDCl3) 
3.57 (s, 2H, CH2CO), 3.79 (s, 3H, CH3), 4.40 (d, J 5.8, 2H, CH2NH), 5.75 (br s, 1H, 
NH), 6.86-6.89 (m, 2H, ArH), 7.16-7.19 (m, 4H, ArH), 7.23-7.26 (m, 1H, ArH), 7.28-
7.31 (m, 2H, ArH); δC (150 MHz, CDCl3) 43.0, 43.7, 55.4, 114.6, 126.8, 127.5, 127.6, 
128.8, 130.7, 138.3, 159.0, 171.5. 
N-Benzyl-2-(2-bromophenyl)acetamide 58d 
 
Yellow solid (276 mg, 90%); mp 143-144 ˚C (CH2Cl2) [Lit.119 144-145 °C]; νmax 
(solid/cm-1) 3272 (N-H), 3055, 3030, 2920, 2871 (C-H), 1642 (C=O); δH (600 MHz, 
CDCl3) 3.77 (s, 2H, CH2CO), 4.44 (d, J 5.7, 2H, CH2NH), 5.75 (br s, 1H, NH), 7.16 (td, 
J 7.7, 1.7, 1H, ArH), 7.21-7.27 (m, 3H, ArH), 7.30 (app t, J 7.6, 3H, ArH), 7.37 (dd, J 
7.5, 1.6, 1H, ArH), 7.58 (dd, J 8.0, 1.0, 1H, ArH); δC (150 MHz, CDCl3) 43.8, 44.2, 
125.0, 127.6, 127.7, 128.2, 128.8, 129.4, 131.9, 133.3, 134.8, 138.1, 169.5. 
N-Benzyl-2-(4-bromophenyl)acetamide 58e 
 
Yellow solid (289 mg, 94%); mp 165-166 ˚C (CH2Cl2); νmax (solid/cm-1) 3280 (N-H), 
3056, 3026, 2917, 2872 (C-H), 1642 (C=O); δH (600 MHz, CDCl3) 3.55 (s, 2H, 
CH2CO), 4.41 (d, J 5.6, 2H, CH2NH), 5.72 (br s, 1H, NH), 7.15 (d, J 8.4, 2H, ArH), 
7.19 (d, J 7.0, 2H, ArH), 7.25-7.28 (m, 1H, ArH), 7.29-7.33 (m, 2H, ArH), 7.45-7.48 
(m, 2H, ArH); δC (150 MHz, CDCl3) 43.2, 43.8, 121.6, 127.7, 127.8, 128.9, 131.2, 
132.2, 133.8, 138.0, 170.2; Found (EI): [M]+ 303.02563 C15H14ONBr, requires 
303.02533. 
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N-Benzyl-2-(3,4-dimethoxyphenyl)acetamide 58f 
 
Brown solid (235 mg, 81%); mp 100-101 ˚C (CH2Cl2) [Lit.120 98-100 °C]; νmax 
(solid/cm-1) 3297 (N-H), 3065, 3033, 3000, 2936, 2835 (C-H), 1634 (C=O); δH (600 
MHz, CDCl3) 3.58 (s, 2H, CH2CO), 3.85 (s, 3H, CH3), 3.86 (s, 3H, CH3), 4.41 (d, J 5.6, 
2H, CH2NH), 5.74 (br s, 1H, NH), 6.76-6.80 (m, 2H, ArH), 6.83 (d, J 8.0, 1H, ArH), 
7.18 (d, J 7.0, 2H, ArH), 7.23-7.26 (m, 1H, ArH), 7.28-7.31 (m, 2H, ArH); δC (150 
MHz, CDCl3) 43.6, 43.7, 55.98, 56.02, 111.6, 112.4, 121.8, 127.2, 127.58, 127.61, 
128.8, 138.3, 148.4, 149.4, 171.3; Found (EI): [M]+ 285.13532 C17H19O3N, requires 
285.13594. 
N-Benzyl-2-(4-chlorophenyl)acetamide 58g 
 
Yellow solid (244 mg, 93%); mp 157-158 ˚C (CH2Cl2) [Lit.121 151-153 °C]; νmax 
(solid/cm-1) 3277 (N-H), 3056, 3027, 2918, 2874 (C-H), 1642 (C=O), 690 (C-Cl); δH 
(600 MHz, CDCl3) 3.56 (s, 2H, CH2CO), 4.41 (d, J 5.8, 2H, CH2NH), 5.76 (br s, 1H, 
NH), 7.18-7.22 (m, 4H, ArH), 7.24-7.28 (m, 1H, ArH), 7.29-7.32 (m, 4H, ArH); δC (150 
MHz, CDCl3) 43.1, 43.8, 127.69, 127.74, 128.9, 129.2, 130.9, 133.3, 133.5, 138.1, 
170.4. 
N-Benzyl-2-(4-phenoxyphenyl)acetamide 58h 
 
Yellow solid (298 mg, 95%); mp 125-126 ˚C (CH2Cl2); νmax (solid/cm-1) 3285 (N-H), 
3085, 3064, 3033, 2921 (C-H), 1636 (C=O); δH (600 MHz, CDCl3) 3.60 (s, 2H, 
CH2CO), 4.43 (d, J 5.9, 2H, CH2NH), 5.71 (br s, 1H, NH), 6.96-7.01 (m, 4H, ArH), 
7.10-7.13 (m, 1H, ArH), 7.18-7.21 (m, 2H, ArH), 7.21-7.24 (m, 2H, ArH), 7.25-7.28 
(m, 1H, ArH), 7.29-7.36 (m, 4H, ArH); δC (150 MHz, CDCl3) 43.2, 43.8, 119.2, 119.3, 
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123.6, 127.6, 127.7, 128.8, 129.5, 129.9, 130.9, 138.2, 156.8, 157.0, 171.0; Found (EI): 
[M]+ 317.14158 C21H19O2N, requires 317.14103.  
N-Benzyl-2-(thiophen-3-yl)acetamide 58i 
 
Yellow solid (212 mg, 91%); mp 96-98 ˚C (CH2Cl2); νmax (solid/cm-1) 3279 (N-H), 
3086, 3062, 3032, 2925 (C-H), 1635 (C=O); δH (600 MHz, CDCl3) 3.65 (s, 2H, 
CH2CO), 4.42 (d, J 5.8, 2H, CH2NH), 5.85 (br s, 1H, NH), 7.01 (d, J 4.8, 1H, ArH), 
7.14-7.15 (m, 1H, ArH), 7.19 (d, J 7.5, 2H, ArH), 7.23-7.34 (m, 4H, ArH); δC (150 
MHz, CDCl3) 38.3, 43.7, 123.7, 127.0, 127.61, 127.62, 128.6, 128.8, 134.8, 138.2, 
170.5; Found (ES): [M+H]+ 232.0789 C13H14ONS, requires 232.0796. 
 (E)-N-Benzyl-3-(thiophen-3-yl)acrylamide 58j 
 
Yellow solid (217 mg, 88%); mp 107-110 ˚C (CH2Cl2); νmax (solid/cm-1) 3275 (N-H), 
3029, 2971 (C-H), 1639 (C=O); δH (600 MHz, CDCl3) 4.55 (d, J 5.7, 2H, CH2NH), 6.05 
(br s, 1H, NH), 6.26 (d, J 15.5, 1H, CHCO), 7.22-7.24 (m, 1H, ArH), 7.26-7.36 (m, 6H, 
ArH), 7.42 (d, J 2.1, 1H, ArH), 7.65 (d, J 15.5, 1H, CHCHCO); δC (150 MHz, CDCl3) 
44.0, 120.2, 125.1, 126.9, 127.4, 127.7, 128.0, 128.9, 135.2, 137.8, 138.3, 166.1; Found 
(ES+): [M+H]+ 244.0800 C14H14NOS, requires 244.0796. 
(E)-N-Benzyl-2-methyl-3-phenylacrylamide 58k 
 
White solid (229 mg, 90%); mp 120-121 ˚C (CH2Cl2); νmax (solid/cm-1) 3332 (N-H), 
3079, 3059, 2921, 2852 (C-H), 1631 (C=O); δH (600 MHz, CDCl3) 2.11 (s, 3H, CH3), 
4.56 (d, J 5.7, 2H, CH2NH), 6.69 (br s, 1H, NH), 7.27-7.40 (m, 11H, ArH and CH); δC 
(150 MHz, CDCl3) 14.5, 44.2, 127.7, 127.98, 128.04, 128.5, 128.9, 129.5, 131.9, 134.3, 
136.2, 138.5, 169.6; Found (ES): [M+H]+ 252.1394 C17H18ON, requires 252.1388. 
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N-Benzyl-2,2,2-trifluoroacetamide 58l 
 
Yellow solid (183 mg, 89%); mp 72-74 ˚C (CH2Cl2) [Lit.122 70-71 °C]; νmax (solid/cm-1) 
3300 (N-H), 3110, 3035, 2923 (C-H), 1702 (C=O); δH (500 MHz, CDCl3) 4.54 (d, J 5.8, 
2H, CH2NH), 6.52 (br s, 1H, NH), 7.28-7.32 (m, 2H, ArH), 7.32-7.41 (m, 3H, ArH); δC 
(125 MHz, CDCl3) 43.9, 116.0 (q, JC-F 285.4), 128.0, 128.2, 129.0, 136.1, 157.5 (q, JC-F 
36.9); δF (282 MHz, CDCl3) -76.2. 
N-Benzylpivalamide 58m55 
 
Brown solid; νmax (solid/cm-1) 3303 (N-H), 2963 (C-H), 1638 (C=O); δH (400 MHz, 
CDCl3) 1.25 (9H, s, CH3), 4.45 (2H, d, J 5.68, CH2), 6.01 (1H, br s, NH), 7.26-7.32 
(3H, m, ArH), 7.33-7.38 (2H, m, ArH); δC (100 MHz, CDCl3) 27.8, 38.8, 43.7, 127.6, 
127.8,128.8, 138.7, 178.5. 
N-Benzylbenzamide 58n 
 
White solid; mp 99-101 °C [Lit.55 100-101 °C]; νmax (solid/cm-1) 3282 (N-H), 3062 (C-
H), 1636 (C=O); δH (500 MHz, CDCl3) 4.66 (2H, d, J 5.66, CH2), 6.40 (1H, br s, NH), 
7.28-7.33 (1H, m, ArH), 7.36 (4H, d, J 4.43, ArH), 7.41-7.45 (2H, m, ArH), 7.50 (1H, t, 
J 7.31, ArH)7.78-7.79 (1H, m, ArH), 7.79-7.81 (1H, m, ArH); δC (125 MHz, CDCl3) 
44.2, 127.0, 127.7, 128.0, 128.7, 128.9, 131.6, 134.5, 138.2, 167.4. 
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N-Benzyl-4-methoxybenzamide 58o 
 
Yellow solid (172 mg, 71%); mp 129-130 ˚C (CH2Cl2) [Lit.123 129-130 °C]; νmax 
(solid/cm-1) 3256 (N-H), 3058, 2957, 2930, 2834 (C-H), 1631 (C=O); δH (500 MHz, 
CDCl3) 3.85 (s, 3H, CH3), 4.64 (d, J 5.7, 2H, CH2NH), 6.28 (br s, 1H, NH), 6.90-6.94 
(m, 2H, ArH), 7.28-7.32 (m, 1H, ArH), 7.36 (m, 4H, ArH), 7.74-7.77 (m, 2H, ArH); δC 
(125 MHz, CDCl3) 44.1, 55.5, 113.8, 126.7, 127.6, 128.0, 128.8, 128.9, 138.5, 162.3, 
167.0. 
N-Benzyl-4-(trifluoromethyl)benzamide 58p 
 
Yellow solid (212 mg, 76%); mp 168-170 ˚C (CH2Cl2) [Lit.114 149-151 °C]; νmax 
(solid/cm-1) 3326 (N-H), 3091, 3071, 3036 (C-H), 1643 (C=O); δH (600 MHz, CDCl3) 
4.65 (d, J 5.6, 2H, CH2NH), 6.53 (br s, 1H, NH), 7.29-7.33 (m, 1H, ArH), 7.33-7.38 (m, 
4H, ArH), 7.68 (d, J 8.2, 2H, ArH), 7.89 (d, J 8.2, 2H, ArH); δC (150 MHz, CDCl3) 
44.5, 123.7 (q, JC-F 272.5), 125.8 (q, JC-F 3.8), 127.6, 128.0, 128.1, 129.0, 133.4 (q, JC-F 
32.7), 137.7, 137.8, 166.2; δF (282 MHz, CDCl3) -63.4. 
N,2-Dibenzylbenzamide 58q 
 
Yellow solid (184 mg, 61%); mp 119-120 ˚C (CH2Cl2);  νmax (solid/cm-1) 3296 (N-H), 
3057, 3025, 3008, 2921, 2873 (C-H), 1633 (C=O), δH (600 MHz, CDCl3) 4.22 (s, 2H, 
CH2Ph), 4.49 (d, J 5.6, 2H, CH2NH), 5.86 (br s, 1H, NH), 7.13 (d, J 7.1, 2H, ArH), 
7.16-7.19 (m, 3H, ArH), 7.21-7.25 (m, 4H, ArH), 7.26-7.32 (m, 3H, ArH), 7.33-7.37 
(m, 1H, ArH), 7.39-7.42 (m, 1H, ArH); δC (150 MHz, CDCl3) 39.0, 44.1, 126.2, 126.5, 
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127.3, 127.7, 128.0, 128.6, 128.9, 129.0, 130.3, 131.3, 136.5, 137.9, 139.0, 140.9, 
169.9; Found (ES): [M+H]+ 302.1532 C21H20NO, requires 302.1545. 
N-Benzyl-4-iodobenzamide 58r 
 
White solid (124 mg, 37%); mp 167-168 ˚C (CH2Cl2) [Lit.124 166-167 °C]; νmax 
(solid/cm-1) 3311 (N-H), 3083, 3060, 3028 (C-H), 1640 (C=O); δH (600 MHz, DMSO-
d6) 4.47 (d, J 6.0, 2H, CH2NH), 7.22-7.26 (m, 1H, ArH), 7.29-7.35 (m, 4H, ArH), 7.66-
7.69 (m, 2H, ArH), 7.84-7.88 (m, 2H, ArH), 9.10 (br t, J 6.0, 1H, NH); δC (150 MHz, 
DMSO-d6) 42.7, 98.9, 126.8, 127.3, 128.3, 129.3, 133.8, 137.2, 139.5, 165.6; Found 
(EI): [M]+ 337.99617 C14H12INO, requires 337.99581. 
(S)-N-Benzyl-2-(4-isobutylphenyl)propanamide 58s 
 
Yellow solid (294 mg, 98%); mp 77-78 ˚C (CH2Cl2); [α
25
D]  +7.2 (c 0.88, CH2Cl2) [Lit.
51 
[α 20D]  +7.1 (c 0.88, CH2Cl2)]; νmax (solid/cm
-1) 3304 (N-H), 2949, 2866 (C-H), 1638 
(C=O); δH (600 MHz, CDCl3) 0.90 (d, J 6.6, 6H, (CH3)2CH), 1.55 (d, J 7.2, 3H, 
CH3CH), 1.85 (app nonet, J 6.8, 1H, (CH3)2CH), 2.45 (d, J 7.0, 2H, CH2CH), 3.58 (q, J 
7.2, 1H, CHCO), 4.37 (dd, J 15.1, 5.7, 1H, CHHNH), 4.41 (dd, J 15.1, 5.8, 1H, 
CHHNH), 5.66 (br s, 1H, NH), 7.10-7.14 (m, 4H, ArH), 7.19-7.29 (m, 5H, ArH); δC 
(150 MHz, CDCl3) 18.6, 22.5, 30.3, 43.5, 45.1, 46.6, 127.3, 127.41, 127.43, 128.6, 
129.6, 138.7, 138.8, 140.6, 174.7; HPLC (hexane/i-PrOH 100:0, 0.5 mL/min, Chiracel 
Daicel AD): tR (S) = 5.01 min (>99%), tR (R) = 7.41 min (<1%). 
N-Butyl-2-p-tolylacetamide 59a 
 
White solid (188 mg, 92%); mp 82-83 ˚C (CH2Cl2); νmax (solid/cm-1) 3301 (N-H), 2959, 
2931, 2866 (C-H), 1649 (C=O); δH (500 MHz, CDCl3) 0.86 (t, J 7.3, 3H, CH3CH2), 1.24 
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(sextet, J 7.3, 2H, CH3CH2), 1.39 (quintet, J 7.3, 2H, CH3CH2CH2), 2.34 (s, 3H, 
CH3Ar), 3.18 (dt, J 7.3, 6.0, 2H, CH2NH), 3.52 (s, 2H, CH2CO), 5.43 (br s, 1H, NH), 
7.11-7.17 (m, 4H, ArH); δC (125 MHz, CDCl3) 13.8, 20.0, 21.2, 31.6, 39.5, 43.6, 129.5, 
129.8, 132.0, 137.1, 171.2; Found (EI): [M]+ 205.14639 C13H19NO, requires 205.14611. 
Methyl 2-(picolinamido)acetate 59b 
 
Purified by column chromatography (PE:EtOAc 1:1). 
White solid (132 mg, 72%); mp 82-84 ˚C (CH2Cl2) [Lit.125 81-82 °C]; νmax (solid/cm-1) 
3375 (N-H), 3059, 2954, 2852 (C-H), 1746 (C=O), 1668 (C=O); δH (600 MHz, CDCl3) 
3.74 (s, 3H, CH3), 4.23 (d, J 5.7, 2H, CH2), 7.38-7.42 (m, 1H, ArH), 7.80 (t, J 7.6, 1H, 
ArH), 8.13 (d, J 7.6, 1H, ArH), 8.49 (br s, 1H, NH), 8.53 (br d, J 4.5, ArH); δC (150 
MHz, CDCl3) 41.3, 52.5, 122.4, 126.6, 137.4, 148.4, 149.3, 164.7, 170.3. 
2-(4-(2-(Benzylamino)-2-oxoethyl)phenyl)acetic acid 59c 
 
B(OCH2CF3)3 (621.8 mg, 2.02 mmol, 2 equiv.) was added to a solution of phenylene 
diacetic acid (192 mg, 0.99 mmol, 1 equiv.) and benzylamine (0.11 mL, 1.01 mmol, 1 
equiv.) in MeCN (2 mL, 0.5 M). The reaction mixture was stirred at 80 °C for 5 h. After 
5 h the solvent was removed in vacuo and the residue diluted in Et2O (20 mL) and 
washed with NaHCO3 (20 mL, 1 M) and extracted with Et2O (3 × 20 mL). The aqueous 
layer was acidifed with HCl (1 M) and extracted with CH2Cl2 (3 × 20 mL). The 
combined organic layers were dried over MgSO4 and concentrated in vacuo to yield the 
product as a white solid (146 mg, 0.52 mmol, 52%); mp 163-166 °C (CH2Cl2); νmax 
(solid/cm-1) 3284 (N-H/O-H), 3030, 3060 (C-H), 1699 (C=O), 1632 (C=O); δH (600 
MHz, DMSO-d6) 3.45 (s, 2H, CH2CO2H), 3.53 (s, 2H, CH2CONH), 4.26 (d, J 6.0, 2H, 
CH2NH), 7.16-7.19 (m, 2H, ArH), 7.20-7.25 (m, 5H, ArH), 7.29-7.32 (m, 2H, ArH), 
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8.55 (br t, J 5.6, 1H, NH), 12.31 (br s, 1H, OH); δC (150 MHz, DMSO-d6) 40.3, 42.0, 
42,2, 126.8, 127.3, 128.3, 128.9, 129.3, 133.1, 134.7, 139.5, 170.2, 172.8; Found (EI): 
[M+H]+ 284.12789 C17H18O3N, requires 284.12866. 
N-(4-Hydroxyphenyl)acetamide 59d 
 
White solid (97 mg, 69%); mp 169-170 ˚C (CH2Cl2) [Lit.126 167-168 °C]; νmax 
(solid/cm-1) 3242 (N-H/O-H), 1632 (C=O); δH (600 MHz, MeOD) 2.07 (s, 3H, CH3), 
6.71-6.74 (m, 2H, ArH), 7.28-7.32 (m, 2H, ArH); δC (150 MHz, MeOD) 23.5, 116.2, 
123.4, 131.7, 155.4, 171.4. 
Piperidin-2-one 60a127 
 
Colourless oil (95 mg, 99%); νmax (film/cm-1) 3245 (N-H), 2945, 2870 (C-H), 1637 
(C=O); δH (500 MHz, CDCl3) 1.69-1.82 (m, 4H, CH2CH2CO and CH2CH2NH), 2.30 (t, 
J 6.5, 2H, CH2CO), 3.26-3.32 (m, 2H, CH2NH), 7.03 (br s, 1H, NH); δC (125 MHz, 
CDCl3) 20.8, 22.2, 31.5, 42.1, 172.9. 
Azepan-2-one 60b 
 
White solid (100 mg, 86%); mp 67-68 ˚C (CH2Cl2) [Lit.128 66-68 °C]; νmax (solid/cm-1) 
3202 (N-H), 2927, 2855 (C-H), 1648 (C=O); δH (500 MHz, CDCl3) 1.60-1.71 (m, 4H, 
CH2CH2CH2NH), 1.72-1.78 (m, 2H, CH2CH2CO), 2.42-2.47 (m, 2H, CH2CO), 3.17-
3.22 (m, 2H, CH2NH), 6.42 (br s, 1H, NH); δC (125 MHz, CDCl3) 23.3, 29.8, 30.6, 
36.8, 42.8, 179.5; Found (EI): [M]+ 113.08274 C6H11ON, requires 113.08351. 
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(S)-tert-Butyl 2-oxopiperidin-3-ylcarbamate 60c 
 
White solid (180 mg, 84%); mp 100-101 ˚C (CH2Cl2) [Lit.129 101-103 °C]; [α
25
D]  −9.5 
(c 1.22, MeOH) [Lit.129 [α 02D]  −10.6 (c 1.22, MeOH)];  νmax (solid/cm
-1) 3264 (N-H), 
2968 (C-H), 1715 (C=O), 1652 (C=O); δH (400 MHz, CDCl3, 58 °C) 1.45 (s, 9H, 
C(CH3)3), 1.54-1.67 (m, 1H, CHCHH), 1.82-1.93 (m, 2H, NHCH2CH2), 2.41-2.50 (m, 
1H, CHCHH), 3.27-3.33 (m, 2H, CH2NH), 4.01 (dt, J 11.3, 5.6, 1H, CH), 5.45 (br s, 
1H, NHCH), 6.33 (br s, 1H, NHCH2); δC (100 MHz, CDCl3, 58 °C) 21.1, 27.9, 28.3, 
41.7, 51.6, 79.5, 155.8, 171.6. 
6.4.  Characterisation of Formamides 
N-Benzylformamide 64a 
 
Mixture of rotamers (1:0.16). Data for major rotamer reported. 
White solid (139 mg, 98%); mp 63-64 °C (CH2Cl2) [Lit.
130 60-62 °C]; νmax (solid/cm-1) 
3269 (N-H), 3089, 3056, 2925, 2886 (C-H), 1637 (C=O); δH (500 MHz, CDCl3) 4.41 (d, 
J 6.0, 2H, CH2), 6.41 (br s, 1H, NH), 7.20-7.28 (m, 3H, ArH) 7.29-7.37 (m, 2H, ArH), 
8.17 (s, 1H, CHO); δC (125 MHz, CDCl3) 42.3, 127.8, 127.9, 128.9, 137.6, 161.1. 
N-Phenethylformamide 64b 
 
Mixture of rotamers (1:0.22). Data for major rotamer reported. 
Colourless oil (152 mg, 99%); νmax (film/cm-1) 3273 (N-H), 3061, 3028, 2934, 2866 (C-
H), 1656 (C=O); δH (400 MHz, CDCl3, 58 °C) 2.84 (t, J 7.1, 2H, PhCH2), 3.55 (app q, J 
6.7, 2H, CH2NH), 5.96 (br s, 1H, NH), 7.14-7.26 (m, 3H, ArH), 7.27-7.34 (m, 2H, 
ArH), 8.09 (s, 1H, CHO); δC (100 MHz, CDCl3, 58 °C) 35.5, 39.2, 126.5, 128.59, 
128.63, 138.6, 161.1. 
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N-(4-Methoxybenzyl)formamide 64c 
 
Mixture of rotamers (1:0.17). Data for major rotamer reported. 
Yellow solid (101 mg, 61%); mp 81-83 ˚C (CH2Cl2) [Lit.131 79-80 °C]; νmax (solid/cm-1) 
3283 (N-H), 3010, 2933, 2891 (C-H), 1642 (C=O); δH (600 MHz, CDCl3) 3.77 (s, 3H, 
CH3), 4.37 (d, J 5.9, 2H, CH2), 6.11 (br s, 1H, NH), 6.83-6.86 (m, 2H, ArH), 7.17-7.20 
(m, 2H, ArH), 8.18 (s, 1H, CHO); δC (150 MHz, CDCl3) 41.7, 55.4, 114.2, 129.2, 129.9, 
159.1, 161.3. 
 (R)-N-(1-Phenylethyl)formamide 64d 
 
Mixture of rotamers (1:0.19). Data for major rotamer reported. 
Pale yellow oil (129 mg, 85%); [α 25D]  +160.9 (c 0.52, CHCl3) [Lit.
132 [α 02D]  +161.4 (c 
0.50, CHCl3)]; νmax (film/cm-1) 3270 (N-H), 3032, 2977, 2931, 2829 (C-H), 1653 
(C=O); δH (500 MHz, CDCl3) 1.45 (d, J 6.9, 3H, CH3), 5.13 (app quintet, J 7.2, 1H, 
CHCH3), 6.71 (br s, 1H, NH), 7.21-7.35 (m, 5H, ArH), 8.04 (s, 1H, CHO); δC (125 
MHz, CDCl3) 22.0, 47.7, 126.2, 127.4, 128.7, 143.0, 160.7; Found (EI): [M]
+ 
149.08325 C9H11ON, requires 149.08351. 
N-(Cyclohexylmethyl)formamide 64e 
 
Mixture of rotamers (1:0.25). Data for major rotamer reported. 
Colourless oil (135 mg, 96%); νmax (film/cm-1) 3280 (N-H), 3060, 2922, 2851 (C-H), 
1657 (C=O); δH (600 MHz, CDCl3) 0.77-0.88 (m, 2H, cyclohexyl), 1.00-1.18 (m, 3H, 
cyclohexyl), 1.34-1.42 (m, 1H, cyclohexyl), 1.53-1.68 (m, 5H, cyclohexyl), 3.01 (t, J 
6.6, 2H, CH2NH), 6.71 (br s, 1H, NH), 8.06 (s, 1H, CHO); δC (150 MHz, CDCl3) 25.8, 
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26.4, 30.8, 37.8, 44.4, 161.8; Found (EI): [M+H]+ 142.122721 C8H16NO, requires 
142.12264. 
N-Cyclohexylformamide 64f 
 
Mixture of rotamers (1:0.30). Data for major rotamer reported. 
Brown oil (95 mg, 78%); νmax (film/cm-1) 3268 (N-H), 3050, 2929, 2854 (C-H), 1652 
(C=O); δH (500 MHz, CDCl3) 1.09-1.39 (m, 5H, cyclohexyl), 1.53-1.63 (m, 1H, 
cyclohexyl), 1.64-1.76 (m, 2H, cyclohexyl), 1.82-1.95 (m, 2H, cyclohexyl), 3.78-3.86 
(m, 1H, CHNH), 5.78 (br s, 1H, NH), 8.07 (s, 1H, CHO); δC (125 MHz, CDCl3) 24.8, 
25.5, 33.1, 47.1, 160.5. 
N-Butylformamide 64g 
 
Mixture of rotamers (1:0.23). Data for major rotamer reported. 
Yellow oil (31 mg, 30%); νmax (film/cm-1) 3280 (N-H), 3058, 2959, 2933, 2868 (C-H), 
1655 (C=O); δH (500 MHz, CDCl3) 0.90 (t, J 7.2, 3H, CH3), 1.33 (sext, J 7.2, 2H, 
CH3CH2), 1.48 (quintet, J 7.2, 2H, CH3CH2CH2), 3.26 (q, J 6.7, 2H, CH2NH), 5.95 (br 
s, 1H, NH), 8.12 (s, 1H, CHO); δC (125 MHz, CDCl3) 13.7, 20.0, 31.5, 37.9, 161.5; 
Found (EI): [M]+ 101.08274 C5H11ON, requires 101.08351. 
N-Phenylformamide 64h 
 
Mixture of rotamers (1:0.93). Data for major rotamer reported. 
Yellow oil (25 mg, 21%); νmax (film/cm-1) 3273 (N-H), 3066, 2923, 2854 (C-H), 1682 
(C=O); δH (600 MHz, CDCl3) 7.08-7.11 (m, 1H, ArH), 7.19 (t, J 7.5, 1H, ArH), 7.31-
7.38 (m, 2H, ArH), 7.53-7.56 (m, 1H, ArH), 8.41 (br s, 1H, NH), 8.71 (d, J 11.3, 1H, 
CHO); δC (150 MHz, CDCl3) 118.9, 125.4, 129.9, 136.8, 162.8. 
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1-Indolinecarbaldehyde 64i 
 
Mixture of rotamers (1:0.22). Data for major rotamer reported. 
Brown solid (55 mg, 38%); mp 56-58 °C (CH2Cl2) [Lit.
133 58-61 °C]; νmax (solid/cm-1) 
3053, 2960, 2921, 2854 (C-H), 1656 (C=O); δH (600 MHz, CDCl3) 3.14 (2H, t, J 8.6, 
CCH2), 4.05 (2H, app td, J 8.5, 0.9, CH2N), 7.04 (1H, td, J 7.2, 1.5, ArH), 7.14-7.22 
(2H, m, ArH), 7.24 (1H, d, J 7.2, ArH) 8.92 (1H, s, CHO); δC (150 MHz, CDCl3) 27.3, 
44.8, 109.5, 124.4, 126.2, 127.7, 132.1, 141.2, 157.7. 
3,4-Dihydro-2(1H)-isoquinolinecarbaldehyde 64j 
 
Mixture of rotamers (1:0.60). Data for major rotamer reported. 
Pale yellow oil (119 mg, 71%); νmax (film/cm-1) 3056, 3026, 2929, 2886 (C-H), 1646 
(C=O); δH (500 MHz, CDCl3) 2.87 (t, J 5.9, 2H, CCH2CH2), 3.60 (t, J 5.9, 2H, 
CCH2CH2), 4.65 (s, 2H, CCH2NH), 7.05-7.19 (m, 4H, ArH), 8.16 (s, 1H, CHO); δC 
(125 MHz, CDCl3) 29.8, 42.4, 43.3, 126.70, 126.71, 126.8, 129.0, 131.8, 133.7, 161.8. 
6.5.  Characterisation of N-protected amino acid amides 
Boc-ʟ-Phenylalanine-benzylamide 65a 
 
Yellow solid (287 mg, 81%); mp 128-129 °C (CH2Cl2) [Lit.
134 128 °C]; [α
25
D]  +5.2 (c 
1.1, CH2Cl2) [Lit.
135 [α
22
D]  +4.9 (c 0.20, CH2Cl2)]; νmax (solid/cm
-1) 3343 (N-H), 3312 
(N-H), 3024, 2927 (C-H), 1678 (C=O), 1659 (C=O); δH (400 MHz, CDCl3, 58 °C) 1.43 
(s, 9H, C(CH3)3), 3.09 (dd, J 13.8, 7.2, 1H, CHCHH), 3.13 (dd, J 13.8, 6.7, 1H, 
CHCHH), 4.32-4.40 (m, 3H, NHCH2 and CH), 5.00 (br s, 1H, NHCH), 6.03 (br s, 1H, 
NHCH2), 7.12-7.16 (m, 2H, ArH), 7.20-7.25 (m, 3H, ArH), 7.25-7.32 (m, 5H, ArH); δC 
(100 MHz, CDCl3, 58 °C) 28.2, 38.6, 43.5, 56.4, 80.2, 126.8, 127.4, 127.6, 128.5, 
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128.6, 129.3, 136.8, 137.8, 155.3, 171.0; HPLC (hexane/i-PrOH 90:10, 0.5 mL/min, 
Chiracel Daicel OD): tR (D) = 10.62 min (<1%), tR (L) = 13.24 min (>99%). 
Boc-ʟ-Methionine-benzylamide 65b 
 
Yellow solid (266 mg, 79%); mp 98-100 °C (CH2Cl2); [α
25
D] −9.1 (c 1.1, CH2Cl2) [Lit.
135 
[α 24D]  −9.2 (c 1.1, CH2Cl2)]; νmax (solid/cm
-1) 3335 (N-H), 3314 (N-H), 3061, 3027, 
2968, 2936 (C-H), 1679 (C=O), 1655 (C=O); δH (400 MHz, CDCl3, 58 °C) 1.41 (s, 9H, 
C(CH3)3), 1.88-1.97 (m, 1H, CHCHH), 2.05 (s, 3H, CH3S), 2.06-2.15 (m, 1H, 
CHCHH), 2.46-2.59 (m, 2H, CH2S), 4.28 (app q, J 7.1, 1H, CH), 4.36 (dd, J 14.8, 5.8, 
1H, CHHNH), 4.43 (dd, J 14.8, 5.9, 1H, CHHNH), 5.42 (br d, J 8.1, 1H, NHCH), 7.19-
7.25 (m, 3H, ArH), 7.26-7.30 (m, 2H, ArH), 6.86 (br s, 1H, NHCH2); δC (100 MHz, 
CDCl3, 58 °C) 15.2, 28.3, 30.4, 32.0, 43.4, 54.1, 80.1, 127.3, 127.5, 128.5, 138.2, 155.7, 
171.6; Found (ES): [M+Na]+ 361.1567 C17H26O3N2SNa, requires 361.1562; HPLC 
(hexane/i-PrOH 92:8, 0.5 mL/min, Chiracel Daicel OD): tR (D) = 9.28 min (<1%), tR 
(L) = 12.48 min (>99%). 
Boc-ʟ-Proline-benzylamide 65c 
 
Yellow solid (186 mg, 61%); mp 124-125 °C (CH2Cl2) [Lit.
136 125-126 °C]; [α
25
D]  
−77.0 (c 1.0, CH2Cl2) [Lit.135 [α
42
D]  −76.2 (c 1.0, CH2Cl2)]; νmax (solid/cm
-1) 3303 (N-
H), 2978, 2933, 2909, 2874 (C-H), 1682 (C=O), 1653 (C=O); δH (400 MHz, CDCl3, 58 
°C) 1.40 (s, 9H, C(CH3)3), 1.78-2.07 (m, 3H, CH2CH2NBoc and CHHCHNBoc), 2.25 
(br s, 1H, CHHCHNBoc), 3.37-3.42 (m, 2H, CH2NBoc), 4.24-4.30 (m, 1H, CHNBoc), 
4.37 (dd, J 14.8, 5.6, 1H CHHNH), 4.46 (dd, J 14.8, 5.7, 1H, CHHNH), 6.82 (br s, 1H, 
NH), 7.18-7.30 (m, 5H, ArH); δC (100 MHz, CDCl3, 58 °C) 24.1, 28.3 (2C), 43.3, 47.0, 
60.6, 80.3, 127.2, 127.5, 128.5, 138.5, 155.2, 172.1; HPLC (hexane/i-PrOH 90:10, 0.5 
mL/min, Chiracel Daicel OD): tR  (D) = 13.08 min (1%), tR (L) = 15.79 min (99%).  
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Cbz-ʟ-Alanine-benzylamide 65d 
 
Yellow solid (245 mg, 78%); mp 138-139 °C (CH2Cl2) [Lit.
31 140-141 °C]; [α 25D]  −8.0 
(c 1.02, CHCl3) [Lit.
31 [α 22D] −8.1 (c 1.3, CHCl3)];  νmax (solid/cm
-1) 3286 (N-H), 3059, 
3035, 2975, 2930 (C-H), 1682 (C=O), 1641 (C=O); δH (500 MHz, CDCl3) 1.37 (d, J 
6.9, 3H, CH3), 4.28-4.32 (m, 1H, CH), 4.34 (dd, J 15.0, 5.7, 1H, CHHPh), 4.41 (dd, J 
15.0, 5.6, 1H, CHHPh), 4.98 (d, J 12.1, 1H, OCHH), 5.01 (d, J 12.1, 1H, OCHH), 5.68 
(br d, J 6.5, 1H, NHCH), 6.88 (br s, 1H, NHCH2), 7.18-7.35 (m, 10H, ArH); δC (125 
MHz, CDCl3) 18.9, 43.5, 50.7, 67.0, 127.5, 127.7, 128.1, 128.3, 128.6, 128.7, 136.2, 
138.1, 156.1, 172.5; HPLC (hexane/i-PrOH 90:10, 0.5 mL/min, Chiracel Daicel AD): tR 
(L) = 5.13 min (95%), tR (D) = 7.88 min (5%). 
Boc-Sarcosine-benzylamide 65e 
 
Yellow solid (265 mg, 95%); mp 82-84 °C (CH2Cl2) [Lit.
137 83-85 °C]; νmax (solid/cm-1) 
3310 (N-H), 3067, 2978, 2931 (C-H), 1664 (C=O), 1685 (C=O); δH (400 MHz, CDCl3, 
58 °C) 1.40 (s, 9H, C(CH3)3), 2.90 (s, 3H, CH3N), 3.83 (s, 2H, CH2CO), 4.41 (d, J 5.9, 
2H, CH2NH), 6.52 (br s, 1H, NH), 7.19-7.24 (m, 3H, ArH), 7.25-7.31 (m, 2H, ArH); δC 
(100 MHz, CDCl3, 58 °C) 28.2, 35.7, 43.3, 53.4, 80.6, 127.3, 127.5, 128.6, 138.2, 
155.9, 169.1; Found (EI): [M]+ 278.16290 C15H22O3N2, requires 278.16249. 
Boc-ʟ-Alanine pyrrolidine amide 66a 
 
Colourless oil (135 mg, 59%); [α
25
D] −6.4 (c 1.1, CHCl3) [Lit.
31 [α
24
D]  −6.8 (c 1.1, 
CHCl3)]; νmax (film/cm-1) 3300 (N-H), 2976, 2936, 2879 (C-H), 1705 (C=O), 1636 
(C=O); δH (400 MHz, CDCl3) 1.24 (d, J 6.8, 3H, CH3CH), 1.36 (s, 9H, C(CH3)3), 1.76-
1.84 (m, 2H, CH2CH2N), 1.91 (app qn, J 6.8, 2H, CH2CH2N), 3.31-3.39 (m, 2H, 
CH2N), 3.41-3.49 (m, 1H, CHHN), 3.51-3.58 (m, 1H, CHHN), 4.37 (app qn, J 6.8, 1H, 
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CH), 5.50 (br d, J 7.8, 1H, NH); δC (100 MHz, CDCl3) 18.6, 24.1, 26.0, 28.3, 45.9, 46.2, 
47.8, 79.3, 155.1, 171.2; Found (EI): [M+H]+ 243.17132 C12H23O3N2, requires 
243.17086; HPLC measured as benzoyl derivative (hexane/i-PrOH 90:10, 0.5 mL/min, 
Chiracel Daicel OD): tR (D) = 15.79 min (<1%), tR (L) = 23.58 min (>99%). 
Boc-ʟ-Phenylalanine pyrrolidine amide 66b 
 
Colourless oil (115 mg, 37%); [α 25D]  +37.2 (c 1.0, CHCl3) [Lit.
31 [α 20D]  +37.5 (c 1.0, 
CHCl3)]; νmax (film/cm-1) 3432 (N-H), 2979, 2880 (C-H), 1702 (C=O), 1631 (C=O); δH 
(400 MHz, CDCl3) 1.40 (s, 9H, C(CH3)3), 1.47-1.77 (m, 4H, 2×CH2CH2N), 2.52-2.59 
(m, 1H, CHHN), 2.90-3.01 (m, 2H, CH2Ph), 3.25-3.46 (m, 3H, CH2NCHH), 4.53-4.61 
(m, 1H, CH), 5.49 (br d, J 8.6, 1H, NH), 7.16-7.28 (m, 5H, ArH); δC (100 MHz, CDCl3) 
24.0, 25.7, 28.3, 40.2, 45.7, 46.2, 53.6, 79.5, 126.8, 128.3, 129.4, 136.6, 155.1, 170.0; 
HPLC (hexane/i-PrOH 90:10, 0.5 mL/min, Chiracel Daicel OD): tR (D) = 10.09 min 
(4%), tR (L) = 13.21 (96%). 
Boc-ʟ-Alanine thiomorpholine amide 66c 
 
Yellow solid (113 mg, 41%); mp 65-68 ˚C (CH2Cl2); [α
25
D]  −3.8 (c 1.03, CHCl3); νmax 
(solid/cm-1) 3317 (N-H), 2980, 2927 (C-H), 1699 (C=O), 1638 (C=O); δH (400 MHz, 
CDCl3) 1.29 (d, J 6.8, 3H, CH3CH), 1.43 (s, 9H, C(CH3)3), 2.53-2.61 (m, 2H, CH2S), 
2.63-2.76 (m, 2H, CH2S), 3.65-3.75 (m, 2H, CH2N), 3.80-3.89 (m, 1H, CHHN), 3.99-
4.08 (m, 1H, CHHN), 4.59 (app qn, J 7.2, 1H, CH), 5.52 (br d, J 8.0, 1H, NH); δC (100 
MHz, CDCl3) 19.3, 27.3, 27.9, 28.4, 44.8, 46.1, 48.1, 79.6, 155.0, 171.3; Found (EI): 
[M]+ 274.13515 C12H22O3N2S, requires 274.13456; HPLC measured as benzoyl 
derivative (hexane/i-PrOH 90:10, 0.5 mL/min, Chiracel Daicel OD): tR (D) = 22.20 min 
(8%), tR (L) = 31.86 min (92%). 
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Benz-ʟ-Alanine-pyrrolidine amide 66d 
 
White solid (118 mg, 49%); mp 89-91 ˚C (PE/EtOAc); νmax (solid/cm-1) 3301 (N-H), 
3061, 2975, 2877 (C-H), 1724 (C=O), 1629 (C=O); δH (400 MHz, CDCl3) 1.42 (d, J 
6.8, 3H, CH3CH), 1.81-1.89 (m, 2H, CH2CH2N), 1.96 (quintet, J 6.7, 2H, CH2CH2N), 
3.39-3.54 (m, 3H, CH2N and CHHN), 3.65 (dt, J 10.1, 6.7, 1H, CHHN), 4.90 (quintet, J 
7.0, 1H, CH), 7.34-7.40 (m, 2H, ArH), 7.41-7.47 (m, 2H, ArH and NH), 7.77-7.81 (m, 
2H, ArH); δC (100 MHz, CDCl3) 18.3, 24.1, 26.0, 46.1, 46.4, 47.3, 127.1, 128.4, 131.5, 
134.1, 166.4, 171.0; Found (ES): [M−H]+ 245.1290 C14H17N2O2, requires 245.1291; 
HPLC (hexane/i-PrOH 90:10, 0.5 mL/min, Chiracel Daicel OD): tR  (D) = 17.08 min 
(2%), tR (L) = 28.56 min (98%). 
Benz-ʟ-Alanine-thiomorpholine amide 66e 
 
White solid (120 mg, 45%); mp 137-138 ˚C (PE/EtOAc); νmax (solid/cm-1) 3310 (N-H), 
3059, 2981, 2918 (C-H), 1631 (C=O); δH (400 MHz, CDCl3) 1.42 (d, J 6.9, 3H, CH3), 
2.52-2.77 (m, 4H, 2 × CH2S), 3.69-3.80 (m, 2H, CH2N), 3.89 (ddd, J 2.8, 6.6, 14.0, 1H, 
CHHN), 4.04 (ddd, J 2.8, 6.6, 13.3, 1H, CHHN), 5.07 (quintet, J 6.9, 1H, CHCH3), 
7.37-7.51 (m, 4H, ArH and NHBz), 7.78-7.83 (m, 2H, ArH); δC (100 MHz, CDCl3) 
19.1, 27.4, 27.9, 44.9, 45.6, 48.2, 127.1, 128.5, 131.6, 134.0, 166.4, 171.1; Found (ES): 
[M−H]+ 277.1011 C14H17N2O2S, requires 277.1011; HPLC (hexane/i-PrOH 90:10, 0.5 
mL/min, Chiracel Daicel OD): tR  (D) = 24.26 min (4%), tR (L) = 34.28 min (96%). 
Boc-ʟ-Ala-ʟ-Phe-OMe 67a 
 
Yellow solid (208 mg, 64%); mp 82-84 ˚C (CH2Cl2) [Lit.138 85-86 °C]; [α
25
D]  +23.2 (c 
1.01, CHCl3) [Lit.
139 [α D]  +23.0 (c 0.61, CHCl3)]; νmax (solid/cm
-1) 3285 (N-H), 3061, 
134 
 
3030, 2926 (C-H), 1636 (C=O), 1547 (C=O); δH (400 MHz, CDCl3, 58 °C) 1.27 (d, J 
7.0, 3H, CH3CH), 1.41 (s, 9H, (CH3)3C), 3.04 (dd, J 13.9, 6.6, 1H, CHHPh), 3.12 (dd, J 
13.9, 6.1, 1H, CHHPh), 3.64 (s, 3H, OCH3), 4.13 (quintet, J 7.0, 1H, CHCH3), 4.81 (dt, 
J 7.6, 6.3, 1H, CHCH2), 5.16 (br d, J 7.6, 1H, NHCHCH2), 6.71 (br d, J 7.3, 1H, 
NHCHCH3), 7.08-7.12 (m, 2H, ArH), 7.15-7.26 (m, 3H, ArH); δC (100 MHz, CDCl3, 
58 °C) 18.1, 28.2, 38.0, 50.4, 51.9, 53.3, 79.9, 126.9, 128.4, 129.2, 136.0, 155.3, 171.7, 
172.4. 
Boc-ʟ-Ala-ᴅʟ-Phe-OMe 67b 
 
Yellow solid (136 mg, 42%); mp 93-95 ˚C (CH2Cl2); [α
25
D]  −58.9 (c 0.99, CHCl3); νmax 
(solid/cm-1) 3283 (N-H), 3254 (N-H), 3134, 3060, 3024 (C-H), 1655 (C=O), 1599 
(C=O), 1544 (C=O); δH (600 MHz, CDCl3) 1.27 (d, J 7.1, 3H, CH3CH), 1.42 (s, 9H, 
(CH3)3C), 3.06 (dd, J 13.8, 6.3, 1H, CHHPh), 3.13 (dd, J 13.8, 5.7, 1H, CHHPh), 3.70 
(s, 3H, OCH3), 4.18 (br t, J 7.1, 1H, CHCH3), 4.85 (m, 1H, CHCH2), 5.04 (br d, J 5.5, 
1H, NHCHCH2), 6.70 (br s, 1H, NHCHCH3), 7.10 (d, J 7.1, 2H, ArH), 7.20-7.24 (m, 
1H, ArH), 7.25-7.29 (m, 2H, ArH); δC (150 MHz, CDCl3) 18.6, 28.4, 38.0, 50.0, 52.5, 
53.2, 80.2, 127.2, 128.7, 129.4, 135.9, 155.5, 171.9, 172.4; Found (ES): [M+Na]+ 
373.1720 C18H26O5N2Na, requires 373.1739. 
6.6.  Characterisation of unprotected amino acid amides 
(S)-2-Amino-3-phenyl-N-propylpropanamide hydrochloride 77a 
 
Off-white solid (118 mg, 90%); mp 150-151 °C [Lit.140 155 °C]; [α
25
D]  +21.7 (c 0.62, 
MeOH) [Lit.140 [α D]  +62.9 (c 0.62, MeOH)]; νmax (solid/cm
-1) 3342 (N-H), 2876 (C-H), 
1656 (C=O); δH (600 MHz, DMSO-d6) 0.73 (t, J  7.5, 3H, CH3), 1.23-1.36 (m, 2H, 
CH2CH3), 2.86-2.92 (m, 1H, CHHPh), 2.99-3.09 (3H, m, CHHPh and NHCH2), 3.97 (br 
s, 1H, CHCH2), 7.22-7.27 (m, 3H, ArH), 7.28-7.33 (m, 2H, ArH), 8.40 (br s, 3H, 
NH3
+Cl-), 8.55 (br t, J 5.5, 1H, NHCH2); δC (150 MHz, DMSO-d6) 11.4, 22.0, 37.0, 
135 
 
40.4, 53.5, 127.1, 128.4, 129.5, 135.1, 167.5; Found (CI): [M-Cl]+ 207.149184 
C12H19N2O, requires 207.14974 
(S)-2-Amino-4-(methylthio)-N-propylbutanamide 77b 
 
Colourless oil (77 mg, 81%); νmax (solid/cm-1) 3349 (N-H), 2901 (C-H), 1648 (C=O); δH 
(600 MHz, CDCl3) 0.83 (t, J  7.4, 3H, CH3), 1.44 (sextet, J 7.3, 2H, CH2CH3), 1.49 (br 
s, 2H, NH2), 1.63-1.70 (m, 1H, CHHCH), 2.01 (s, 3H, SCH3), 2.01-2.08 (m, 1H, 
CHHCH), 2.51 (t, J 7.4, 2H, CH2S), 3.11 (q, J 6.9, 2H, NHCH2), 3.38 (dd, J 4.7, 8.1, 
1H, CH), 7.27 (br s, 1H, NH); δC (150 MHz, CDCl3) 11.5, 15.4, 22.9, 30.7, 34.3, 40.8, 
54.4, 174.6; Found (CI): [M+H]+ 191.121334 C8H19N2SO, requires 191.12181. 
(S)-2-Amino-4-methyl-N-propylpentanamide 77c 
 
Colourless oil (87 mg, 82%); νmax (solid/cm-1) 3325 (n-H), 2849 (C-H), 1661 (C=O); δH 
(600 MHz, CDCl3) 0.83-0.87 (m, 6H, CH3CH2 and CH3CH), 0.89 (d, J 6.4, 3H CH3), 
1.24-1.29 (m, 1H, CH(CH3)2), 1.33-1.49 (m, 4H, NH2 and CH2CH3), 1.58-1.70 (m, 2H, 
CH2CH), 3.30 (dd, J 3.8, 9.8, 1H, CHNH2), 3.13 (app. q, J 6.6, 2H, NHCH2), 7.30 (br s, 
1H, NH); δC (150 MHz, CDCl3) 11.5, 21.4, 22.9, 23.5, 24.9, 40.7, 44.2, 53.6, 175.7; 
Found (CI): [M+H]+ 173.165643 C9H21N2O, requires 173.16539. 
(S)-N-propylpyrrolidine-2-carboxamide 77e 
 
Colourless oil (67 mg, 86%); [α
25
D]  −63.2 (c 1.0, MeOH); νmax (solid/cm
-1) 3325 (N-H), 
2899 (C-H), 1660 (C=O); δH (600 MHz, CDCl3)  0.84 (t, J 7.4, 3H, CH3), 1.40-1.49 (m, 
2H, CH2CH3), 1.57-1.67 (m, 2H, CHCH2CH2), 1.82 (app sextet, J 6.4, 1H, CHCHH), 
136 
 
2.00-2.29 (m, 2H, NH and CHCHH), 2.81 (dt, J 6.3, 10.2, 1H, CHHNH), 2.93 (dt, J 6.8, 
10.2, 1H, CHHNH) 3.06-3.16 (m, 2H, CONHCH2), 3.64 (dd, J 5.3, 9.2, 1H, CH), 7.60 
(br s, 1H, CONH); δC (150 MHz, CDCl3) 11.4, 23.0, 26.3, 30.9, 40.6, 47.3, 60.6, 175.2; 
Found (CI): [M+H]+ 157.134661 C8H17N2O, requires 157.13409. 
2-(Methylamino)-N-propylacetamide hydrochloride 77f 
 
White solid (72 mg, 84%); mp 128-129 °C; νmax (solid/cm-1) 3340 (N-H), 2901 (C-H), 
1659 (C=O); δH (600 MHz, DMSO-d6) 0.86 (t, J 7.3, 3H, CH3CH2), 1.43 (sextet, J 7.3, 
2H, CH2CH3), 2.52 (s, 3H, CH3NH2
+Cl-), 3.07 (m, 2H, CH2CH2CH3), 3.65 (s, 2H, 
CH2NH), 8.56 (br s, 1H, NH), 8.99 (br s, 2H, NH2
+Cl-); δC (150 MHz, DMSO-d6) 11.4, 
222, 32.6, 40.4, 48.9, 164.8; Found (CI): [M-Cl]+ 131.117931 C6H15N2O, requires 
131.11844. 
 (S)-2-Amino-N1,N4-dipropylsuccinamide hydrochloride 77g 
 
Off-white solid (89 mg, 68%); mp 165-167 °C; νmax (solid/cm-1) 3342 (N-H), 3280 (N-
H), 2960, 2930, 2873 (C-H), 1660 (C=O), 1646 (C=O); δH (600 MHz, DMSO-d6) 0.84 
(td, J 1.9, 7.4, 6H, 2 × CH3), 1.41 (septet, J 6.9, 4H, 2 × CH2CH3), 2.63 (dd, J 7.5, 16.1, 
1H, CHCHH), 2.68 (dd, 5.5, 16.1, 1H, CHCHH), 2.96-3.13 (m, 4H, 2 × CH2), 4.01 (br 
s, 1H, CH), 8.22 (br s, 3H, NH3
+Cl-), 8.30 (br t, J 5.5, 1H, NH), 8.46 (br t, J 5.5, 1H, 
NH); δC (150 MHz, DMSO-d6) 11.4, 11.5, 22.1, 22.2, 35.9, 40.4, 40.5, 49.5, 167.7, 
168.2; Found (CI): [M-Cl]+ 216.170142 C10H22N3O2, requires 216.17120. 
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(S)-2-Amino-3-methyl-N-propylbutanamide 77k 
 
White solid (84 mg, 95%); mp 78-80 °C; [α 25D]  −3.8 (c 1.0, MeOH); νmax (solid/cm
-1) 
3311 (N-H), 2900 (C-H); 1645 (C=O); δH (600 MHz, CDCl3) 0.73 (t, J 7.0, 3H, 
CH3CH), 0.84 (t, J 7.4, 3H, CH3CH2), 0.90 (d, J 7.0, 3H, CH3CH), 1.35 (br s, 2H, NH2), 
1.44 (sextet, J 7.4, 2H, CH2CH3), 2.16-2.23 (m, CH(CH3)2), 3.06-3.20 (m, 3H, CHNH2 
and CH2NH), 7.31 (br s, 1H, NH); δC (150 MHz, CDCl3) 11.5, 16.1, 19.8, 23.0, 30.9, 
40.7, 60.2, 174.4; Found (CI): [M+H]+ 157.149348 C8H19N2O, requires 159.14974. 
 (S)-2-Amino-N-propylpropanamide hydrochloride 77l 
 
White solid (60 mg, 71%); mp 197-198 °C; νmax (solid/cm-1) 3330 (N-H), 2850 (C-H), 
1650 (C=O); δH (600 MHz, DMSO-d6) 0.86 (t, J 7.4, 3H, CH3CH2), 1.34 (d, J 7.2, 3H, 
CH3CH), 1.43 (sextet, J 7.2, 2H, CH2CH3), 3.01-3.12 (m, 2H, CH2NH), 3.79 (br quint, J 
6.0, 1H, CH), 8.21 (br s, 3H, NH3
+Cl-), 8.49 (br t, J 5.5, 1H, NH); δC (150 MHz, 
DMSO-d6) 11.4, 17.3, 22.2, 40.4, 48.2, 169.3; Found (CI): [M-Cl]
+ 131.118930, 
C6H15N2O, requires 131.11844. 
 (S)-2-Amino-N-(4-methoxybenzyl)-3-phenylpropanamide 78b 
 
White solid (122 mg, 86%); mp 78-80 °C; [α
25
D]  +3.9 (c 1.0, MeOH); νmax (solid/cm
-1) 
3295 (N-H), 2890 (C-H), 1670 (C=O); δH (600 MHz, CDCl3)  1.42, (br s, 2H, NH2), 
2.73 (dd J 9.2, 13.7, 1H, CHHPh), 3.29 (dd, J 4.1, 13.7, 1H, CHHPh), 3.63 (dd, J 4.1, 
9.2, 1H, CHNH2), 3.79 (s, 3H, CH3), 4.33-4.41 (m, 2H, CH2NH), 6.83-6.86 (m, 2H, 
ArH), 7.14-7.18 (m, 2H, ArH), 7.20-7.26 (m, 3H, ArH), 7.28-7.32 (m, 2H, ArH), 7.52 
(br s, 1H, NH); δC (150 MHz, CDCl3) 41.1, 42.7, 55.4, 56.6, 114.1, 126.9, 128.8, 129.2, 
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129.5, 130.6, 138.0159.0, 174.1; Found (CI): [M+H]+ 285.160994 C17H21N2O2, requires 
285.16030. 
(S)-2-Amino-3-phenyl-N-(pyridin-2-ylmethyl)propanamide 78c 
 
Light brown solid (112 mg, 88%); mp 109-110 °C; [α 25D]  −6.1 (c 1.0, MeOH); νmax 
(solid/cm-1) 3351 (N-H), 2872 (C-H), 1640 (C=O); δH (600 MHz, CDCl3) 1.63 (br s, 
2H, NH2), 2.73 (dd, J 9.5, 13.8, 1H, PhCHH), 3.30 (dd, J 4.0, 13.8, 1H, PhCHH), 3.68 
(dd, J 4.0, 9.5, 1H, CHCO), 4.57 (d, J 5.3, 2H, CONHCH2), 7.18 (dd, J 5.2, 7.0, 1H, 
ArH), 7.20-7.25 (m, 4H, ArH), 7.27-7.31 (m, 2H, ArH), 7.64 (td, J 1.6, 7.7, 1H, ArH), 
8.17 (br s, 1H, NH), 8.53 (d, J 4.4, 1H, ArH); δC (150 MHz, CDCl3) 41.2, 44.5, 56.8, 
122.1, 122.4, 126.9, 128.8, 129.4, 136.9, 138.1, 149.3, 157.0, 174.5; Found (CI): 
[M+H]+ 256.144138 C15H18N3O, requires 256.14499. 
 (S)-N-Allyl-2-amino-3-phenylpropanamide hydrochloride 78f 
 
Brown solid (107 mg, 89%); mp 125-126 °C; [α 25D]  −6.0 (c 1.0, MeOH); νmax (solid/cm
-
1) 3280 (N-H), 2983 (C-H), 1650 (C=O); δH (600 MHz, DMSO-d6) 3.05 (d, J 7.2, 2H, 
CH2CH), 3.61-3.67 (m, 1H, NHCHH), 3.71-3.77 (m, 1H, NHCHH), 4.01 (m, 1H, 
CHNH3
+Cl-), 4.98-5.02 (m, 2H, CH2=CH), 5.64-5.71 (m, 1H, CH=CH2), 7.23-7.29 (m, 
3H, ArH), 7.30-7.34 (m, 2H, ArH), 8.40 (br m, 3H, NH3
+Cl-), 8.68 (br m, 1H, NH); δC 
(150 MHz, DMSO-d6) 37.0, 40.9, 53.5, 115.7, 127.1, 128.5, 129.5, 134.3, 135.1, 167.6; 
Found (CI): [M-Cl]+ 205.133821 C12H17N2O, requires 205.13409. 
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(S)-2-Amino-N-cyclohexyl-3-phenylpropanamide 77h 
 
Pale brown solid (85 mg, 65%); mp 95-97 °C [Lit.141 96 °C]; [α 25D]  −15.7 (c 0.2, 
CHCl3); νmax (solid/cm-1) 3400 (N-H), 2845 (C-H), 1649 (C=O); δH (600 MHz, CDCl3)  
1.05-1.19 (m, 3H, 3 × Cy-H), 1.29-1.49 (m, 4H, NH2 and 2 × Cy-H), 1.55-1.61 (m, 1H, 
1 × Cy-H), 1.63-1.70 (m, 2H, 2 × Cy-H), 1.80-1.88 (m, 2H, 2 × Cy-H), 2.69 (dd, J 9.1, 
13.7, 1H, CHH), 3.22 (dd, J 4.3, 13.7, 1H, CHH), 3.55 (dd, J 4.3, 9.1, 1H, CHNH2), 
3.69-3.77 (m, 1H, CHNH), 7.08 (br d, J 7.2, 1H, NH), 7.18-7.24 (m, 3H, ArH), 7.27-
7.31 (m, 2H, ArH); δC (150 MHz, CDCl3) 24.9, 25.6, 33.1, 33.2, 41.2, 47.7, 56.5, 126.9, 
128.8, 129.4, 138.1, 173.3; Found (CI): [M+H]+ 247.180811 C15H23N2O, requires 
247.18104. 
Ethyl (S)-2-((tert-butyldimethylsilyl)oxy)propanoate 80 
 
tert-Butylchlorodimethylsilane (16.0 g, 0.11 mol, 1.2 equiv.), was added to a stirring 
solution of S-ethyl lactate (10 mL, 0.09 mol, 1 equiv.) and imidazole (9.0 g, 0.13 mol, 
1.4 equiv.) in DMF (88 mL). The solution was stirred for 30 min at rt, water (150 mL) 
was added and the reaction mixture extracted with Et2O (2 × 150 mL). The combined 
organic layers were washed with brine (150 mL), dried over MgSO4 and concentrated 
under reduced pressure to give 80 as a colourless oil (20.49 g, 0.088 mol, 98%); δH (400 
MHz, CDCl3) 0.07 (s, 3H, SiCH3), 0.11 (s, 3H, SiCH3), 0.90 (s, 9H, SiC(CH3)3), 1.40 
(d, J 6.8, 3H, CH3CH), 3.73 (s, 3H, CH3O),  4.31 (q, J 6.8, 1H, CHCH3), 4.11-4.25 (m, 
2H, CH2CH3); δC (100 MHz, CDCl3) -5.3, -5.0, 14.2, 18.3, 21.3, 25.7, 60.7, 68.5, 174.1. 
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(S)-2-((tert-Butyldimethylsilyl)oxy)propanal (S)-81 
 
Diisobutylaluminium hydride (44 mL, 1.1 M in cyclohexane, 48.4 mmol, 1.6 equiv.) 
was added dropwise (20 mL/h) to a stirring solution of ester 80 (7 g, 30.1 mmol, 1 
equiv.) in Et2O (200 mL) at -100 °C. After completion of addition, the reaction was 
stirred for 10 min at -78 °C then quenched by dropwise addition of MeOH (2 mL) and 
H2O (5 mL). After warming to rt and stirring for 1.5 h Na2SO4 and MgSO4 were added 
and the suspension stirred for 15 min, then filtered through a short plug of celite and 
silica eluting with Et2O. The filtrate was concentrated under reduced pressure and the 
residue distilled to give aldehyde (S)-81 as a colourless liquid (4.56 g, 24.2 mmol, 
80%); bp 79-81 °C (19 Torr) [Lit.142 67-68 °C (14 Torr)]; δH (600 MHz, CDCl3) 0.08 (s, 
3H, SiCH3), 0.09 (s, 3H, SiCH3), 0.91 (s, 9H, SiC(CH3)3), 1.27 (d, J 6.9, CHCH3), 4.08 
(qd, J 1.2, 6.9, CHCH3), 9.60 (d, J 1.2, CHO); δC (150 MHz, CDCl3) -4.7, -4.6, 18.3, 
18.6, 25.8, 73.9, 204.4. 
Methyl (R)-2-((tert-butyldimethylsilyl)oxy)propanoate  
 
tert-Butylchlorodimethylsilane (18.0 g, 0.12 mol, 1.2 equiv.), was added to a stirring 
solution of R-methyl lactate (10 mL, 0.10 mol, 1 equiv.) and imidazole (10.0 g, 0.15 
mol, 1.5 equiv.) in DMF (90 mL). The solution was stirred for 30 min at rt, water (150 
mL) was added and the reaction mixture extracted with Et2O (2 × 150 mL). The 
combined organic layers were washed with brine (150 mL), dried over MgSO4 and 
concentrated under reduced pressure to give the ester as a colourless oil (17.85 g, 81.7 
mmol, 82%); δH (400 MHz, CDCl3) 0.07 (s, 3H, SiCH3), 0.10 (s, 3H, SiCH3), 0.90 (s, 
9H, SiC(CH3)3), 1.28 (t, J 7.1, 3H, CH3CH2), 1.40 (d, J 6.8, 3H, CH3CH), 4.34 (q, J 6.8, 
1H, CHCH3), 4.11-4.25 (m, 2H, CH2CH3); δC (100 MHz, CDCl3) -5.3, -5.0, 18.3, 21.4, 
25.7, 68.4, 51.8, 51.9, 174.6. 
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(R)-2-((tert-Butyldimethylsilyl)oxy)propanal (R)-81 
 
Diisobutylaluminium hydride (47 mL, 1.1 M in cyclohexane, 51.7 mmol, 1.6 equiv.) 
was added dropwise (20 mL/h) to a stirring solution of methyl (R)-2-((tert-
butyldimethylsilyl)oxy)propanoate (7 g, 32.1 mmol, 1 equiv.) in Et2O (200 mL) at -100 
°C. After completion of addition, the reaction was stirred for 10 min at -78 °C then 
quenched by dropwise addition of MeOH (2 mL) and H2O (5 mL). After warming to rt 
and stirring for 1.5 h Na2SO4 and MgSO4 were added and the suspension stirred for 15 
min, then filtered through a short plug of celite and silica eluting with Et2O. The filtrate 
was concentrated under reduced pressure and the residue distilled to give aldehyde (R)-
81 as a colourless liquid (4.35 g, 23.1 mmol, 72%); bp 83-86 °C (28 Torr); δH (600 
MHz, CDCl3) 0.08 (s, 3H, SiCH3), 0.09 (s, 3H, SiCH3), 0.91 (s, 9H, SiC(CH3)3), 1.27 
(d, J 6.9, CHCH3), 4.08 (qd, J 1.0, 6.8, CHCH3), 9.60 (d, J 1.0, CHO); δC (150 MHz, 
CDCl3) -4.72, -4.66, 18.3, 18.6, 25.8, 73.9, 204.4. 
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7. Appendix 
7.1.  Appendix 1 – Determination of enantiomeric excess by HPLC and 
derivatisation 
Compounds 6h and 6i were converted to the corresponding N-benzoyl derivatives 6k 
and 6l as described below in order to measure the enantiomeric ratio. 
Representative Procedure for Boc deprotection 
Boc-ʟ-Alanine pyrrolidine amide was stirred in a 1:1 solution of TFA and CH2Cl2 (5 
ml) for 1 h. The reaction mixture was the concentrated in vacuo to yield the crude salt. 
The product was carried forward to the next step without further purification. 
Representative Procedure for benzoyl protection 
Benzoyl chloride (2 equiv.) was added dropwise to ʟ-alanine pyrrolidine amide TFA 
salt (1 equiv.) and triethylamine (3 equiv.) in CH2Cl2 at 0 °C. The reaction mixture was 
allowed to warm to room temperature and stirred for 2 h. The reaction mixture was then 
diluted with CH2Cl2, washed with water (10 ml), dried over MgSO4 and concentrated in 
vacuo. The crude product was purified by column chromatography (PE-EtOAc 2:1) to 
yield the N-benzoyl amino acid amide. 
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(±)-N-Benzyl-2-(4-isobutylphenyl)propanamide 
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(S)-N-Benzyl-2-(4-isobutylphenyl)propanamide 58s 
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Boc-ᴅʟ-Phenylalanine-benzylamide  
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Boc-ʟ-Phenylalanine-benzylamide 65a  
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Boc-ʟ-Phenylalanine-benzylamide 65a (8 h reaction time) 
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Boc-ᴅʟ-Methionine-benzylamide 
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Boc-ʟ-Methionine-benzylamide 65b 
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Boc-ᴅʟ-Proline-benzylamide 
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Boc-ʟ-Proline-benzylamide 65c 
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Cbz-ᴅʟ-Alanine-benzylamide 
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Cbz-ʟ-Alanine-benzylamide 65d 
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Bz-ᴅʟ-Alanine pyrrolidine amide 
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Bz-ʟ-Alanine pyrrolidine amide 66d (obtained from 66a) 
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Bz-ʟ-Alanine pyrrolidine amide 66d (Directly from N-benzoyl alanine) 
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Bz-ʟ-Alanine pyrrolidine amide 66d (obtained from 6h; 8 h reaction time) 
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Bz-ᴅʟ-Alanine thiomorpholine amide 
 
 
  
159 
 
Bz-ʟ-Alanine thiomorpholine amide 66e (obtained from 66c) 
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Bz-ʟ-Alanine thiomorpholine amide 66e (directly from N-benzoyl alanine) 
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Bz-ʟ-Alanine thiomorpholine amide 66e (directly from N-benzoyl alanine; 8 h 
reaction time) 
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Boc-ᴅʟ-Phenylalanine pyrrolidine amide 
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Boc-ʟ-Phenylalanine pyrrolidine amide 66b 
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7.2.  Appendix 2 – HPLC and NMR spectra for aldehyde 81 method 
development 
Boc-ʟ-Methionine-benzylamide 65b for aldehyde 81 comparison 
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Boc-ʟ-Alanine benzylamide for aldehyde 81 comparison
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Boc-ʟ-Phenylalanine-benzylamide 65a for aldehyde 81 comparison 
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ʟ-Methionine-benzylamide 65b imine with aldehyde (R)-81  
 
ʟ-Methionine-benzylamide 65b imine with aldehyde (S)-81  
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ʟ-Alanine-benzylamide imine with aldehyde (R)-81  
 
ʟ-Alanine-benzylamide imine with aldehyde (S)-81  
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ʟ-Phenylalanine-benzylamide 65a imine with aldehyde (R)-81  
 
ʟ-Phenylalanine-benzylamide 65a imine with aldehyde (S)-81  
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7.3.  Appendix 3 – 13C-NMR spectra for er determination 
(S)-2-Amino-3-phenyl-N-propylpropanamide 77a – (R)-81 
 
(S)-2-Amino-3-phenyl-N-propylpropanamide 77a – (S)-81 
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(S)-2-Amino-4-(methylthio)-N-propylbutanamide 77b – (R)-81 
 
(S)-2-Amino-4-(methylthio)-N-propylbutanamide 77b – (S)-81 
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(S)-2-Amino-4-methyl-N-propylpentanamide 77c – (R)-81 
 
(S)-2-Amino-4-methyl-N-propylpentanamide 77c – (S)-81 
 
173 
 
(S)-2-amino-3-methyl-N-propylbutanamide 77k – (R)-81 
 
(S)-2-amino-3-methyl-N-propylbutanamide 77k – (S)-81 
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(S)-2-Amino-N-propylpropanamide 77l – (R)-81 
 
(S)-2-Amino-N-propylpropanamide 77l – (S)-81 
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7.4.  Appendix 4 – NMR study spectra 
 1H-NMR study 
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13C-NMR study 
 
 
 
  
178 
 
 
  
179 
 
19F-NMR study
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11B-NMR study
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